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Although much is known about food-drug interaction and its impact on the clinical 
outcome of a therapeutic drug, spice-drug interactions remain relatively unexplored 
despite the widespread use of spices on a daily basis by different people groups. The 
hypothesis for this project was that spices consumed as food supplements could affect 
oral drug bioavailability by interfering with intestinal drug transport. 
 
To prove our hypothesis, a series of spices commonly encountered in the South East 
Asian diet, i.e. piperine (active component of pepper), capsaicin (active component of 
chilli), the garlic derivatives, diallylsulfide (DAS) and diallyldisulfide (DADS), garlic 
aqueous extract and ginger ethanol extract, spices, were screened for their potential to 
modulate oral drug bioavailability.  MTT assay results showed that the garlic aqueous 
extract at concentrations higher than 4 mg/ml and the ginger ethanolic extract at ≥ 60 
mg/ml were cytotoxic against the Caco-2, LLC-PK1 and L-MDR1 cells. Capsaicin at ≥ 
500 µM was also cytotoxic towards the Caco-2 cells. In contrast, DAS (up to 300 µM), 
DADS (up to 300 µM) and piperine (up to 500 µM) did not affect the viability of the 3 
cell lines. Bi-directional [3H]-digoxin transport data across the polarized L-MDR1 cell 
monolayers indicated that the P-gp function was inhibited by sub-cytotoxic 
concentrations of piperine and capsaicin, with both spices capable of producing 
comparable inhibitory activity as the established P-gp inhibitor, verapamil. Both spices 
also modulated the paracellular transport of [14C]-mannitol across the Caco-2 cell 
monolayers. Although the ginger extract showed potential inhibitory action on the P-gp, 
its activity was significantly weaker. Garlic extract and its constituents, DAS and DADS, 
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also modified digoxin transport, but not in a manner consistent with a P-gp inhibitor. On 
the basis of these results, piperine and capsaicin were selected for further experimentation. 
 
To delineate the action of the spices on the P-gp transporter, the cytotoxicity of piperine 
and capsaicin, as well as their effects on the paracellular transport pathways, were 
evaluated upon prolonged cellular exposure. MTT assay showed that the proliferation of 
Caco-2, LLC-PK1 and L-MDR1 cells was inhibited by 72h of co-incubation with 
piperine and capsaicin at 50 and 100 µM, concentrations which were non-cytotoxic upon 
short-term contact with the cells. The two spices exhibited greater anti-cell proliferation 
activity at higher concentrations and longer co-incubation times. Cell cycle analysis 
showed the accumulation of cells at the G1/G0 phase but, compared to established cell 
cycle modulators, piperine and capsaicin could only be regarded to have modest effects 
on the cell cycle progression of the 3 epithelial cell lines evaluated. 
 
Concurrent exposure to piperine or capsaicin enhanced the paracellular transport of [14C]-
mannitol across the polarized Caco-2 cell monolayers. AB and BA mannitol Papp values 
were increased by 2.2 and 1.4 fold, respectively, by 100 µM of piperine, while capsaicin 
at the same concentration caused a 1.5-fold increase in both AB and BA mannitol Papp 
values. These effects were intensified by co-culturing the cell monolayers with either 
spice for 18 days prior to the transport experiments. Interestingly, the spices had to be 
present during the transport experiments, as spice removal from pre-exposed cell 
monolayers just prior to the transport experiments reduced the mannitol Papp values to 
levels comparable with those for unexposed cells. The mechanism underlying the spice 
 IX
action had not been determined with certainty, but the tight junction proteins, ZO-1, 
occludin and F-actin, were unlikely to play major roles. Immunostaining of the Caco-2 
cells revealed marginal changes in F-actin distribution by piperine and capsaicin, and in 
ZO-1 distribution by piperine. However, western blot analysis of Caco-2 cell monolayers 
cultured on TranswellTM inserts showed no change in ZO-1, occludin and actin 
expressions.  
 
Another study conducted on Caco-2 cell monolayers showed piperine and capsaicin to 
have very similar effects on P-gp expression and activity in vitro. This study was novel, 
because the biological activities of piperine and capsaicin have rarely been compared in 
parallel experiments despite their remarkably similar chemical structures. Exposure of the 
Caco-2 cells to piperine or capsaicin at 50 or 100 µM for 4 h resulted in lower P-gp 
efflux activity, whereas a prolonged exposure of 48 or 72 h to either spice led to an up-
regulation of cellular P-gp expression accompanied by enhanced P-gp efflux activity. 
Western blot results indicated that capsaicin was a weaker P-gp protein inducer, although 
the resultant changes in bi-directional [3H]-digoxin transport profile produced by 
equivalent doses of capsaicin and piperine were comparable. Real-time PCR analysis 
demonstrated a concomitant up-regulation of the MDR1 mRNA level in the cells, 
suggesting a transcriptional mechanism by both spices.  
 
A study involving male Wistar rats was subsequently conducted to evaluate whether a 
prolonged consumption of piperine and capsaicin would modify tissue P-gp expression 
under the complex in vivo conditions. Western blot analysis indicated that the intragastric 
 X
administration of 112 µg/kg/day of piperine for 14 consecutive days increased the rodent 
P-gp protein level in the ileum and reduced the P-gp level in the liver. The rat kidney P-
gp level was, however, unaffected. In comparison, the intragastric administration of 128 
µg/kg/day of capsaicin for 14 days down-regulated both the rat liver and kidney P-gp 
levels, but did not significantly change the rat intestinal P-gp level. The changes in rodent 
tissue P-gp levels could not be correlated with the mdr1a mRNA levels, determined by 
RT-PCR analyses, suggesting a post-transcriptional modulation of the P-gp protein 
expression. These results differed from the in vitro data, probably reflecting the species 
difference in the cells studied and the influences of the absorption, distribution, 
metabolism and elimination processes on spice activity. The findings, however, 
underscore the scope for further experimentation, as the doses of piperine and capsaicin 
administered to the rats were equivalent to those consumed by human populations that 
used pepper and chilli liberally in their diets. However, it will be prudent to investigate 
the influence spice consumption may have on drug absorption and disposition profiles in 
human subjects until conclusive statements can be made about spice-drug interactions. In 
the meantime, caution is urged when potent drugs which are P-gp substrates are to be 
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50 or 100 μM of piperine for 72h were cultured for another 3 days in the 
absence of piperine. P-gp protein level was determined by western blot 
using C219 as primary antibody. β-actin was used to confirm equal 
protein loading. Upper bands, P-gp; lower bands, β-actin. From left to 
right, control (culture medium), piperine 50 µM treated cells, piperine 100 
µM treated cells. The result of one typical experiment out of three is 
shown. The bar graph shows the quantification of band intensity; Con, 
control; P 50, piperine 50 µM; P 100, piperine 100 µM. Data are 
expressed as mean ± S.E.M. (n=3). *, significantly different from control 
group (p<0.05). 130 
 
5.5 Reversibility of P-gp up-regulation by capsaicin. Caco-2 cells exposed to 
50 or 100 μM of capsaicin for 72h were cultured for another 3 days in the 
absence of piperine. P-gp protein level was determined by western blot 
using C219 as primary antibody. β-actin was used to confirm equal 
protein loading. Upper bands, P-gp; lower bands, β-actin. From left to 
right, control (culture medium), capsaicin 50 µM treated cells, capsaicin 
100 µM treated cells. The result of one typical experiment out of three is 
shown. The bar graph shows the quantification of band intensity; Con, 
control; C 50, capsaicin 50 µM; C 100, capsaicin 100 µM. Data are 
expressed as mean ± S.E.M. (n=3). *, significantly different from control 
group (p<0.05). 131 
 
6.1 Histological staining of intestinal tissues (A, duodenum; B, jejunum and C, 
ileum) harvested from rats administered intragastrically with vehicle 
(Upper row) and piperine at a dose of 112 µg/kg (Lower row) for 14 days. 
One representative tissue slide out of 5 is shown. 146 
 
6.2 Histological staining of rat intestine (A, duodenum; B, jejunum and C, 
ileum) harvested from rats administered intragastrically with vehicle 
(Upper row) and capsaicin at a dose of 128 µg/kg (Lower row) for 14 days. 
One representative tissue slide out of 5 is shown. 146 
 
 
6.3 Expression of P-gp protein in the ileum of rats administered 
intragastrically with vehicle (control, n=4) and piperine at a dose of 112 
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µg/kg (treated, n=4) once daily for 14 consecutive days. Rats were 
sacrificed on day 15. Proteins were determined by western blot using 
C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, 
quantification of band intensity; data are expressed as mean ± S.E.M. 
(n=4). *, significantly different from control group (p<0.05). 148 
 
6.4 Expression of P-gp protein in the ileum of rats administered 
intragastrically with vehicle (control, n=4) and capsaicin at a dose of 128 
µg/kg (treated, n=4) once daily for 14 consecutive days. Rats were 
sacrificed on day 15. Proteins were determined by western blot using 
C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, 
quantification of the band intensity; data are expressed as mean ± S.E.M. 
(n=4). *, significantly different from control group (p<0.05). 149 
 
6.5 Expression of P-gp protein in the liver of rats administered intragastrically 
with vehicle (control, n=4) and piperine at a dose of 112 µg/kg (treated, 
n=4) once daily for 14 consecutive days. Rats were sacrificed on day 15. 
Proteins were determined by western blot using C219 as primary antibody. 
A, immunoblots. Upper bands, P-gp; lower bands, β-actin. Left 4 lanes, 
control; right 4 lanes, treated group. B, quantification of the band intensity; 
data are expressed as mean ± S.E.M. (n=4). *, significantly different from 
control group (p<0.05). 150 
 
6.6 Expression of P-gp protein in the liver of rats administered intragastrically 
with vehicle (control, n=5) and capsaicin at a dose of 128 µg/kg (treated, 
n=5) once daily for 14 consecutive days. Rats were sacrificed on day 15. 
Proteins were determined by western blot using C219 as primary antibody. 
A, immunoblots. Upper bands, P-gp; lower bands, β-actin. Left 5 lanes, 
control; right 5 lanes, treated group. B, quantification of the band intensity; 
data are expressed as mean ± S.E.M. (n=5). *, significantly different from 
control group (p<0.05). 151 
 
6.7 Expression of P-gp protein in the kidney of rats administered 
intragastrically with vehicle (control, n=4) and piperine at a dose of 112 
µg/kg (treated, n=4) once daily for 14 consecutive days. Rats were 
sacrificed on day 15. Proteins were determined by western blot using 
C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, 
quantification of the band intensity; data are expressed as mean ± S.E.M. 
(n=4). 152 
 
6.8 Expression of P-gp protein in the kidney of rats administered 
intragastrically with vehicle (control, n=4) and capsaicin at a dose of 128 
µg/kg (treated, n=4) once daily for 14 concecutive days. Rats were 
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sacrificed on day 15. Proteins were determined by western blot using 
C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, 
quantification of the band intensity; data are expressed as mean ± S.E.M. 
(n=4). *, significantly different from control group (p<0.05). 153 
 
6.9 Expression of mdr1a in the intestine of rats administered intragastrically 
with vehicle (control, n=4) and piperine at a dose of 112 µg/kg (treated, 
n=4) once daily for 14 concecutive days. Rats were sacrificed on day 15. 
mdr1a level were determined by RT-PCR using β-actin as control. A, RT-
PCR bands from duodenum; B, RT-PCR bands from jejunum; C, RT-PCR 
bands from ileum. Upper bands, P-gp; lower bands, β-actin. Left 4 lanes, 
control; right 4 lanes, treated group. D, quantification of the band intensity; 
data are expressed as mean ± S.E.M. (n=4). 155 
 
6.10 Expression of mdr1a in the intestine of rats administered intragastrically 
with vehicle (control, n=4) and capsaicin at a dose of 128 µg/kg (treated, 
n=4) once daily for 14 concecutive days. Rats were sacrificed on day 15. 
mdr1a level were determined by RT-PCR using β-actin as control. A, RT-
PCR bands from duodenum; B, RT-PCR bands from jejunum; C, RT-PCR 
bands from ileum. Upper bands, P-gp; lower bands, β-actin. Left 4 lanes, 
control; right 4 lanes, treated group. D, quantification of the band intensity; 
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1.1  Oral drug bioavailability  
The oral route represents the most common and acceptable means for drug administration 
to the human body. Drugs that are orally administered are generally absorbed from the 
gastrointestinal (GI) tract into the systemic circulation. The bioavailability of an orally 
administered drug is the fraction of the drug dose that reaches the general circulation 
unchanged. 
 
Oral drug bioavailability is influenced by a variety of factors that lead to intra- and inter-
individual variability in drug response. The influencing factors can be broken down into 
components that affect drug delivery to the intestine (gastric emptying rate, pH), drug 
absorption from the intestinal lumen (dissolution rate, lipophilicity, particle size and 
preferred absorption pathway of drug), drug metabolism (enzymes in intestinal lumen and 
enterocytes, first pass hepatic extraction, enterohepatic circulation), and active extrusion 
of drug from enterocytes into the lumen (drug efflux pumps). Among these factors, the 
effective passage of drug across the intestinal epithelial, and the intestinal phase І 
metabolism and active extrusion of absorbed drug have been recognized as the major 
determinants of oral drug bioavailability (Kim et al., 1999).  
 
Among the extrinsic factors that can affect oral drug bioavailability, food is regarded to 
play a major role. Food can interact with a co-administered drug before and after GI 
absorption, as well as during the distribution, metabolism and elimination phases. Several 
dietary constituents and phytochemicals, e.g. charcoal-broiled or smoked meat (Conney 
et al., 1976), cruciferous vegetables (Ji and Morris, 2005), high salt content (Darbar et al., 
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1997) and grapefruit juice (Lown et al., 1997), have been reported to affect drug 
disposition. Health supplements, e.g. St. John’s wort (Durr et al., 2000), garlic (Reicks 
and Crankshaw, 1996) and piperine (Bano et al., 1991) have also been shown over the 
last few years to affect oral drug bioavailability in human and animal models. St John’s 
wort can induce the expression of the cytochrome P450 3A4 (CYP3A4) enzyme and P-
glycoprotein (P-gp) efflux drug transporter in the rat and human intestines by activating 
the pregnane X receptor (Durr et al., 2000). This in turn caused the plasma concentration 
of clinically important drugs, such as cyclosporine, HIV protease inhibitors and digoxin, 
to be significantly reduced when they were co-administered with the herb (Henderson et 
al., 2002). Grapefruit juice, on the other hand, has been shown in clinical studies to 
increase the plasma concentration of many drugs by inhibiting the intestinal CYP3A4 
metabolic activity (Becquemont et al., 2001; Lown et al., 1997). Apart from these two 
well-known examples, however, the mechanisms involved in other food-drug interactions 
remained to be evaluated.  
 
In this project, we have chosen to focus on spice-drug interactions because spices are 
widely consumed in Asian populations, yet spice-drug interactions remained poorly 
understood. In the following chapters, the processes that affect oral drug bioavailability 
will be elaborated. The mechanisms of drug absorption and the membrane proteins 
involved in intestinal drug transport will be discussed. In addition, brief descriptions of 
the spices of interest, as well as published data on their biological activity, are provided 
to rationalize our study. 
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1.2   Oral drug absorption 
The human GI tract consists of the mouth, throat (pharynx), esophagus, stomach, small 
and large intestines. The small intestine is the organ where most digestion and absorption 
of xenobiotics take place. Its primary function is to extract from its luminal contents 
needed nutrients, electrolytes, minerals and water, while at the same time excluding 
bacteria, antigens and toxins. The small intestine can be separated into the three regions 
of duodenum, jejunum and ileum based on morphological and structural characteristics. 
The pH of the duodenum is 6 to 6.5, and the majority of nutrients, vitamins and drugs are 
absorbed in this 6-inch area of the GI tract. Beyond the duodenum are the jejunum and 
ileum, which lack the high surface area of the duodenum. The pH rises to about 7.5 in 
this region, and only small amounts of xenobiotics are absorbed across the lipid 
membranes in this section. 
 
The small intestine is morphologically and functionally differentiated to mediate and 
regulate solute and fluid exchange between the intestinal lumen and the general 
circulation. Its anatomy provides for a very large surface area which is highly perfused 
with blood to facilitate the process of absorption. The epithelium is composed of many 
finger-like projections, known as villi, which extensively amplify the surface area of the 
small intestine. The villi and crypts provide the machinery for enterocyte production, 
maturation and replacement. The villi further extend into projections called microvilli, 
which made up the brush border membrane of the enterocytes. The brush border further 
amplifies the intestinal surface and, along with the glycocalyx, provides a specialized 
microenvironment at the cell-lumen interface. At the cellular and molecular levels, the 
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enterocytes present with non-symmetry in the apical (luminal) and basolateral (serosal or 
abluminal) membranes, named respectively for the membranes facing the gut lumen and 
blood. The polarized distribution of cellular structure and function is essential for the 
support of vectorial solute and fluid transport. The gaps between the enterocytes are 
plugged by tight junctions, which are selectively permeable structures at the apical pole 
that prevent unregulated leakage across the epithelium. At the molecular level, elaborate 
arrays of specific plasma membrane transporters are expressed at the apical and 
basolateral membranes to facilitate xenobiotic entry and exit from the enterocytes, as well 
as sustain transepithelial transport.  
 
The intestinal epithelial barrier is contributed by a cellular component and a paracellular 
component. The cellular component comprises of the luminal and abluminal cell 
membranes, while the paracellular component is the pathway between adjacent 
enterocytes. Transport of small hydrophilic molecules by diffusion along the paracellular 
route is restricted by the junctional complex and the lateral intercellular spaces. The 
junctional complex is made up of the tight junctions, adherens or intermediate junctions, 
desmosomes, and gap junctions. Among them, the tight junction is the most important 
component for restricting the passage of small solutes through the paracellular pathway. 
Translocation of a molecule across the cellular barrier can occur by several routes, 
generally classified as passive diffusion, carrier-mediated transport, endocytosis and 
pinocytosis.  
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1.2.1  Passive diffusion 
Passive diffusion refers to the transport of a solute down a concentration or 
electrochemical gradient without the assistance of a transport protein or the expenditure 
of energy. Drug molecules can traverse the intestinal epithelium by passive diffusion 
either through the enterocyte (transcellular route) or through the intercellular tight 
junction (paracellular route). The properties of the permeant and the cellular barrier 
determine which route predominates. In principle, the paracellular route can be used by 
all solutes, but access is often severely limited by the small radius of the intercellular pore, 
which is estimated to be between 3 and 13 Å (Fordtran et al., 1965; Fine et al., 1995). 
Consequently, this route is not considered to play a major role in drug absorption except 
for the transport of hydrophilic compounds with molecular weight (MW) lower than 500 
Da (He et al., 1998). Most drugs that are transported by passive diffusion across the 
intestinal epithelia will traverse the cellular membranes.  
 
The process of transcellular passive diffusion is believed to include the partitioning of the 
permeant between the contents of the GI lumen and the lipid bilayer of the enterocyte. 
Rate of transport is defined by the Fick’s Law (Benet, 1973):  
V = PA·ΔC = (DK/h) A·ΔC 
where V is the transport rate; A, the surface area; ΔC, the concentration difference across 
the membrane; D, the solute diffusivity across the membrane; K, the solute partition 
coefficient between the membrane and aqueous compartment; and h is the membrane 
thickness. Permeability (P) via the transcellular route is a function of the partition 
coefficient (K) parameter, which depends on drug lipophilicity and size;  drug diffusivity 
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(D), which is influenced by solute size and membrane composition; and the membrane 
thickness (h).  
 
Fick’s law is also applied to describe the rate of transport of a solute by passive diffusion 
along the paracellular route. In this case, solute permeability (P) is a function of its 
diffusivity (D), which in turn is dependent on solute charge and size, as well as on the 
drag force acting on the solute.  
 
In either case, the passive absorption process is predominantly governed by the 
concentration gradient of the permeant across the luminal and basal membranes. The rate 
of transport is often directly proportional to the gradient. Transport of solute by passive 
diffusion is not usually saturable or inhibited by other drugs unless the physical 
properties of the drug or the plasma membrane are affected in some way. Drug 
movement over short distances by diffusion is rapid, but diffusion across biological 
membranes may be slow.  
 
1.2.2  Carrier-mediated transport 
Some compounds that are not absorbed effectively by passive diffusion because they are 
present at very low concentrations and/or are too hydrophilic are, however, effectively 
translocated across the intestinal barrier by carrier-mediated transport. Carrier-mediated 
transport processes involve a membrane-bound carrier and are classified into active and 
facilitated transport. 
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Facilitated transport refers to solute translocation along an electrochemical gradient via a 
membrane protein carrier (Teichmann and Stremmel, 1990). It does not utilize biological 
energy but is saturable at high solute concentrations. This process is competitively 
inhibited by chemically and sterically similar substrates (Gore and Hoinard, 1987). It can 
also be inhibited by unrelated compounds that react with or bind to reactive groups in the 
carrier protein (Strugala et al., 2000). The rate of transport follows the Michaelis-Menten 
type equation:  
                  Vmax [S] 
      ([S] + Km) 
 
where V = rate of transport; [S] = solute concentration; Vmax = maximum transport rate; 
and Km = solute-carrier affinity. 
 
Active transport refers to the transport of a solute, often against its concentration gradient, 
via a membrane protein carrier which is coupled, either directly or indirectly, to a 
metabolic energy source (Neale and Wiseman, 1968). Like the protein carriers involved 
in facilitated diffusion, active transporters may serve as uniporters (carriers or channels 
that transport only one substrate) (Kakuda and MacLeod, 1994), symporters (also known 
as co-transporters, these simultaneously transport two substances by using the 
concentration gradient of one solute to transport the other solute against its concentration 
gradient) (Dai et al., 1996) or antiporters (also known as counter-transporters, these 
simultaneously transport two substances across the membrane in opposite directions) 
(Burdo et al., 2006). Active transport is characterized by high substrate specificity (Burdo 
et al., 2006), and the rate of transport is attenuated at low temperature. The active 
V =
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transport rate also follows the saturable transport kinetics defined by the Michaelis-
Menten type equations. 
 
 
Figure 1.1 Multiple pathways for the intestinal absorption of a compound: (1) passive, 
transcellular; (2) active; (3) facilitated diffusion; (4) passive, paracellular; (5) absorption 
limited by P-gp and/or other efflux transporters; (6) intestinal first-pass metabolism 
followed by absorption of parent and metabolite; and (7) receptor-mediated transport. 
(Balimane et al., 2006) 
 
Apart from being transported into cells, a variety of substrates can be actively transported 
out of cells by membrane protein carriers (Funakoshi et al., 2003). This process, called 
active efflux, is believed to play a critical physiological role in limiting the absorption 
and accumulation of potentially toxic substances (De Angelis et al., 2005). However, it 
also confers resistance to a diverse range of therapeutic agents in diseased and cancerous 
tissues, where the extent of intracellular drug accumulation is limited not so much by the 
ability of the drug to enter the cells but by its tendency to leave (Funakoshi et al., 2003). 
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Like other active transport mechanisms, the efflux transport processes are saturable, and 
can be inhibited by structurally similar and diverse solutes. 
 
1.3  Intestinal drug transporter systems 
1.3.1 Introduction 
A wide variety of transporters are located in the brush border and basolateral membranes 
of the intestine. Some of these transporters facilitate drug absorption whereas others work 
as efflux pumps to hinder drug absorption. Each transporter exhibits peculiar substrate 
specificity; with some having broader specificities than others. The distribution and 
characteristics of the transporters also exhibit regional differences along the intestine, 
suggesting their diverse physiological functions and, in some cases, pathological 
responses (Iida et al., 2005).  
 
Peptide transporters Peptide transporters mediate the H+-coupled active transport of di- 
or tripeptides across the brush-border membrane of the small intestine. The acidic 
luminal pH generated by the Na+/H+ exchanger in the brush-border membrane serves as 
the driving force for the transport of the small peptides. PEPT-1 (Fei et al., 1994) is 
perhaps the best known of the intestinal peptide transporters. PEPT-1 has been targeted as 
a gateway for enhancing oral drug delivery (Foltz et al., 2004) because of its capacity to 
also mediate the transport of peptide-like drugs, such as the β-lactam antibiotics 
(Okamura et al., 2003). 
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Organic cationic transporters (OCT) The OCT transporters are members of the organic 
ion transporter super-family (SLC22), and they facilitate the transport of a variety of 
structurally diverse organic cations, including drugs (Biermann et al., 2006) and 
endogenous compounds (Gründemann et al., 1998). OCT1 was the first member to be 
cloned from the rat kidney in 1994 (Gründemann et al., 1994). Subsequently, OCT2 
(Gorboulev et al., 1997) and OCT3 (Kekuda et al., 1998; Gründemann et al., 1998) were 
cloned and characterized. OCT1 and OCT2 are expressed in the basolateral membrane of 
hepatocytes, enterocytes, and renal proximal tubular cells (Urakami et al., 1998), while 
OCT3 has a more widespread tissue distribution that includes the placenta (Kekuda et al., 
1998). On the basis of their distribution pattern and substrate specificity, the OCT is 
postulated to participate in the tissue uptake of endogenous and exogenous compounds in 
the body. This has been demonstrated in OCT1 knockout mice, where the metformin 
concentration in the liver was 30-fold lower than that in normal mice (Wang et al., 2002). 
However, as the OCT3 could also facilitate drug uptake into the heart (Gründemann et al., 
1998) and across the placenta (Zwart et al., 2001), the full spectrum of physiological 
functions performed by these transporters remains to be established. 
 
Organic anionic transporters The absorption of anionic drugs has, for a long time, been 
explained on the basis of the pH-partition theory, and attributed to the passive diffusion 
of non-ionized species generated in the intestinal lumen. Recent studies have, however, 
demonstrated the involvement of transporters in the intestinal absorption of weak organic 
acids. Such transporters include members of the organic anion transporter (OAT) family, 
organic anion transporting polypeptide (OATP) family and monocarboxylic acid 
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transporter (MCT) family. The MCT has been found to mediate the transport of various 
short-chain fatty acids (Halestrap and Price, 1999), whereas the OAT and OATP could 
participate in the cellular uptake of a large number of chemically divergent substrates, 
such as bile acids (Marin et al., 2003), prostaglandins (Taogoshi et al., 2005), digoxin 
(Sugiyama et al., 2001), methotrexate (Takeuchi et al., 2001), and rifampicin (Hirano et 
al., 2006). OAT family members were found extensively in the liver (Kobayashi et al., 
2005) and kidney (Habu et al., 2003). In contrast, the OATPs are expressed in many 
tissues, including the blood-brain barrier (Taogoshi et al., 2005), choroid plexus (Ohtsuki 
et al., 2003), lung (Jacquemin et al., 1994), heart (Adachi et al., 2003a), intestine 
(Dresser et al., 2002; Hagenbuch and Meier, 2004), liver (Kullak-Ublick et al., 2001), 
kidney (Cheng et al., 2005), placenta (Cheng et al., 2005), and testes (Adachi et al., 
2003a). Thus far, 11 human isoforms of the OATP family (Mikkaichi et al., 2004) and 4 
human isoforms of the OAT family (Xu et al., 2005) have been identified. Although their 
physiological functions remain to be verified, the wide-spread distribution and broad 
substrate specificity of the OATPs and OATs underscore their important roles in drug 
absorption and disposition. 
 
ABC transporters The ABC transporters refer to the ATP-binding cassette family of 
transporter proteins often associated with tumor cells that exhibit multi-drug resistance 
(MDR). MDR is mediated by the transporters actively maintaining the intracellular drug 
level below the cell-killing threshold by expelling drug molecules out of the cells, the 
extrusion process being driven by the energy of ATP hydrolysis (Ambudkar et al., 1992). 
Notwithstanding the association with tumor cells (Cole and Deeley, 2002; Leslie et al., 
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2005), the ABC transporters are believed to play essential roles in drug absorption, 
distribution and elimination because of their widespread distribution in normal tissues, 
particularly in absorptive epithelia, and broad substrate specificity (Cordon-Cardo et al., 
1990). 
 
The P-glycoprotein (P-gp), a 170-kDa transmembrane protein, is perhaps the best known 
of the ABC transporters (Ambudkar et al., 1999). This transporter is expressed in tumor 
cells and normal tissues (Cordon-Cardo et al., 1990; Thiebaut et al., 1987), and is widely 
used as a model to study the interactions between ABC transporters and xenobiotics. 
Another ABC protein distantly related to the P-gp is the 190-kDa multi-drug resistance 
protein 1 (MRP1, encoded by ABCC1). Other members that have been discovered and 
cloned include the MRP2 (encoded by ABCC2), MRP3 (ABCC3), MRP4 (ABCC4), 
MRP5 (ABCC5), MRP6 (ABCC6), MRP7 (ABCC10), MRP8 (ABCC11), and MRP9 
(ABCC12) (Cole et al., 1992; Evers et al., 1998; Kool et al., 1997; Beck et al., 2005; 
Hopper et al., 2001; Bera et al., 2001; Bera et al., 2002). Unlike the P-gp and MRP1, the 
clinical relevance of MRP2 to 9 in anticancer drug resistance has yet to be determined. 
Another ABC transporter of clinical interest is the breast cancer resistance protein (BCRP, 
encoded by ABCG2), so named because it was first isolated from a multi-drug-resistant 
breast cancer cell line devoid of P-gp-mediated drug efflux (Bates et al., 2001; Doyle et 
al., 1998). Subsequent studies have since established the expression of BCRP in normal 
tissues, including the intestine (Gutmann et al., 2005) and human stem cells (Zhou et al., 
2001), suggesting a broad physiological role.  
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There is partial differentiation in substrate specificity amongst the ABC transporters. The 
P-gp transports a diverse range of uncharged and positively charged compounds, 
including cytotoxic (Zhu et al., 2005) and non-toxic (van der Sandt et al., 2000) agents. 
In contrast, the substrates of the MRP subfamily include amphiphilic anionic agents 
(Hooijberg et al., 1999) and anionic conjugates (Depeille et al., 2004). The spectrum of 
ABCG2 substrates has not yet been explored in detail (Sarkadi et al., 2004). However, 
some chemotherapeutic agents, such as vincristine (Mercier et al., 2003), were found to 
be transported by more than one ABC members, suggesting an overlap in substrate 
specificity. 
 
Given the plethora of drug transporters that have been, and continued to be, discovered, it 
was necessary to focus on a specific protein transporter to generate mechanistic data on 
spice-drug interactions. For this project, we had singled out the P-gp for further study 
because it is well characterized, and has an established role in MDR in cancer 
chemotherapy and in clinically important drug-drug interactions. 
 
1.3.2  The P-glycoprotein (P-gp) 
The P-gp was first identified by Juliano and Ling as a surface phosphorylated 
glycoprotein expressed in drug-resistant Chinese hamster ovary cells (Juliano and Ling, 
1976). Since then, two members of the P-gp gene family (MDR1 and MDR2) have been 
found to exist in human and three members (mdr1a, mdr1b and mdr2) in mice (Schinkel, 
1997; Gottesman and Pastan, 1993). The human MDR1 and rodent mdr1a/1b were 
identified to encode the P-gp functioning as a drug efflux transporter, whereas the P-gp 
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associated with the human MDR2 (formerly known as MDR3) and mouse mdr2 were 
initially believed to be involved in phospholipid transport (van Helvoort et al., 1996; 
Ruetz and Gros, 1994). Smith et al. (Smith et al., 2000) have, however, observed an 
increased directional transport of digoxin, paclitaxel and vinblastine across polarized 
monolayers of MDR2-transfected cells, suggesting that the MDR2 P-gp was also able to 
transport a range of drugs in addition to phospholipids. In the following paragraphs, the 
current knowledge regarding the P-gp and its role in drug absorption, distribution, 
metabolism and excretion are discussed. In addition, the potential for P-gp-mediated 
drug-drug interactions and the associated clinical implications are elaborated. 
 
1.3.2.1  Structure and mechanistic model 
The P-gp is a phosphorylated and glycosylated protein made up of 1280 amino acids. It 
consists of two membrane-spanning domains (MSD) and two nucleotide-binding 
domains (NBD) (Germann, 1996) (Figure 1.2). Each of the MSD contains six 
hydrophobic transmembrane segments which form pore-like structures (Rosenberg et al., 
1997). The intracellular hydrophilic NBD is also the ATP-binding domain and it exhibits 
significant ATPase activity (Ambudkar et al., 1992). Site-directed mutagenesis and 
antibody mapping studies suggest that the two cassettes of human P-gp interact 
cooperatively to form a single functional unit (Loo and Clarke, 1994; Mnller et al., 1996). 
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Figure 1.2 Schematic diagram showing the transmembrane arrangement of P-
glycoproteins (Leslie et al., 2005). 
 
Despite extensive investigations on the mechanistic model of the P-gp over the past 
decade (Ford and Hait, 1990; Higgins and Gottesman, 1992), scientists have yet to agree 
on a functioning model. The accumulated literature data suggest that ATP binding and 
hydrolysis are essential for the functioning of the P-gp, and that one molecule of drug is 
expelled at the expense of two ATP molecules (Gottesman and Pastan, 1993). There is 
evidence that the drug-binding sites are scattered throughout the transmembrane domains, 
intracellular loops, and even the ATP-binding domains of the P-gp molecule (Qu and 
Sharom, 2002). Others have suggested that the catalytic cycle is a complicated process, 
where the drug and nucleotide binding sites coordinately function to extrude the 
substrates by an ATP-driven energy-dependent process (Sauna et al., 2001).  
 
1.3.2.2  P-gp substrates 
A distinguishing feature of the P-gp is its ability to recognize and transport a broad 
spectrum of structurally unrelated drugs with dissimilar intracellular targets, and with 
MW ranging from 250 (cimetidine) to 1202 (cyclosporine) Da (Pan et al., 1994; Wu et al., 
1995). Drugs transported by the P-gp have been shown to include cytotoxics produced by 
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fungi or plants, such as the anthracyclines (Kubota et al., 2001), vinca alkaloids 
(Cisternino et al., 2003) and paclitaxel (Taub et al., 2005); peptide antibiotics, such as 
gramicidin D (Kondratov et al., 2001) and valinomycin (Nagy et al., 2001); steroid 
hormones, such as cortisol (Farrell et al., 2002); immunosuppressive agents, such as 
cyclosporine A (Qadir et al., 2005); and calcium channel blockers, such as verapamil 
(Johnson et al., 2003). These substrates share few common features except that they are 
hydrophobic or amphipathic molecules, suggesting that substrate partitioning into the 
lipoidal cell membrane is a prerequisite for P-gp interaction. 
 
Several structure-activity relationship studies have indeed concurred that the lipophilicity 
and hydrogen bonding capacity of a compound are important parameters for determining 
its P-gp binding affinity (Chiba et al., 1998; Ecker et al., 1999; Seelig and 
Landwojtowicz, 2000). Seelig (Seelig, 1998b) further proposed the presence of electron 
donor (hydrogen bond acceptor) groups to be an essential feature, while others 
emphasized the surface area and amphiphilic characteristic of the substrate (Osterberg 
and Norinder, 2000). Taken together, it appears that the main determinant of P-gp 
specificity is the ability of the substrate to intercalate with the lipid membrane bilayer, 
and as this is readily met by substrates having the appropriate amphiphilicity, it may 
explain the unusually broad substrate specificity of the P-gp. Such broad specifications 
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1.3.2.3  P-gp inhibitors 
P-gp inhibitors refer to the chemicals, including P-gp substrates, which can selectively 
interfere with P-gp efflux function. The proposed mechanisms can be generalized into 
three types: (a) blockade of drug binding sites (Tsuruo et al., 1981); (b) interference of 
ATP hydrolysis (Shapiro and Ling, 1997); and (c) alteration of cell membrane integrity 
(Drori et al., 1995). Compounds that inhibit ATPase activity, e.g. quercetin (Shapiro and 
Ling, 1997), can be advantageous as inhibitors as they are unlikely to be transported by 
the P-gp, and are effective at low doses. However, as the detailed mechanism of 
inhibition for these agents has not been elucidated, any consideration for clinical 
application is premature at this juncture. Pharmaceutical surfactants, e.g. polyethylene 
glycol, cremophor EL and Tween 80 (Hugger et al., 2002b; Hugger et al., 2002a), have 
recently been characterized as a class of P-gp inhibitors that act by changing the 
secondary and tertiary structures of membrane lipids. Despite their approval for use in 
pharmaceutical formulations, these surfactants may not be ideal P-gp inhibitors because 
they lack specificity for the P-gp transporter. Moreover, there is only limited in vitro data 
to date on the surfactant-mediated inhibition of the P-gp. 
 
Most of the known P-gp inhibitors work by blocking the drug binding sites, which 
presents opportunities in MDR reversal in cancer chemotherapy (Ford and Hait, 1990). 
However, as the P-gp is also extensively expressed in normal tissue and is enrolled in 
drug absorption and disposition, the indiscriminate use of such P-gp inhibitors is to be 
discouraged (Chen et al., 1999b). Based on specificity and affinity, these P-gp inhibitors 
can be classified into three groups. First-generation inhibitors are pharmacological 
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actives which are in clinical use for other indications but have been shown to inhibit the 
P-gp. These include the calcium channel blockers (e.g. verapamil) (Tsuruo et al., 1981), 
immunosuppressants (e.g. cyclosporin A) (Slater et al., 1986), anti-hypertensives (e.g. 
quinidine) (Evers et al., 1998) and antiestrogens (e.g. tamoxifen and toremifena) (Kirk et 
al., 1994). The usage of these compounds is limited by their toxicity due to the high 
concentrations required to inhibit the P-gp. Second-generation modulators are agents that 
lack the pharmacological activity of the first-generation compounds and usually possess a 
higher P-gp affinity. Some of them are derivatives of the first generation inhibitors, e.g. 
the non-immunosuppressive analogues of cyclosporin A (PSC 833) (Twentyman and 
Bleehen, 1991), D-isomer of verapamil (dexverapamil) (Wilson et al., 1995); and others 
(biricodar (Peck et al., 2001), GF120918 (Hyafil et al., 1993) and MS-209 (Terao et al., 
1996)). However, this class of compounds tends to inhibit two or more ABC transporters, 
which can lead to complex drug–drug interactions. Several novel third-generation P-gp 
blockers are under development to improve the treatment of multi-drug resistant tumors. 
Modulators, such as LY335979 (Rubin et al., 2002) and XR9576 (Walker et al., 2004), 
have been identified as highly selective P-gp inhibitors with a 10-fold higher potency 
than the first- and second-generation inhibitors. The clinical application of these 
inhibitors has yet to be validated. 
 
Apart from the synthetic and semi-synthetic chemicals, several natural products, e.g. fruit 
juices (Xu et al., 2003) and green tea (Jodoin et al., 2002), have also been shown to 
modulate the P-gp function. Although there is scant clinical data on these products, and 
their mechanisms of inhibition remain to be clarified, research in this area has intensified 
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in recent years because natural products are generally regarded to have better toxicity 
profiles than the synthetic compounds. 
 
1.3.2.4  Role of P-gp in drug interactions 
In human, the P-gp is found on the apical surface of columnar epithelial cells of the small 
intestine, the biliary canalicular membrane of hepatocytes, the apical surface of epithelial 
cells in the proximal renal tubules, and the apical surfaces of endothelial cells in the 
placenta and the blood capillaries of the brain (Cordon-Cardo et al., 1990; Thiebaut et al., 
1987). Consequently, functional P-gp can limit drug uptake from the GI lumen into the 
enterocytes, and from the blood circulation into the brain and placenta. On the other hand, 
it can enhance drug elimination from the hepatocytes, renal tubules and intestinal 
epithelial cells into the adjacent luminal space. To elucidate the influence of the P-gp 
towards drug pharmacokinetics, one has to examine its roles in drug absorption, 
distribution and disposition.  
 
1.3.2.4.1  Drug absorption 
Both in vitro and in vivo models have been utilized to elucidate the role of the P-gp in 
intestinal drug absorption. In vitro models consisted mainly of epithelial cell monolayers 
cultured on semi-permeable culture inserts (Yee, 1997) and isolated intestine segments 
mounted on special chamber systems (Saitoh et al., 2003). Of the variety of cell lines 
applied as surrogate intestinal models, the Caco-2 cell line, which is derived from a 
human colon adenocarcinoma (Vincent et al., 1985), is one of the most widely reported. 
P-gp is constitutively expressed in the apical membrane of the Caco-2 cells, and it has 
Chapter 1.     Introduction 
 21
been shown to polarize the transport of vinblastine (Hunter et al., 1993), cyclosporine 
(Augustijns et al., 1993), peptides such as AcPhe(NMePhe)2NH2 (Burton et al., 1993), 
and other P-gp substrates across Caco-2 cell monolayers cultured on permeable inserts. 
The higher basal-to-apical (BA) transport of these substrates, relative to the apical-to-
basal (AB) transport, is typically, abolished in the presence of P-gp inhibitors, such as 
verapamil or MRK16 (Hunter et al., 1993).  
 
In vivo studies on P-gp mediated drug transport have utilized animal models, such as the 
rat, and human volunteers, although P-gp involvement in drug absorption in human is 
harder to predict due to experimental limitations. Clinical trials on P-gp interactions are 
mainly restricted to the comparison of drug absorption parameters (AUC, the area under 
the plasma drug concentration-time curve, and Cmax, the maximum plasma concentration) 
obtained with and without the co-administration of a P-gp inhibitor. Although this is not a 
direct method, the data generated have reflected variations between these two treatments. 
In a study involving healthy volunteers, the co-administration of verapamil was found by 
Schwarz et al. (Schwarz et al., 1999) to markedly increase the absorption of talinolol, a 
P-gp substrate. In another study, the co-administration of 15 mg/kg of cyclosporine 
increased by more than 10-fold the bioavailability of paclitaxel administered orally at a 
low dose of 60 mg/m2 to five cancer patients (Meerum Terwogt et al., 1999). While these 
are clinically useful data, the validity of attributing the pharmacokinetic changes solely to 
the P-gp has been questioned because the inhibition studies do not preclude the 
involvement of other transporter systems. Nor do they take into account drug metabolism 
by the CYP enzymes. To overcome this shortcoming, investigators have attempted to 
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correlate the drug absorption profiles with the P-gp protein and/or MDR1 mRNA levels 
in the intestine (Fricker et al., 1996). For instance, Durr et al. (Durr et al., 2000) have 
attributed the decreased bioavailability of peroral digoxin that accompanied St. John’s 
wort consumption to a 1.4-fold induction of the intestinal P-gp by the herb.  
 
More direct evidence of drug-P-gp interactions have been obtained in animal models. An 
example is the comparison of drug absorption profiles obtained in mdr1a (-/-) knockout 
mice, which do not express functional P-gp, with those in control wild-type mdr1a (+/+) 
mice. In one such study, the plasma AUC of peroral and IV paclitaxel was observed to be 
2- and 6-fold higher, respectively, in mdr1a (-/-) mice than in mdr1a (+/+) mice 
(Sparreboom et al., 1997).  
 
Immunohistological studies using the MRK16 antibody has shown a non-uniform 
distribution of the P-gp along the human small intestinal epithelia. P-gp expression was 
observed to increase from the proximal to the more distal parts of the intestine (Fojo et al., 
1987), with high protein levels found on the apical surface of the columnar epithelial 
cells but not in the crypt cells (Thiebaut et al., 1987). The intestinal MDR1 mRNA levels 
and in vivo P-gp transport function are in agreement with this gradient of expression 
(Valenzuela et al., 2004). This non-uniform distribution may result in the P-gp having 
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1.3.2.4.2  Drug distribution 
Drugs are often administered at a location distant from their intended site of action, and 
they have to be transported across several biomembranes to reach the target tissue and 
site of action. Efficient drug transport across certain biomembranes, such as the blood 
brain barrier (BBB), remains a challenge, and the role played by the P-gp in this regard is 
becoming increasingly recognized.  
 
The BBB, which comprises endothelial cells lining the brain capillaries, represents an 
important physical, biochemical and transport barrier that serves to limit the access of 
many xenobiotics to the central nervous system (CNS). The P-gp has been shown by 
immunocytochemical studies to be located on brain microvessel endothelial cells 
(Cordon-Cardo et al., 1990) and the choroids plexus, a network of endothelial cells that 
form a barrier between the cerebrospinal fluid and blood (Rao et al., 1999). The 
localization pattern of the P-gp within the CNS is consistent with a putative protective 
role against the accumulation of xenobiotics, either by limiting brain uptake or increasing 
efflux from the brain. This has been confirmed by studies in which the modulation of the 
P-gp function at the BBB was shown to substantially alter the CNS pharmacokinetics, 
efficacy and toxicity of P-gp substrates (Schinkel et al., 1994; Mayer et al., 1996). 
 
The P-gp is also highly expressed in the trophoblasts of the human placenta (Nakamura et 
al., 1997), where it is believed to protect the fetus from the xenobiotics in the mother. P-
gp efflux transport of vinblastine, vincristine and digoxin have been demonstrated in 
cultured human placenta choriocarcinoma epithelial cells (BeWo cells), which were 
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shown by western blots to express high levels of P-gp (Ushigome et al., 2000). In the 
presence of cyclosporine, the efflux activity was blocked, suggesting that it was mediated 
by the P-gp. 
 
1.3.2.4.3  Drug disposition 
Drugs are generally eliminated from the human body by metabolism in the liver and/or 
excretion in the kidney. P-gp in the liver is located on the canalicular (apical) membrane, 
and it functions to accelerate the biliary excretion of substrates by transporting them from 
the hepatocytes into the canalicular space (Kusuhara et al., 1998). The processes involved 
in biliary excretion include the transport of drug molecules across the sinusoidal 
(basolateral) membrane of the hepatocytes by passive diffusion and/or active transport 
(Meijer et al., 1997), followed by diffusion of the drug molecules across the cytoplasm to 
the canalicular membrane. During the second process, the P-gp, and possibly other efflux 
transporter systems, will pump the drug molecules into the bile. Often, the drug 
molecules are biotransformed as they pass through the hepatocytes, in which case, the P-
gp may also transport the drug metabolites into the bile. 
 
Recent evidence suggests that the P-gp may also play a key role in renal drug elimination 
by actively secreting drug molecules into the urine. The P-gp is expressed on the apical 
(luminal) membrane of the proximal renal tubule cells (Thiebaut et al., 1987) and 
possibly in other portions of the nephron, such as the loop of Henle (Thiebaut et al., 
1987). Drug uptake across the basolateral membrane of the renal epithelial cells, which 
express a number of drug uptake transporters, is the first step in the renal excretion 
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process. P-gp substrates taken up by the renal cells must diffuse across to the apical 
membrane, in a way similar to the situation in the liver, to interact with the P-gp 
(Simmons et al., 1997). As the renal P-gp is responsible for the final step of transporting 
P-gp substrates into the urine (Koepsell et al., 1999), it may facilitate drug elimination 
from the systemic circulation (Ito et al., 2000). In view of these processes, an impaired P-
gp function may conceivably lead to decreased substrate elimination, and result in drug 
toxicity in susceptible individuals. 
 
1.4  Spice-drug interactions 
The use of spices as food additives has been widely practiced since ancient times. Apart 
from enhancing the flavor of food, spices also exhibit biological effects, including the 
modulation of drug bioavailability. Jensen-Jarolim et al. (Jensen-Jarolim et al., 1998) 
have shown that the extracts of crude paprika and cayenne pepper fruit could lower the 
transepithelial electrical resistance (TEER) of HCT-8, a human intestinal epithelial cell 
line, to less than 1/10 of baseline values, and facilitate the permeation of hydrophilic 
dextran molecules and charged ions across the cell monolayer. As dextran molecules of 
up to 14 kDa were transported, the authors postulated that these two spices might assist in 
the absorption of important plant-derived allergenic proteins (14 to 17 kDa), raising 
important implications on food intolerance and allergic reactions to food.  
 
Given the regular and widespread consumption of spices in Asian populations, it is 
imperative to have a database on spice-drug interactions for health-care professionals. 
Unfortunately, there is a dearth of mechanistic data on this area of research, and this 
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needs to be urgently addressed. It is the aim of this project to generate data to address 
some of the information gaps. In the next few paragraphs, spices common to the local 
diet are described, together with literature evidence which suggest, directly or indirectly, 
that these spices may interact with intestinal drug transporter proteins to modulate oral 
drug bioavailability. In particular, we are interested in the bioactive components in 
pepper, capsicum, garlic and ginger that are responsible for these biological activities. 
 
1.4.1  Pepper 
Piper nigrum L, commonly known as black pepper and long pepper, is a widely used 
spice in populations that thrive on spicy cuisines. Although the pepper consumption level 
in these populations has not been documented, it is likely to be higher than the value of 
359 mg per person per day reported for the average consumption of black pepper in the 
US (Kindell, 1984). Pepper has also been used in Ayurvedic medicine for the treatment 
of various diseases (Atal et al., 1981). One such preparation, which consists of black 
pepper, long pepper and ginger, is known by the Sanskrit name trikatu and it is used to 
treat gastric and abdominal disorders, asthma, bronchitis, dysentery, pyrexia and 
insomnia. Another preparation, known by the Sanskrit name pippali, consists of long 
pepper alone. Piperine, which is present at concentrations of between 3 to 9% in black 
pepper (Winton and Winton, 1939), is believed to be one of the major bioactive 
substances in these Ayurvedic remedies (Johri and Zutshi, 1992). 
 
Piperine (Figure 1.4a) is a water-insoluble alkaloid found in the fruits of plants belonging 
to the piperaceae family. A weak base that is tasteless at first, piperine leaves a burning 
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aftertaste. It belongs to the vanilloid family of compounds, which also includes capsaicin, 
the pungent substance in hot chili peppers.  
 
Piperine has been reported to possess antioxidant (Mittal and Gupta, 2000), anti-
inflammatory (Stohr et al., 2001), chemopreventive (Bai and Xu, 2000) and immune-
enhancing (Lin et al., 1999b) activities. Recent in vivo experiments have suggested that 
piperine at the dose of 5-60 mg could enhance the oral bioavailability of drugs and 
nutrients, including amoxicillin (Hiwale et al., 2002), cefotaxime (Hiwale et al., 2002), 
nimesulide (Gupta et al., 2000), coenzyme Q10 (Badmaev et al., 2000), vitamin C and 
beta-carotene (Majeed et al., 1996). Piperine has also been shown to promote the 
pharmacological effect of pentobarbitone (Mujumdar et al., 1990). Several mechanisms 
may account for these results. Piperine has been reported to inhibit gastric emptying in 
rats, and GI transit in mice, in a dose- and time-dependent manner (Bajad et al., 2001). It 
is also known to interact with CYP enzymes at the functional and expression levels 
(Munns et al., 1997). In one study, piperine administered intraperitoneally (i.p.) to rats at 
a daily dose of 1.4 mmol/kg body weight was observed to cause a 2-fold increase in total 
CYP content in the liver microsome after 3 days (Kang et al., 1994). The responses of 
individual CYP subtypes to the i.p. piperine were, however, different, as the CYP 2B and 
CYP 1A levels were upregulated while the CYP 2E1 level was suppressed. In another 
study, piperine was shown to impair CYP1A1 function, possibly by direct binding to the 
enzyme, without affecting the protein expression in cultured rat hepatoma 5L cells (Reen 
et al., 1996). Piperine at 50 µM has also been shown to inhibit the CYP3A4-mediated 
metabolism of verapamil in the human liver microsomes (Bhardwaj et al., 2002). 
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In addition, piperine may interact with the P-gp efflux pump, as it has been shown to 
reduce the polarized transport of digoxin and cyclosporine across confluent Caco-2 cell 
monolayers at IC50 values of 15.5 and 74.1 µM, respectively (Bhardwaj et al., 2002). 
Data generated from various in vivo models have further demonstrated the capacity of 
piperine to alter the pharmacokinetics of P-gp substrates. In a clinical study of patients 
with pulmonary tuberculosis, rifampin was shown to have a 2-fold higher plasma 
concentration when it was co-consumed with piperine (Zutshi et al., 1985; Bhardwaj et 
al., 2002). In healthy human volunteers, co-administered oral piperine (20 mg) 
(Velpandian, 2001; Bano et al., 1987) or black pepper (1g) (Velpandian et al., 2001) was 
observed to significantly increase the AUC and elimination half-life of peroral phenytoin 
(Schinkel et al., 1996). However, since the orally administered piperine (dose 0.6 mg) 
was also able to modify the elimination of phenytoin administered by intravenous 
injection in mice (Velpandian et al., 2001), it has been suggested that metabolic 
impairment, in addition to P-gp inhibition, might have contributed to the piperine-
phenytoin interaction. In addition to being a P-gp substrate, phenytoin is metabolized by 
the CYP2C9, CYP2C19, CYP3A4, CYP3A5, and CYP3A7 enzymes (Bajpai et al., 1996; 
Cuttle et al., 2000; Komatsu et al., 2000; Munns et al., 1997; Veronese et al., 1991). 
Moreover, 4 different metabolites of piperine have been identified in the rodent urine 
(Bhat and Chandrasekhara, 1986), suggesting that the spice undergoes enzymatic 
metabolism following oral administration.  
 
Soup containing 1 g/200 ml of black pepper has a piperine concentration of about 1.1 
mM (Jensen-Jarolim et al., 1998). When consumed and mixed with gastric fluid, which 
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averaged about 1-3 liters (Johnson, 2001), it is possible for the intestinal piperine 
concentration to fall within the range that can compromise the function and/or expression 
of the P-gp transporter and CYP enzymes in the GI tract. Therefore, it should not be 
surprising that piperine-drug interactions could occur at the absorption, distribution and 
disposition phases.  
 
1.4.2  Capsicum  
Capsicum is commonly known as chili pepper, hot pepper, cayenne, red pepper, tabasco 
paprika pepper, sweet pepper, bell pepper or green pepper. Archeologists have estimated 
that capsicum was used as food in Mexico as long as 9,000 years ago (Rumsfield and 
West, 1991). In folk medicine, capsicum is regarded as an aphrodisiac, depurative, 
digestive, stomachic, carminative, antispasmodic, diaphoretic, antiseptic, counterirritant, 
rubefacient, styptic and tonic (Govindarajan and Sathyanarayana, 1991). Taken internally, 
capsicum has been used to treat asthma, pneumonia, diarrhea, cramps, colic, toothache, 
flatulent dyspepsia without inflammation and insufficiency of peripheral circulation 
(Govindarajan and Sathyanarayana, 1991). It has been applied externally as a lotion or 
ointment to treat neuralgia, including rheumatic and arthritic pain (Rumsfield and West, 
1991), and unbroken chilblains (cold injuries) (Duke, 1985; Leung and Foster, 1996; 
Newall et al., 1996). When applied as whole fruits or red pepper powder, the typical 
doses for medicinal purposes vary between 30-120 mg, with the usual dose being 60 mg 
(Newall et al., 1996).  
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Of the series of homologous branched- and straight chain alkyl vanillylamides, 
collectively known as capsaicinoids, that are present in capsicum, the most potent and 
predominant is capsaicin (Figure 1.4b) (Cordell and Araujo, 1993). Capsaicinoids are 
collectively found in amounts of 0.1% to 1%, with quantities varying according to soil 
and climate conditions (Rumsfield and West, 1991). The capsaicin content of red hot 
peppers ranges from 0.1 to 1% (Govindarajan and Sathyanarayana, 1991). Analysis of 
capsaicin content in different diets indicates that an intake of 20 mg of capsaicin is 
associated with a spicy meal (Limlomwongse et al., 1979). The dose of capsaicin in a 
typical Indian or Thai diet is reported to be about 128 μg/kg human body weight 
(Rumsfield and West, 1991).  
 
Capsaicin has prominent pharmacologic and toxicologic properties (Surh and Lee, 1995; 
Szallasi and Blumberg, 1999), making it the target of numerous investigations since its 
initial identification in 1919. The role of this pungent vanilloid in multistage 
carcinogenesis, particularly in human cancer, is quite controversial (Surh and Lee, 1996). 
Although capsaicin is suspected to be a potential carcinogen or co-carcinogen, there is a 
substantial body of data supporting its chemopreventive and chemoprotective effects 
(Surh et al., 1998). Capsaicin has antioxidant properties, and is able to attenuate oxidative 
damage and lipid peroxidation in various organs of experimental animals (De and Ghosh, 
1992; Toskulkao and Tekittipong, 1996). It also possesses anti-inflammatory properties 
(Clementi et al., 1994; Inoue et al., 1995), and can inhibit platelet aggregation, possibly 
through the blockade of phospholipase A2 (Wang et al., 1984). In addition, capsaicin can 
repress calcium-ionophore stimulated pro-inflammatory responses (Savitha and Salimath, 
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1995), and exert protective effects against ethanol-induced gastric mucosal injury in rats 
(Kang et al., 1995) through the suppression of COX-2 activity (Park et al., 2000).  
 
Less is known about capsaicin-drug interactions, although capsaicin has been reported to 
interact with xenobiotic-metabolizing enzymes, in particular the microsomal CYP-
dependent monooxygenases involved in the activation, as well as the detoxification, of 
various chemical carcinogens and mutagens (Surh and Lee, 1995). Capsaicin-P-gp 
interaction has recently been reported by Nabekura et al (Nabekura et al., 2005), who 
showed higher intracellular accumulation of daunorubicin and rhodamine 123 in KB-C2 
cells in the presence of capsaicin. The authors attributed this to an inhibition of the P-gp 
function, as the efflux of rhodamine 123 from these cells was also decreased by capsaicin. 
 
1.4.3  Garlic 
Widely used to flavor food, garlic has also in recent years been promoted as a health 
supplement. A survey conducted in 1997 by the U.S.A. National Agricultural Statistics 
Service showed garlic products to be the most popular of 91 dietary supplements 
(Amagase et al., 2001). The German Kommission E monograph (German Kommission E 
monograph, 1988) further recommends a daily intake of 1–2 cloves or 4 g of garlic to 
build up health benefits. Garlic has been reported to have hypolipidemic (Chaudhuri et al., 
1984), antiplatelet (Makheja and Bailey, 1990), immune-enhancing (Lamm and Riggs, 
2001), anticancer (Welch et al., 1992), chemopreventive (Arunkumar et al., 2006), 
hepatoprotective (Wang et al., 1998), antihypertension (Pedraza-Chaverri et al., 1998) 
and procirculatory (Balasenthil et al., 2000) effects.  
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A wide variety of compounds of varying complexity, e.g. allixin, ajoene and 
diallylsulfide, have been identified that are synthesized in situ whenever garlic is crushed, 
cut, minced, or chopped. Some of the organosulfur compounds, e.g. diallylsulfide (DAS), 
diallyldisulfide (DADS), AMS (allyldisulfide), allylmethyldisulfide (AMDS) and 
diallyltrisulfide (DATS) (Figure 1.3) are believed to be responsible for the beneficial 
biological effects of garlic.  
 
                                     DAS      CH2=CH-CH2-S-CH2-CH=CH2 
                                     DADS   CH2=CH-CH2-S-S-CH2-CH=CH2 
    AMS        CH2=CH-CH2-S-CH3 
                                     AMDS       CH2=CH-CH2-S-S-CH3 
                                     DATS   CH2=CH-CH2-S-S-S-CH2-CH=CH2 
Figure 1.3 Chemical structures of organosulfur compounds found in garlic: DAS 
(diallylsulfide), DADS (diallydisulfide), AMS (allyldisulfide), AMDS 
(allylmethyldisulfide) and DATS (diallyltrisulfide). 
 
The capacity of garlic to modulate CYP enzyme activity and expression has been 
supported by in vitro and in vivo data, the type and degree of modulation being dependent 
on the dose regimen, animal species and tissue, and the garlic constitution (Foster et al., 
2001). Oral administration of garlic oil for 3 days, at a daily dose of 200 mg/kg, was 
shown to decrease the level of pyrazine-inducible CYP2E1 by approximately 40% in rats 
(Kwak et al., 1995). In another study, immunodetectable CYP2E1 protein level was 
decreased to 30-60% of the control level 15 h after the rats were gavaged with DAS, 
DADS or AMS, in cottonseed oil at a dose of 1.75 mmol/kg (Reicks and Crankshaw, 
1996). On the other hand, rodent CYP1A1 and CYP2B1 levels were enhanced by thrice 
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weekly oral administration of garlic oil (80 or 200 mg/kg), DAS (20 or 80 mg/kg body 
weight), DADS (80 mg/kg body weight), or DATS (70 mg/kg body weight) for 6 weeks 
(Wu et al., 2002). However, the induced enzymes did not appear to be functional, as the 
higher enzyme levels were not accompanied by enhanced metabolic activity. These 
findings were in agreement with another rodent study (Guyonnet et al., 2000), where the 
oral administration of DAS and DADS was reported to have no effects on CYP1A and 
CYP2B metabolic activities.  
 
Garlic-drug interaction in human was discovered serendipitously. Garlic has generally 
been regarded as safe until two HIV-positive patients, who had been taking garlic or 
garlic supplements for more than two weeks, developed severe GI toxicity when they 
were put on ritonavir therapy (laroche et al., 1998). Subsequently, the AUC and Cmax of 
another antiviral agent, saquinavir, were also observed to decrease by about 50% in 10 
healthy volunteers who consumed saquinavir and garlic caplets alternately over a 39-day 
study period (Piscitelli et al., 2002). The chronicity of co-administration appears to be 
important, because the co-administration of a single dose of garlic supplement (10 mg) 
with ritonavir (400 mg) in 10 healthy subjects failed to demonstrate an interaction 
(Gallicano et al., 2003). As ritonavir and saquinavir are P-gp substrates, early postulation 
was that their interaction with garlic may have occurred via a modulation of P-gp efflux 
activity. However, a screening of four garlic products (aqueous extract of a garlic capsule 
and fresh garlic from 3 different sources) for their potential to interact with the P-gp 
produced inconclusive evidence (Foster et al., 2001). Rather, the various products of 
garlic, including the extracts of fresh garlic, different brands of garlic supplements, and 
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representative samples of garlic oil, freeze dried garlic and aged garlic, were shown in the 
same study to inhibit the metabolic activities of CYP2C9*1, CYP2C19, CYP3A4, 
CYP3A5 and CYP3A7 (Foster et al., 2001). There is obviously much scope for further 
research into the mechanisms of garlic-drug interactions.  
 
1.4.4  Ginger 
Besides its extensive use as a dietary condiment, ginger has also been applied in 
traditional oriental herbal medicines for the management of symptoms in common cold, 
digestive disorders, rheumatism, neuralgia, colic and motion-sickness (Afzal et al., 2001). 
In vitro studies have shown that the water- and organic solvent-extracts of ginger, as well 
as some isolated ginger constituents, possess antioxidant properties (Srivastava and 
Mustafa, 1989; Krishnakantha and Lokesh , 1993; Jitoe et al., 1992; Kiuchi et al., 1992; 
Reddy and Lokesh, 1992). The ginger rhizome is a rich source of biologically active 
constituents, the main pungent principles being the gingerols, which are a series of 
homologues with a range of unbranched alkyl chain lengths. The most abundant gingerol 
in the ginger rhizome is [6]-gingerol (Figure 1.4c) (Govindarajan, 1982; Baranowski, 
1985), while the dehydrated gingerol product, shoagol (Figure 1.4e), is the predominant 
pungent constituent in dried ginger powder (Govindarajan, 1982). Gingerol can also be 
converted to zingerone (Figure 1.4d) (Bartley and Jacobs, 2006) after cooking.  
 
[6]-gingerol has been found to possess various pharmacological and physiological effects, 
including analgesic (Onogi et al., 1992), anti-inflammatory (Sharma et al., 1994), 
gastroprotective (al Yahya et al., 1989), and cardiotonic (Kobayashi et al., 1987) 
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activities. It also has a potent inhibitory effect on prostaglandin biosynthesis (Kiuchi et 
al., 1992). On the other hand, very little is known of the effect of ginger on drug 
pharmacokinetics. One study, which evaluated the interaction between ginger and the P-
































Figure 1.4  Chemical structures of a, piperine; b, capsaicin; c, gingerol; d, zingerone and 
e, shoagol 
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1.5 Statement of purpose 
Food-drug interactions can arise when food and drugs are co-administered and the food 
influences the bioavailability of the drug by modulating the drug transport pathway 
and/or the activity of drug metabolic enzymes. Clinically important drug interactions can 
lead to poor therapeutic outcomes caused by ineffective therapy or adverse effects, in 
some cases with fatal consequences. Given that the consumption of spices is widespread, 
especially amongst South-East Asian populations, it is likely that those spice constituents 
which can modulate the activity of drug transporters or metabolic enzymes will have an 
impact on the pharmacokinetics of many clinically useful drugs. 
   
We hypothesize that the constituents in pepper, hot chilli, garlic and ginger (collectively 
known as “spices”) can affect the bioavailability of clinically important drugs by 
modulating drug transport across absorptive epithelium. Figure 1.4 shows the structures 
of piperine, capsaicin, zingerone, gingerol and shoagol, the spice constituents that were of 
interest in this project.  
 
A comparison of the chemical structures of these compounds reveals several similarities. 
Like vanillin (van den Heuvel et al., 2001), they bear an aromatic ring with two ortho-
oxygen atoms, which exist either as an ether-phenol combination, as in the case of 
capsaicin and ginger constituents, or as an acetal, as found in piperine. All compounds 
also have a side chain which bears a carbonyl group and is attached to the aromatic ring 
at position 4. The carbonyl is an amide for capsaicin and piperine, and a ketone for ginger 
constituents. It is located at a similar distance from the aromatic ring for capsaicin and 
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ginger constituents, but is located further afield for piperine. We surmised that the 
structural similarities of piperine, capsaicin and ginger constituents underpin a common 
mechanism of interaction with drug transporters.  
 
We further speculated that the chronic consumption of these spices might modify the 
intestinal expression of transporter proteins, thereby contributing to peculiar drug 
absorption profiles in populations that show a preference for these spices in their daily 
diet. Very often, the variation in drug absorption amongst different populations is 
attributed to genomics, or the presence of different phenotypes with respect to drug 
transporters (Xing et al., 2006; Bosch et al., 2006). However, data in the literature 
suggest that food preference do affect drug pharmacokinetic profiles in some populations. 
Using population pharmacokinetic analysis, Nix et al (Nix et al., 2004) found that 
administration of clofazimine with a high fat meal provides the increased bioavailability 
whereas both orange juice and aluminum-magnesium antacid produced a reduction in 
mean bioavailability of clofazimine. Dietary components, such as lettuce, broccoli and 
black tea have been reported to contribute on the CYP2E1 genotype viariance (Marchand 
et al., 1999). It is our contention that, aside from genomics, the food preference of a 
population may also affect the level of expression of transporter proteins that are critical 
to drug absorption and disposition. 
 
This project set out to evaluate the hypothesis by examining the effect of the spices on the 
transport profile of drugs known to be substrates of the P-gp efflux pump. The P-gp was 
chosen because it has been widely studied, and the systems and protocols for evaluating 
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the function and expression of this transporter protein are fairly established in the 
literature. The roles of the P-gp in MDR phenotypes and in clinically important drug-drug 
interactions have also been extensively reported. Both in vitro and in vivo models were 
used in this project. The in vitro models allow mechanistic data to be generated, while the 
in vivo models present data that may more closely correlate to clinical applications. 
 
In addition to experiments conducted to evaluate the effects of the spices on P-gp 
function and expression, we established the cytotoxicity profiles of the spices to delineate 
their effects on general cell function from their specific action on the P-gp. We also 
examined the effects of the spices on the intercellular tight junction. This served dual 
functions. First, it ascertained the extent to which the paracellular transport pathway 
contributed towards total drug permeability across the biological membranes. Second, the 
data highlighted potential absorption enhancers amongst the spice constituents tested.  
 
Experiments for the project were conducted with the following specific objectives: 
1. To establish the in vitro cytotoxicity profile of the spices against the Caco-2, 
LLC-PK1 and L-MDR1 cell models. 
2. To determine the cytotoxicity of peroral spices against intestinal epithelial in the 
rat model.  
3. To evaluate the effects of the spices on the paracellular route of transport in the 
Caco-2 cell model. 
4. To evaluate the effects of the spices on the function and expression of the P-gp in 
cell models and animal tissues. 
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2.1  Introduction 
During the past decade, as clinical data began to show that spices could modulate drug 
absorption, a series of in vitro experiments were carried out to explore the factors 
contributing to these effects. Using the cultured human ileocoecal carcinoma cell line, 
HCT-8, as surrogate intestinal epithelium, Jensen-Jarolim et al (Jensen-Jarolim et al., 
1998) showed that the Solanaceae spices (paprika, cayenne pepper, and chili pepper) 
could increase the epithelial permeability of macromolecules and ions by decreasing the 
TEER. More recently, Bhardwaj et al (Bhardwaj et al., 2002) demonstrated the capacity 
of piperine to inhibit the P-gp-mediated transport of digoxin and cyclosporine across the 
Caco-2 cell monolayers. The authors further showed that piperine could inhibit CYP3A4 
activity in vitro (Bhardwaj et al., 2002). Despite this progress, mechanistic data on spice-
drug interactions remained sparse, and this provided the impetus for this project.  
 
As there is a wide range of spices commonly used in South East Asian cuisines, a 
preliminary screening was conducted at the outset of the project to select promising 
spices for further studies. Spices were screened for their ability to modulate the P-gp- 
mediated efflux activity. The P-gp was selected as the drug transporter of interest because 
of its physiological role in drug absorption (Yee, 1997) and its pathological role in 
conferring multi-drug resistance to cancer cells (Mercier et al., 2003). The screening 
program also elucidated the effects of the spices on the paracellular transport pathway. 
The data was necessary to eliminate any confounding effects the paracellular route may 
play in modulating the epithelial permeability of P-gp substrates. In addition, they could 
highlight the potential absorption enhancers amongst the spices. 
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Several in vitro, in situ and in vivo techniques have been established for the screening of 
chemical entities for their ability to inhibit the P-gp and other drug transporters. In vitro 
assays include the measurement of cellular drug accumulation (Scala et al., 1997) and 
efflux (Alvarez et al., 1998), or ATPase (Xia et al., 2006) activity. Of these techniques, 
the assay of drug transport across intestinal or cultured cell monolayers is one of the most 
commonly employed (Yee, 1997; Hunter et al., 1993). To evaluate P-gp-mediated 
transport, the ratio of basal–to-apical (BA) to apical-to-basal (AB) permeability of known 
substrates, like rhodamine 123, digoxin and vinblastine, is compared in the presence and 
absence of inhibitors (Stephens et al., 2001). Concentration-dependent inhibition of 
apical P-gp efflux will result in decreased BA permeability with concomitant increase in 
AB permeability, such that the ratio of BA to AB permeability approaches unity as the 
inhibitor dose increases.  
 
For this project, the P-gp function was evaluated through the transport of [3H]-digoxin 
across confluent cell monolayers cultured on a permeable membrane support matrix. 
Digoxin, a cardiac glycoside, is an established P-gp substrate (Taub et al., 2005) widely 
used to demonstrate P-gp meditated efflux (Kim et al., 1999). Changes in the P-gp 
function also have considerable impact on the therapeutic outcome of digoxin (Christiane 
et al., 2001). Three different cell lines, the Caco-2, LLC-PK1 and L-MDR1 cells, were 
utilized for this project. The cell lines were selected based on the criteria that the cells 
would (a) express the drug efflux transporter, and (b) form functionally polarized cell 
monolayers, complete with tight intercellular junctions. The features of exhibiting 
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microvilli when grown on permeable filters and achieving a high transepithelial electrical 
resistance in confluent monolayers were other prerequisites. 
 
Caco-2 cells were derived from a human colon adenocarcinoma (Vincent et al., 1985). 
When grown on semipermeable filters, these cells spontaneously differentiate in culture 
to form confluent monolayers which resemble the small intestinal epithelium both 
structurally and functionally (Bohets et al., 2001). Because of this property, they have 
been widely applied as a simple in vitro model of the intestinal mucosa for the study of 
drug transport and metabolism. They also allow an excellent insight into the kinetic and 
mechanistic processes involved, although careful interpretation of the data is required as 
the membrane protein expression varies from culture to culture (Hosoya et al., 1996), and 
the passage number does not always correlate with the protein level (Hosoya et al., 1996). 
Another disadvantage of Caco-2 cells is the long culture period of 21 to 28 days required 
for the cells to become fully differentiated. In addition, the cells have been found to 
express a multitude of drug transporters, including other multidrug resistance proteins 
(Nakumura et al., 2003), making it difficult to attribute inhibitor specificity to any one 
particular membrane transporter.  
 
To overcome the shortcomings of the Caco-2 cell monolayers for P-gp-related transport 
experiments, cell lines that expressed a high level of P-gp have been established. 
Examples of these include the MDCK-MDR1 (Soldner et al., 2000) and L-MDR1 (Kim 
et al., 1998) cell lines, which are, respectively, Madin-Darby canine kidney (MDCK) and 
porcine kidney (LLC-PK1) cells transfected with the cDNA of the human MDR1 gene. 
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The L-MDR1 cells were used in this study because a significant correlation has been 
shown to exist between the transcellular transport data obtained with L-MDR1 and LLC-
PK1 cell monolayers and those obtained from in situ intestinal experiments performed 
using mdr1a/1b (-/-) and normal mice (Adachi et al., 2003b). In addition, the relatively 
short culture time required for these cells and the availability of wild-type cells for use as 
controls in permeability studies render the L-MDR1 cells an excellent tool for identifying 
P-gp efflux activity. Unlike the Caco-2 cells, the L-MDR1 and LLC-PK1 cells can 
differentiate into columnar epithelium with tight junctions within a short period of 3-7 
days (Kim et al., 1998). 
 
[14C]-mannitol transport experiments were conducted to evaluate the effects of the spices 
on the paracellular transport pathway. [14C]-mannitol is a radiolabelled hydrophilic 
marker widely used to measure the leakiness of the intercellular tight junction and the 
integrity of confluent cell monolayers (Crespi et al., 1996). It is not known to be taken up 
by absorptive cells in significant amount but is highly permeable through the tight 
junctions of cell monolayers (Artursson, 1990). Polarized confluent Caco-2 cell 
monolayers with demonstrated integrity of tight junctions were used as the in vitro model 
of the intact intestinal epithelium for the paracellular mannitol transport experiments. The 
measurement of TEER provided supplementary data on the integrity of the paracellular 
transport pathway. 
 
In vitro cytotoxicity profiles of the spices were established prior to the screening program. 
This allowed the determination of appropriate spice doses to be used for the drug 
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transport studies so that the data would not be compromised by other cytotoxic effects. 
Several approaches have been used to measure the in vitro cytotoxicity of materials (da 
Costa et al., 1999). A simple method is to evaluate cell membrane integrity, with 
associated assumptions of cell proliferation or death, by staining the exposed cells with 
the vital dye, trypan blue (Tennant, 1964). However, this method cannot be adapted for 
high-throughput screening. A more accurate method is to determine the cellular uptake of 
tritium-labeled thymidine (Twentyman et al., 1984), but the procedure is time-consuming 
and involves the handling of radioactive substances. A safer and equally accurate 
alternative to the radiometric cytotoxicity evaluation is the widely accepted MTT (3-(4.5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay (Scudiero et al., 1988), 
which was applied in this project. MTT is a yellow tetrazolium salt that is reduced in the 
mitochondria of metabolically active cells to insoluble purple formazan crystals, which 
can be solubilized by the addition of a detergent, and quantified by spectrophotometric 
means. For each cell type, a linear relationship between viable cell number and 
absorbance can be established, enabling an accurate and straightforward quantification of 
changes in cell viability upon exposure to the material of interest. The MTT method for 
assessing cell viability has been applied to evaluate drug sensitivity (Finlay et al., 1986), 
biomaterial cytotoxicity (Smith et al., 1992), response to growth factors (Manthorpe et al., 
1986), and cell activation (Gerlier and Thomasset, 1986). Its wide application attests to 
the ease and speed of this assay, in particular to the processing of samples. The substrate 
does not interfere with the measurement of the product, and absorbance may be measured 
directly after a few minutes of solubilization, although the color generated is stable for a 
few hours at room temperature (Smith et al., 1992). Other advantages include the 
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cleavage of the substrate by all living and metabolically active cells, but not by dead cells, 




Caco-2 cells (passage 40) were from the RIKEN Cell Bank (RIKEN RCB0988, Saitama, 
Japan); LLC-PK1 cells (passage 190) were obtained from the American Type Culture 
Collection (ATCC; Rockville, MD, USA); the LLC-PK1 derivative cell line containing 
the human MDR1 (L-MDR1 cells, passage 220) was generously provided by Dr AH 
Schinkel (Netherlands Cancer Institute, Amsterdam, Netherlands). 
 
Minimum essential medium (MEM), M199 medium, Opti MEM, fetal bovine serum 
(FBS) and non-essential amino acid (NEAA) were from Gibco BRL LifeTechnology 
(Grand Island, NY, USA); sodium lauryl sulfate (SDS) and 3-(4.5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT) were from BDH Chemicals Ltd (Poole, 
England); Hank’s balanced salt solution (HBSS), N-[2-hydroxyethyl]piperazine-N’-[2-
ethanesulfonic acid] (HEPES), penicillin, streptomycin, sodium bicarbonate (NaHCO3), 
trypan blue, trypsin-EDTA, dimethylsulfoxide (DMSO), capsaicin, diallylsulfide (DAS), 
diallyldisulfide (DADS), piperine, digoxin, verapamil and dextran were from the Sigma 
Chemical Co. (St. Louis, MO, USA); [14C]-mannitol (specific activity 53.7 mCi/mmol) 
and [3H]-digoxin (37.0 Ci/mmol) were purchased from PerkinElmer Lifesciences 
(Wellesley, MA, USA); liquid scintillation cocktail was from Amersham Biosciences 
(Little Chalfont, Buckinghamshire, England); and TranswellTM polycarbonate inserts (12 
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mm diameter, 0.4 and 3.0 µm pore size) were from Corning Costar Corp. (Bedford, MA, 
USA). 
 
2.3  Methods 
2.3.1 Spices 
Commercial samples of purified piperine and capsaicin, the major biologically active 
constituents of pepper and capsicum, respectively, were used. The concentration range 
applied for the cytotoxicity and drug transport experiments were chosen based on a 
literature review (Monsereenusorn, 1983; Saito and Yamamoto, 1996; Johnson et al., 
2003) and the doses consumed in a typical daily diet of an Asian community (Pei, 1983). 
Spice concentrations for the drug transport experiments were below the cytotoxic doses. 
 
Aqueous extracts of garlic were evaluated. However, it was recognized that the type and 
quantity of garlic components in the aqueous extracts were difficult to control because 
they were influenced by a multitude of factors, including the source of the garlic and the 
sheer complexity of compounds that could be synthesized in situ whenever garlic was 
crushed, cut, minced or chopped (Weinberg et al., 1992). To minimize composition 
variability, garlic was obtained from one source and the preparation protocols were 
closely adhered to. In addition, pure samples of the garlic components, DAS and DADS, 
were obtained from commercial sources for the experiments. Again, the concentration 
ranges of the garlic samples used in this project were based on literature reports (Lin et 
al., 2002; Sundaram and Milner, 1996), and the concentrations applied for the transport 
experiments were within the safe ranges determined from the cytotoxicity experiments. 




Ginger extracts were used because there are several ginger derivatives and some of them 
are not available commercially. As gingerol, the main component of ginger, is a highly 
lipophilic compound, an ethanol extract of ginger was prepared and used in this study. 
The concentrations of ginger extract used for the drug transport studies were again within 
the sub-cytotoxic dose range. 
 
2.3.2 Dosing solutions 
Capsaicin was dissolved in DMSO to prepare a stock solution of 100 mM. The stock 
solution was serially diluted with HBSS-HEPES (HBSS supplemented with 10 mM 
HEPES, pH 7.4) to give test solutions with capsaicin concentration in the range of 10 to 
500 µM. Stock solutions of DAS, DADS and piperine in DMSO were similarly prepared 
at concentrations of 10 % (v/v), 10 % (v/v) and 100 mM, respectively, and the test 
solutions obtained by serially diluting the stock solutions with prewarmed (37oC) HBSS-
HEPES. Test solutions of piperine could not be prepared at concentrations higher than 
100 µM because the spice component would precipitate out of solution. Therefore, at 200 
and 500 µM, piperine dosing solutions were in cloudy suspension form. Test solutions of 
DAS and DADS were prepared in the concentration range of 50 to 300 µM. 
 
The dose of garlic was calculated on the basis of the weight of fresh garlic (in mg) used 
to prepare 1 ml of extract (Singh et al., 1996). To prepare the garlic aqueous extract, 10 g 
of fresh skinned garlic was minced in 200 ml of HBSS-HEPES in a domestic blender 
(Braun, Germany) to a uniform consistency. The suspension was centrifuged at 4oC, 
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40000 g (Avanti J-25 centrifuge, Beckman Coulter, Inc., Germany) for 30 min, and the 
supernatant was stored at -20oC (freezer) until analysis. The day before the MTT assay, 
the samples were thawed to room temperature and diluted with HBSS-HEPES to give 
solutions in the concentration range of 1 to 5 mg/ml. These solutions were stored at 4°C 
overnight. 
 
To prepare the ginger extract, 70 ml of absolute ethanol was added to 140 g of skinned 
fresh ginger previously minced in the blender. After 5 min, the yellow extract was 
decanted to a beaker, and the extraction process was repeated 2 more times. The yellow 
extracts were pooled, filtered (Whatman Grade 1: 11µm), and dried in a rotary vacuum 
evaporator (Laborota 4003, Heidolph, Australia). Aliquots of the resultant viscous, oily 
mass, designated as GE, were stored in 2 ml-centrifuge tubes at 4oC and used within one 
week of preparation. Working solutions of ginger extract in the concentration range of 10 
to 180 mg/ml were prepared by re-dissolving the ginger extract in HBSS-HEPES solution. 
 
pH (pH meter 345, Corning, Inc., Corning, NY, USA) and osmolality (vapor pressure 
osmometer 5520, Wescor Inc., Longan, USA) of the test solutions of all spices were 
measured just prior to the MTT assay. Samples were adjusted to pH 7.4, if necessary, 
with 1 N NaOH. Osmolality of all samples were found to be within the isotonic range of 
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2.3.3 Cell culture 
Caco-2 cells, at a seeding density of 3-4 ×105 cells per 75 cm2 tissue culture flask (NUNC, 
Denmark), were cultured in 15 ml of MEM at 37oC in 5% CO2/ 95% air atmosphere in a 
CO2 incubator (NuAire, Plymouth, MN, USA) The medium was changed on every 
second day until the cells reached 80-90% confluency, usually in 5-7 days. Cells were 
trypsinized with 5 ml of 0.05% trypsin-EDTA solution and cell viability test was 
performed using a hemacytometer (Tiefe, Germany). The numbers of living and dead 
cells were counted after diluting the cell suspension with an equal volume of 0.4% trypan 
blue solution. The culture cycle was repeated if the cell density was in the range of 105 
cells/ml of 15 ml medium, and the cell viability was greater than 98%. 
 
LLC-PK1 and L-MDR1 cells were similarly cultured in M199 medium supplemented 
with 0.5 mg/ml streptomycin, 0.5 mg/ml penicillin and 10% v/v FBS (Schinkel et al., 
1995). Cells were passaged at a subculture ratio of 1:4 every 4-5 days. 
 
2.3.4 MTT assay 
Caco-2 (passage 47-53), LLC-PK1 (passage 234-240) and L-MDR1 (passage 225-231) 
cells, at the seeding density of 104 cells/well (105 cells/ml, 0.1 ml/well), were cultured in 
96-well plates (NUNC, Denmark) for 48 h in the CO2 incubator. The cytotoxicity 
experiments were initiated by replacing the medium in each well with 100 µl of spice 
solutions in HBSS-HEPES. Control samples included 0.1% of SDS in HBSS-HEPES as 
positive control, and 0.1% of dextran in HBSS-HEPES as negative control. After 4 h of 
incubation in the CO2 incubator, the medium in each well was aspirated and the cells 
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incubated with 100 µl of MTT solution (1 mg/ml in HBSS-HEPES) for a further 4 h at 
37oC. The MTT solution was then removed, and the cells were washed twice with PBS 
solution. The intracellular formazan product was solubilized with 150 µl of DMSO, and 
the absorbance of the lysate was measured in a plate reader at 590 nm (Spectra Fluor 
plate reader, Tecan, Austria). Cell viability was calculated as a percent based on the 
absorbance measured relative to the absorbance obtained from cells exposed only to 
HBSS-HEPES. 
 
2.3.5  [14C]-mannitol transport across Caco-2 cell monolayers 
Caco-2 cells (passage 47-53) were seeded at a density of 1-2×105 cells/well onto 
TranswellTM inserts (0.4 µm pore size, 12 mm diameter; Corning Costar Corp., Bedford, 
MA, USA). The cells were cultured with 0.5 and 1.5 ml of MEM medium in the apical 
and basal chambers, respectively, at 37oC in 5% CO2 / 95% air atmosphere in the CO2 
incubator. Medium was changed every 2-3 days. Drug transport experiments were 
performed on Day 18-21 post-seeding, when the integrity of the Caco-2 cell monolayers 
was established by measuring the TEER (Millicell-ERS, Millipore, Bedford, MA, USA). 
Cells were washed once with prewarmed transport medium (HBSS-HEPES buffer, pH 
7.4) following the aspiration of culture medium from both chambers, then equilibrated 
with the transport medium for 30 min in the incubator. Cell monolayers with TEER 
values greater than 200 Ω·cm2 (after deducting for blank) were subsequently used for 
transport experiments. 
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Control dosing solution was prepared by dissolving [14C]-mannitol (10 µM, 0.54 µCi/ml) 
in HBSS-HEPES. Test dosing solutions were prepared by adding the required spice at 
specified concentration into the dosing solution. For experiments involving the co-
administration of spices, the spice of interest was also added at the specified 
concentration to the receiving chamber in order to eliminate confounding effects due to 
diffusion (Kawahara et al., 2000). Permeability experiment was initiated by applying the 
control or test solution to the apical chamber (0.5 ml; for apical-to-basal (AB) transport) 
or basal chamber (1.5 ml; for basal-to-apical (BA) transport). At 0, 30, 60, 120 and 180 
min, 50 µl aliquots were sampled from the receiver chamber and these were immediately 
replaced with 50 µl of fresh HBSS-HEPES solution to maintain the medium volume in 
the receiver chamber. Each sample was incubated overnight with 3 ml of scintillation 
cocktail before analysis in a liquid scintillation counter (LS 3801, Beckman Instruments, 
Inc., CA, USA). TEER was again measured at the end of the transport experiment, after 
the mannitol solution was replaced with transport medium and the cells incubated at 37°C 
for a further 30 min. The ratio of TEER values measured after and before the transport 
experiments was calculated. Apparent permeability coefficient (Papp) for [14C]-mannitol 
was determined according to the following equation: 
Papp= (dQ/dt)/(A·C0) (cm/s)  (1) 
where Papp was the apparent permeability coefficient (cm/s); dQ/dt the steady state flux 
(nmol/s); A, the surface area of the insert membrane (1.13 cm2); and C0, the initial 
mannitol concentration in the donor chamber (10 nmol/cm3). Net efflux was calculated as 
the ratio of mean BA Papp to mean AB Papp  
Net efflux= (Papp, BA) / (Papp, AB) (2). 
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2.3.6  [3H]-digoxin transport across LLC-PK1 and L-MDR1 cell monolayers 
LLC-PK1 (passage 234-240) and L-MDR1 (passage 225-231) cell monolayers were 
prepared by seeding the respective cells onto the TranswellTM inserts (3.0 µm pore size, 
12 mm diameter; Corning Costar Corp., Bedford, MA, USA) at a density of 3-4×105 cells 
per well. Cells were cultured in 0.5 ml of supplemented M199 medium in the CO2 
incubator, with medium exchange on alternative days. Transport experiments were 
conducted 5-7 days post seeding. Cell monolayers with TEER values greater than 200 
Ω·cm2 (after deducting for blank) were subsequently used for transport experiments. 
 
About 1-2 h before the start of the transport experiments, the culture medium in the 
TranswellTM inserts was replaced with OptiMEM, a serum-free transport medium. After 
60 min of pre-incubation, the Opti MEM in the apical (AB transport) or basal (BA) 
chamber was replaced with 0.7 ml of digoxin (5 µM, 0.5 µCi/ml in OptiMEM) solution. 
Parallel experiments were conducted with the addition of 100 µM of verapamil (positive 
control) or specified concentration of a selected spice in both chambers. At 0, 1, 2, 3 and 
4 h, 50 µl aliquots were sampled from the receiver chambers, mixed overnight with 3 ml 
of scintillation cocktail and analyzed in the liquid scintillation counter. Withdrawn 
samples were replaced with equal volumes of prewarmed transport medium. Monolayer 
TEER values were measured immediately before and after the transport experiments, the 
protocols being similar to those described in section 2.3.5. Digoxin permeability was 
calculated as Papp and percent transported. The latter was determined based on the amount 
of digoxin presented in the receiver chamber relative to the initial digoxin loading in the 
donor chamber. Net efflux ratio was also calculated. 
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2.3.7 Statistical analyses 
Experiments were repeated at least four times. Results are expressed as mean ± SD or 
SEM. Differences between mean values were evaluated using one-way ANOVA with the 
Tukey’s test applied for paired comparisons of mean values (SPSS 10.0, SPSS Inc., 
Chicago, IL, USA). A difference between means was considered significant if the p value 
was less than or equal to 0.05. 
 
2.4 Results and discussion 
2.4.1 MTT assay 
Figures 2.1-2.11 show the cytotoxicity profiles of the spices against the Caco-2, LLC-
PK1 and L-MDR1 cells as determined by the MTT assay. A spice is assumed to be non-
cytotoxic if it produced comparable or higher cell viability relative to the negative control 
(0.1% dextran). On this basis, capsaicin at concentrations ≥500 µM (Figure 2.2), aqueous 
garlic extract at concentrations ≥4 mg/ml (Figure 2.4) and ginger extract at 
concentrations ≥60 mg/ml (Figure 2.5) were deemed to be cytotoxic to Caco-2 cells.  
 
In contrast, piperine (up to 500 µM) (Figure 2.1), DAS (up to 300 µM) (Figure 2.3) and 
DADS (up to 300 µM) (Figure 2.3) were non-cytotoxic against the Caco-2 cells in the 
concentration ranges studied. 
 





















Figure 2.1 Cytotoxicity of piperine as a function of concentration as determined by the 
MTT assay on Caco-2 cells. HBSS, HBSS-HEPES buffer, pH 7.4 (vehicle control, 
assumed to yield 100% viability); NEG, 0.1% dextran (negative control); POS, 0.1% 
SDS (positive control); P 10, 10 µM; P 25, 25 µM; P 50, 50 µM; P 100, 100 µM; P 200, 


















Figure 2.2 Cytotoxicity of capsaicin as a function of concentration as determined by the 
MTT assay on Caco-2 cells. HBSS, HBSS-HEPES buffer, pH 7.4 (vehicle control, 
assumed to yield 100% viability); NEG, 0.1% dextran (negative control); POS, 0.1% 
SDS (positive control); C 10, 10 µM; C 25, 25 µM; C 50, 50 µM; C 100, 100 µM; C 200, 
200 µM; C 500, 500 µM. 
 



































Figure 2.3 Cytotoxicity of DAS and DADS as a function of concentration as determined 
by the MTT assay on Caco-2 cells. HBSS, HBSS-HEPES buffer, pH 7.4 (vehicle control, 
assumed to yield 100% viability); NEG, 0.1% dextran (negative control); POS, 0.1% 
SDS (positive control); DAS 50, DAS 50 µM; DAS 100, DAS 100 µM; DAS 200, DAS 
200 µM; DAS 300, DAS 300 µM; DADS 50, DADS 50 µM; DADS 100, DADS 100 µM; 



















Figure 2.4 Cytotoxicity of the aqueous extract of garlic as a function of concentration as 
determined by the MTT assay on Caco-2 cells. HBSS, HBSS-HEPES buffer, pH 7.4 
(vehicle control, assumed to yield 100% viability); NEG, 0.1% dextran (negative control); 
POS, 0.1% SDS (positive control); Gar 1, 1 mg/ml; Gar 2, 2 mg/ml; Gar 3, 3 mg/ml; Gar 
4, 4 mg/ml; Gar 5, 5 mg/ml. 
 
 





















Figure 2.5 Cytotoxicity of the ginger extract as a function of concentration as determined 
by the MTT assay on Caco-2 cells. HBSS, HBSS-HEPES buffer, pH 7.4 (vehicle control, 
assumed to yield 100% viability); NEG, 0.1% (negative control); POS, 0.1% SDS 
(positive control); Gin 12, 12 mg/ml; Gin 24, 24 mg/ml; Gin 30, 30 mg/ml; Gin 60, 60 





Cytotoxicity profile of the spices against the LLC-PK1 and L-MDR1 cells are presented 
in Figures 2.6-2.11. Piperine (up to 100 µM) (Figure 2.6), capsaicin (up to 200 µM) 
(Figure 2.7), DAS (up to 300 µM) (Figure 2.8) and DADS (up to 300 µM) (Figure 2.9) 
did not elicit any cytotoxic effect on the LLC-PK1 and L-MDR1 cells. In contrast, garlic 
extract at concentrations ≥4mg/ml and ginger extract at concentrations ≥60mg/ml showed 
moderate toxicity against both cell types. 
 























Figure 2.6 Cytotoxicity of piperine as a function of concentration as determined by the 
MTT assay on LLC-PK1 and L-MDR1 cells. HBSS, HBSS-HEPES buffer, pH 7.4 
(vehicle control, assumed to yield 100% viability); NEG, 0.1% dextran (negative control); 






















Figure 2.7 Cytotoxicity of capsaicin as a function of concentration as determined by the 
MTT assay on LLC-PK1 and L-MDR1 cells. HBSS, HBSS-HEPES buffer, pH 7.4 
(vehicle control, assumed to yield 100% viability); NEG, 0.1% dextran (negative control); 
POS, 0.1% SDS (positive control); C 10, 10 µM; C 25, 25 µM; C 50, 50 µM; C 100, 100 
µM; C 200, 200 µM. 
 
 






















Figure 2.8 Cytotoxicity of DAS as a function of concentration as determined by the MTT 
assay on LLC-PK1 and L-MDR1 cells. HBSS, HBSS-HEPES buffer, pH 7.4 (vehicle 
control, assumed to yield 100% viability); NEG, 0.1% dextran (negative control); POS, 
0.1% SDS (positive control); DAS 50, 50 µM; DAS 100, 100 µM; DAS 200, 200 µM; 


























Figure 2.9 Cytotoxicity of DADS as a function of concentration as determined by the 
MTT assay on LLC-PK1 and L-MDR1 cells. HBSS, HBSS-HEPES buffer, pH 7.4 
(vehicle control, assumed to yield 100% viability); NEG, 0.1% dextran (negative control); 
POS, 0.1% SDS (positive control); DADS 50, 50 µM; DADS 100, 100 µM; DADS 200, 
200 µM; DADS 300, 300 µM. 
 
 






















Figure 2.10 Cytotoxicity of the aqueous extract of garlic as a function of concentration as 
determined by the MTT assay on LLC-PK1 and L-MDR1 cells. HBSS, HBSS-HEPES 
buffer, pH 7.4 (vehicle control, assumed to yield 100% viability); NEG, 0.1% dextran 
(negative control); POS, 0.1% SDS (positive control); Gar 0.5, 0.5mg/ml; Gar 1, 1 mg/ml; 




















Figure 2.11 Cytotoxicity of the ginger extract as a function of concentration as 
determined by the MTT assay on LLC-PK1 and L-MDR1 cells. HBSS, HBSS-HEPES 
buffer, pH 7.4 (vehicle control, assumed to yield 100% viability); NEG, 0.1% (negative 
control); POS, 0.1% SDS (positive control); Gin 10, 10 mg/ml; Gin 20, 20 mg/ml; Gin 30, 
30 mg/ml; Gin 60, 60 mg/ml. 
 
In subsequent drug transport experiments on the Caco-2, LLC-PK1 and L-MDR1 cell 
monolayers, only the sub-cytotoxic concentrations of spices were used, with the 
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assumption that the spices at these concentrations did not cause substantial epithelial 
damage to the cells. 
 
2.4.2  [14C]-mannitol transport across Caco-2 cell monolayers 
Figure 2.12 shows the transport data for [14C]-mannitol across confluent Caco-2 cell 
monolayers. In the absence of spices, [14C]-mannitol (10 µM) fluxes in the AB and BA 
direction were comparable and linear with time over 180 min. The corresponding Papp 
values were 1.09 (±0.16) ×10-6 and 1.02 (±0.16) ×10-6 cm/s, respectively, yielding a net 
efflux ratio of 0.94. These values were consistent with literature values (Markowska et al., 
2001), suggesting the presence of intact intercellular tight junctions in the cell 
monolayers.  
y = 0.6935x + 19.014
R2 = 0.9978



























Figure 2.12 Cumulative transport of [14C]-mannitol (10 µM) across confluent Caco-2 
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Table 2.1 gives the Papp values and net efflux ratios when [14C]-mannitol transport across 
the Caco-2 cell monolayers was conducted in the presence of the spices. It was apparent 
from the Papp values that the spices exhibited different modulating effects on the mannitol 
transport. While DAS, at the concentrations employed, did not significantly modify the 
mannitol Papp values, high concentrations of piperine, capsaicin, aqueous garlic extract 
and ethanolic ginger extract were found to increase mannitol permeability across the 
Caco-2 cell monolayers. The effects of piperine were concentration-dependent. It did not 
change the Papp values significantly at concentrations below 100 µM, but raised the 
digoxin AB Papp value by 2.2 fold and the BA Papp by 1.4 fold when applied at 100 µM. 
Such polarized effects were not observed at the higher piperine concentration of 500 µM, 
which increased the AB and BA Papp values equally by about 2 fold.  
 
Capsaicin at 100 µM and above also increased the AB and BA Papp values, albeit to a 
lesser extent (1.3 to 1.4-fold) than piperine, without changing the net efflux ratio. Neither 
was the net efflux ratio of mannitol affected by DADS, which was the only spice to cause 
a reduction in bi-directional mannitol permeability at concentrations of 100 and 300 µM. 
Its activity contrasted sharply with those of the other garlic constituent, DAS, which was 
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Table 2.1 AB and BA permeability coefficient (Papp) and net efflux ratio for [14C]-
mannitol transport across polarized Caco-2 cell monolayers. Mannitol transport was 
conducted in the absence (control) and presence of spices. 
 
Papp (×10-6 cm/s) Sample AB BA Net efflux ratio 
Control 1.09 ± 0.16 1.02 ± 0.18 0.94 
Piperine (µM)    
10 1.10 ± 0.08 1.09 ± 0.06 0.99 
50 1.20 ± 0.10 1.23 ± 0.12 1.03 
100 2.21 ± 0.37* 1.43 ± 0.20* 0.65 
500 2.01 ± 0.36* 1.92 ± 0.21* 0.96 
Capsaicin (µM)    
10 1.10 ± 0.08 1.07 ± 0.03 0.97 
50 1.15 ± 0.20 1.15 ± 0.10 1.00 
100 1.46 ± 0.09* 1.47 ± 0.16* 1.01 
250 1.37 ± 0.17* 1.39 ± 0.19* 1.01 
DAS (µM)    
100 1.11 ± 0.16 1.08 ± 0.20 0.97 
300 0.996 ± 0.12 1.05 ± 0.10 1.05 
DADS (µM)    
100 0.41 ± 0.07* 0.37 ± 0.04* 0.90 
300 0.42 ± 0.05* 0.35 ± 0.06* 0.83 
Garlic extract (mg/ml)    
1.5 1.51 ± 0.25* 2.46 ± 0.19* 1.63 
3.0 1.82 ± 0.23* 4.78 ± 0.38* 2.63 
Ginger extract (mg/ml)    
12 0.91 ± 0.19 1.19 ± 0.13 1.31 
24 1.22 ± 0.20 1.81 ± 0.14* 1.48 
30 1.26 ± 0.09 1.94 ± 0.12* 1.54 
Data are presented as mean ± SD, n=4. * p≤0.05 compared to control. Net efflux ratio 
was calculated as mean BA Papp to mean AB Papp. HBSS-HEPES (pH 7.4) was the 
transport medium. Spices were added to both donor and receiver chambers.  
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Conversely, the 3rd garlic sample, comprising the aqueous extract, was observed to 
enhance mannitol permeability at the concentrations of 1.5 and 3 mg/ml. Although these 
concentrations were non-cytotoxic against the Caco-2 cells, they produced a dramatic 
enhancement of the BA mannitol Papp value, by as much as 4.8 fold when applied at 3 
mg/ml. The aqueous garlic extract also produced a polarizing effect on the mannitol 
transport, as evident by the higher net efflux ratios obtained in its presence. A unilateral 
promotion of mannitol transport in the BA direction was also observed with the ginger 
extract at concentrations ≥24 mg/ml. Accordingly, the net efflux of mannitol was 
increased with increasing concentration of ginger extract from 24 to 30 mg/ml. 
 
Table 2.2 shows the TEER changes in the Caco-2 cell monolayers in response to the 
spices. The tabulated values refer to the final TEER, measured after the mannitol 
transport experiments, expressed as a percentage of the corresponding initial TEER. In 
the absence of spices, the Caco-2 cell monolayers did not show significant changes in 
TEER following exposure for 180 min to 10 µM of [14C]-mannitol in HBSS-HEPES (pH 
7.4).  
 
The spices generally lowered the cellular TEER in a concentration-dependent manner, 
although DADS again bucked the trend by increasing the TEER at the concentrations 
employed. In general, the TEER values were in agreement with the measured mannitol 
permeability in that lower mannitol Papp was associated with higher TEER and vice versa. 
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Table 2.2 Changes in TEER (post-transport TEER expressed as a percent to pre-transport 
TEER, mean ± SEM, n=4-6) of Caco-2 cell monolayers after AB and BA mannitol 
transport experiments conducted over 180 min at 37oC in the absence (control) and 
presence of spices.  
 
Samples TEER % 
Control 98.9 ± 1.4 
Piperine (µM)  
10 96.5 ± 5.5 
50 97.9 ± 4.5 
100 77.8 ± 7.0* 
500 41.4 ± 2.1* 
Capsaicin (µM)  
10 97.4 ± 5.3 
50 94.8 ± 6.0 
100 80.6 ± 8.5* 
250 56.14 ± 2.9* 
DAS (µM)  
100 98.4 ± 4.2 
300 92.2 ± 7.0 
DADS (µM)  
100 110.4 ± 7.0 
300 113.3 ± 3.0* 
Garlic extract (mg/ml)  
1.5 67.0 ± 3.1* 
3.0 60.2 ± 7.5* 
Ginger extract (mg/ml)  
12 100.3 ± 4.5 
24 89.8 ± 7.7 
30 82.2 ± 4.5* 
Data are presented as mean ± SD, n=4. * p<0.05 compared to control. 
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2.4.3  [3H]-digoxin transport across LLC-PK1 and L-MDR1 cell monolayers 
Effects of spices on P-gp function was evaluated by measuring the transepithelial 
transport of [3H]-digoxin across LLC-PK1 and L-MDR1 cell monolayers. There were no 
significant differences in TEER measured before (0 h) and after (4 h) the drug transport 
experiments for both cell types (Table 2.3). In the absence of spices, digoxin transport in 
the L-MDR1 cells was strongly polarized, the efflux ratio being 5.5 (Table 2.4). In the 
presence of 100 µM of verapamil, digoxin transport in the AB direction was enhanced 
while that in the BA direction was inhibited, and the net efflux ratio was reduced to 1.3. 
Although digoxin transport was also polarized in the parental LLC-PK1 cells, suggesting 
the presence of endogenous porcine P-gp, a much lower efflux ratio of 2.0 was obtained. 
The co-administration of verapamil effectively abolished the polarized digoxin transport 
in the LLC-PK1 cells. 
 
In parallel experiments, spices were supplemented into the transport medium. The 
corresponding Papp values and efflux ratios are given in Table 2.4. Piperine and capsaicin 
exhibited similar activities as verapamil on the digoxin transport across the L-MDR1 
cells. They increased AB digoxin transport with concomitant inhibition of BA digoxin 
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Table 2.3 Changes in TEER (post-transport TEER expressed as a percent to pre-transport 
TEER, mean ± SEM, n=4-6) of L-MDR1 and LLC-PK1 cell monolayers after AB and 
BA mannitol transport experiments conducted over 4 h at 37oC in the absence (control) 
and presence of spices.  
 
 
Sample L-MDR1 LLC-PK1 
Control 97.6±2.3 96.2±3.4 
Piperine (µM)   
10 94.4±4.6 92.9±5.2 
25 96.3±3.0 102.1±4.1 
50 91.3±4.6 93.5±2.5 
100 90.4±6.1 92.7±3.1 
Capsaicin (µM)   
10 95.2±4.5 101.5±6.9 
25 99.5±4.8 97.4±8.1 
50 90.2±6.3 97.4±5.1 
100 90.5±7.9 93.5±4.2 
200 90.1±5.2 92.0±4.9 
DADS (µM)   
100 95.3±5.3 91.8±7.2 
200 90.9±6.4 96.5±5.4 
300 94.2±2.3 95.1±3.6 
DAS (µM)   
100 101.3±4.1 96.5±4.6 
200 97.5±4.8 100.5±3.4 
300 96.7±4.5 91.4±5.7 
Garlic extraction (mg/ml)   
0.25 96.7±5.2 99.±4.9 
0.5 95.1±5.8 99.5±8.1 
1 104.5±6.7 101.8±4.1 
Ginger extraction (mg/ml)   
10 93.1±6.1 94.2±4.2 
20 103.5±6.3 92.5±4.9 
30 90.3±6.8 94.6±7.5 
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Piperine at a concentration of 50 μM and capsaicin at a concentration of 100 μM 
produced comparable inhibition effects on the polarity of digoxin transport, as measured 
by the efflux ratio, as 100 μM of verapamil. At higher concentrations, piperine and 
capsaicin produced even lower digoxin efflux ratios that approached unity, suggesting an  
abolishment of P-gp activity. In contrast, the garlic samples comprising of DAS, DADS 
and the aqueous extract, while also increasing the AB Papp values of digoxin, did not 
lower the BA Papp values to the same extent as verapamil. Consequently, the digoxin 
efflux ratios remained relatively high under the influence of these spices, suggesting that 
their modulating effects may not be related to an inhibition of the P-gp function. Digoxin 
Papp values obtained with the ethanolic extract of ginger also had the fingerprint of a P-gp 
inhibitor, but the effects were weaker than those observed for piperine and capsaicin. 
Given its poor cytotoxicity profile at higher concentrations and high potential for 
composition variability, the ginger extract was not deemed an attractive candidate for 
further studies.  
 
2.5 Conclusions 
The MTT assay showed that the aqueous extract of garlic at concentrations higher than 4 
mg/ml and the ethanolic extract of ginger at concentrations ≥ 60 mg/ml were cytotoxic 
against the Caco-2, LLC-PK1 and L-MDR1 cell monolayers. Capsaicin, at concentrations 
≥ 500 µM, was also cytotoxic to the Caco-2 cells. In contrast, DAS (up to 300 µM), 
DADS (up to 300 µM) and piperine (up to 500 µM) did not affect the viability of the 
Caco-2, LLC-PK1 and L-MDR1 cells as measured by the MTT assay. 
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Table 2.4 AB and BA permeability coefficient (Papp) and net efflux ratio for [3H]-digoxin 
transport across L-MDR1 and LLC-PK1 cell monolayers. Digoxin transport was 
conducted in the absence (control) and presence of spices.  
 
L-MDR1 cells LLC-PK1 cells 
Papp (×10-6) (cm/s) Papp (×10-6) (cm/s) Sample 
AB BA 
Net 
efflux AB BA 
Net 
efflux 
Control 1.26±0.06 6.94±0.15 5.51 2.02±0.22 4.01±0.18 1.99 
100 µM 
verapamil 
2.93±0.09* 3.91±0.13* 1.33 3.12±0.31 3.17±0.08* 1.02 
Piperine (µM)   
10 2.28±0.25* 5.51±0.19* 2.42 2.27±0.25 3.59±0.16 1.58 
25 2.53±0.17* 4.78±0.16* 1.89 2.13±0.13 3.21±0.19* 1.54 
50 2.65±0.21* 3.57±0.24* 1.33 2.24±0.11 3.12±0.09* 1.39 
100 3.47±0.16* 3.45±0.14* 0.99 2.53±0.21 2.89±0.04* 1.14 
Capsaicin (µM)   
10 2.01±0.08* 4.54±0.15* 2.26 1.85±0.08 4.44±0.07 2.40 
25 2.44±0.25* 4.60±0.12* 1.89 2.68±0.11* 3.75±0.09 1.40 
50 2.85±0.24* 4.58±0.13* 1.61 2.49±0.13 3.10±0.07* 1.24 
100 2.94±0.19* 3.65±0.03* 1.24 2.56±0.09 3.08±0.07* 1.20 
200 3.07±0.07* 3.45±0.02* 1.12 3.02±0.08* 3.16±0.06* 1.05 
Data are presented as mean±SD, n=4-6. Net efflux ratio calculated as mean BA Papp to 
mean AB Papp *, p<0.05 relative to control. HBSS-HEPES (pH 7.4) was transport 
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Table 2.4 Continued. AB and BA permeability coefficient (Papp) and net efflux ratio for 
[3H]-digoxin transport across L-MDR1 and LLC-PK1 cell monolayers. Digoxin transport 
was conducted in the absence (control) and presence of spices.  
 
L-MDR1 cells LLC-PK1 cells 
Papp (×10-6) (cm/s) Papp (×10-6) (cm/s) Sample 
AB BA 
Net 
efflux AB BA 
Net 
efflux 
Control 1.26±0.06 6.94±0.15 5.51 2.02±0.22 4.01±0.18 1.99 
100 µM 
verapamil 
2.93±0.09* 3.91±0.13* 1.33 3.12±0.31 3.17±0.08* 1.02 
DADS (µM)   
100 1.68±0.08* 5.20±0.10* 3.10 2.11±0.21 4.14±0.20 1.96 
200 2.07±0.13* 5.76±0.20* 2.78 2.46±0.17 4.13±0.20 1.68 
300 3.35±0.33* 5.77±0.27* 1.72 2.82±0.11* 3.87±0.23 1.37 
DAS (µM)   
100 1.71±0.07* 6.71±0.24 3.93 2.77±0.13* 3.61±0.20 1.30 
200 2.08±0.10* 6.55±0.31 3.15 2.11±0.20 3.81±0.16 1.81 




0.25 1.21±0.02 6.35±0.18* 5.25 1.82±0.09 3.08±0.16* 1.69 
0.50 2.40±0.12* 7.44±0.16 3.10 2.02±0.13 3.14±0.08* 1.55 




10 2.27±0.07* 4.36±0.18* 1.60 2.46±0.13 2.93±0.10* 1.19 
20 2.80±0.21* 4.89±0.11* 1.75 2.93±0.09* 2.94±0.13* 1.00 
30 2.80±0.15* 4.04±0.09* 1.44 2.37±0.04 2.27±0.07* 0.96 
Data are presented as mean±SD, n=4-6. Net efflux ratio calculated as mean BA Papp to 
mean AB Papp *, p<0.05 relative to control. HBSS-HEPES (pH 7.4) was transport 
medium. Spice was also to both donor and receptor compartments. 
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DADS at concentrations of 100 and 300 µM tightened the paracellular junctions of the 
Caco-2 cell monolayers, causing the monolayer TEER to increase and [14C]-mannitol 
transport to decrease. In contrast, piperine at 100 and 500 µM, and capsaicin at 100 and 
250 µM, facilitated mannitol transport through the Caco-2 cell monolayers. Ginger 
extract at the concentration range of 24 to 30 mg/ml caused modest increase in mannitol 
transport. In these cases, the enhanced mannitol transport was accompanied by 
substantial lowering of the cell monolayer TEER. DAS at 100 and 300 µM did not 
significantly affect the bi-directional mannitol transport across the Caco-2 cell 
monolayers. 
 
Bi-directional [3H]-digoxin transport data across the polarized L-MDR1 cell monolayers 
indicated that the P-gp function was inhibited by piperine and capsaicin in a 
concentration-dependent manner. Both spices were capable of producing comparable 
inhibitory activity as the established P-gp inhibitor, verapamil. Although the ginger 
extract showed potential inhibitory action on the P-gp, its activity was comparatively 
weaker than that produced by 100 µM of verapamil. Garlic extract and its constituents, 
DAS and DADS, also modified digoxin transport, but not in a manner consistent with a 
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3.1 Introduction 
As the screening of common spices had shown piperine and capsaicin to modulate P-gp 
activity at non-cytotoxic concentrations, these two spices were the focus of attention in 
subsequent studies. The first of such studies involved the investigation of piperine and 
capsaicin on cellular proliferation. The rationale for this study was two-fold. Firstly, 
spices are consumed on a regular basis over long periods by specific people groups, and it 
will be interesting to determine the effects of these spices on cellular proliferation. 
Secondly, in the evaluation of the spices on P-gp expression, cells were exposed to the 
spices for several days. To delineate the cytotoxicity of the spices from their specific 
action on P-gp expression, it was necessary to apply the MTT assay on the cells 
following prolonged exposure to the spices.  
 
Of the two spices, capsaicin has been more extensively studied for its role in cell 
proliferation over the past decades. As for piperine, there have been very limited 
literature reports in this area, and the reports have been restricted to in vivo experiments 
using animal lung carcinoma models (Selvendiran et al., 2004; Selvendiran and 
Sakthisekaran, 2004). To date, no conclusion has yet been established on the 
carcinogenic potential and anti-proliferation activities of these two spices (Surh and Lee, 
1996; Surh et al., 1998), although capsaicin was implicated to have both carcinogenic and 
chemopreventive properties. Epidemiological studies have linked the consumption of 
chilli to an increased risk of stomach and liver cancer (Archer and Jones, 2002). Yet, 
increasing number of in vitro studies involving a wide range of cancer cell lines, 
including leukemia cells (Zhang et al., 2003), prostate cancer cells (Mori et al., 2006) and 
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hepatocarcinoma cells (Jung et al., 2001), have shown capsaicin to possess anti-
proliferation activity against cancer cells. Capsaicin appeared to inhibit cell proliferation 
by interfering with signal transduction pathways, cell cycle arrest as well as apoptosis 
(Jung et al., 2001; Zhang et al., 2003; Min et al., 2004). The controversial findings on 
capsaicin and the limited studies on piperine indicate that there is further scope for 
research in this area. In addition, there is little published information on intestinal cell 
proliferation in the presence of piperine and capsaicin. For these reasons, the cytotoxic 
profiles of piperine and capsaicin, upon prolonged exposure to the cell models used in 
this project, were studied. 
 
The second rationale for this study hinges on the observation that changes in cell 
proliferation rate may affect the function and expression of membrane transporters, 
particularly if they impact on the cell self-selection process. For example, the anti-
proliferation effect of the anticancer drug, doxorubicin, has been found to be associated 
with an overall increase in membrane P-gp expression because of the higher death rate 
amongst cells with lower P-gp level (Pesic et al., 2006). Such selection process, if any, 
will directly interfere with the evaluation of spice-mediated changes in transporter 
expression and function. 
 
The objective of this chapter was to evaluate the effects of piperine and capsaicin on the 
proliferation of Caco-2, LLC-PK1 and L-MDR1 cells. The concentrations of piperine and 
capsaicin applied for this study were those shown to be non-cytotoxic upon acute 
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exposure to the cells (section 2.4.1). In addition, we examined the influences of the spices 
on the cell cycle of these cells by flow cytometric analysis. 
 
Cellular proliferation is a tightly regulated process involving an ordered sequence of 
molecular events ensuring that, before division, cells have completed DNA replication 
and chromosome segregation (Corroyer et al., 1996). The cell cycle therefore defines a 
specific pattern of cell division. Cell cycle progression is regulated through major 
checkpoints located before the entry into the DNA synthesis (S) phase and into the 
mitotic (M) phase (Sherr, 1994). On this basis, the cell cycle of eukaryotic cells can be 
divided into four consecutive but distinct phases: the G1/G0, S, G2 and M phases. 
 
The G1/G0 (resting) phase generally has the longest duration in the cell cycle. Cells in G1 
phase may withdraw from the cell cycle and undergo quiescence, otherwise known as G0 
phase. Cells in G0 phase no longer have the capacity to proliferate but undergo the 
process of terminal differentiation in order to undertake their specialized function. 
Commitment to G0 may occur when cells reach maximal confluence (contact inhibition) 
or when nutrients are in short supply. Failure of cells to terminally differentiate triggers 
their progression through the cell cycle and it is during the late stage of G1 that the cells 
prepare themselves for entry into the S phase and another round of replication. The S 
(DNA synthesis) phase is the only period of the cell cycle in which DNA synthesis can 
occur. It has a typical duration of between 6 and 8 h for cultured cells. It is during the 
first half of the S phase that DNA and histone synthesis is maximal. The G2 phase is an 
additional gap phase that separates the S and M phases of the cell cycle. This phase is an 
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important regulatory period of the cell cycle where progression to mitosis may be delayed 
if the DNA is damaged or external environmental factors are unfavorable. The M phase is 
the period of the cell cycle where nuclear division occurs, and it can be further 
subdivided into two distinct phases where the cells first undergo chromosomal 




Materials for cell culture and the MTT assay were similar to those listed in section 2.2. 
Materials for cell cycle analysis included propidium iodide (PI) and RNase A from 




3.3.1 MTT assay 
Caco-2 (passage 52-56), LLC-PK1 (Passage 230-240) and L-MDR1 (passage 225-235) 
cells were cultured in 96-well plates using methods similar to those described in section 
2.3.4. Following cell attachment (24h post-incubation), the culture medium in each well 
was replaced with fresh culture medium containing 0 to 100 µM of piperine or capsaicin, 
which had previously been sterilized by filtering through 0.2 µm filter (Millipore, 
Billerica, MA, USA). After another 72h of culture in the CO2 incubator, the medium was 
aspirated and the cells washed thrice with PBS buffer. Cell viability was determined by 
the MTT assay as described in section 2.3.4. 
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3.3.2 Flow cytometric analysis of cell cycle 
LLC-PK1 (Passage 245-250), L-MDR1 (Passage 225-229) cells, at the number of 
1.5×106, and Caco-2 (Passage 55-60) cells, at the number of 3×106, were separately 
seeded into 75-cm2 tissue culture flasks with 15 ml of the respective culture medium. 
Culture media used were M199 (for LLC-PK1 and L-MDR1 cells) and MEM (for Caco-2 
cells). After 24 h in the CO2 incubator, the cells were exposed to fresh culture medium 
containing piperine or capsaicin (50 and 100 µM). Cells cultured in fresh medium devoid 
of spices were taken as controls. 
 
Cell cycle analysis was performed after 24 and 48 h of incubation. Floating cells were 
collected from the spent medium via centrifugation at 5000 g, 4oC, for 5 min using a 
Hettich Micro 22 microcentrifuge (Andreas Hettich GmbH& Co KG, Tuttlingen, 
Germany). Attached cells were trypsinized, washed with cold PBS, and pooled with the 
floating cells. The cells were fixed with 75% of ethanol, stored at -20oC overnight, 
washed again with PBS and then stained. The staining solution comprised of 200 µg/ml 
of RNase A, 20 µg/ml of propidium iodide and 0.1% of Triton X-100 in PBS. Cells were 
analyzed in a Cyan LX (Dako-Cytomation, Fort Collins, CO, USA) instrument and at 
least 104 events were recorded. Cell cycle distribution was analyzed using the 




Chapter 3.    Effects of piperine and capsaicin on cell proliferation 
 77
 
3.3.3 Statistical analyses 
Treated groups were compared with control groups for statistical difference using one-
way ANOVA, with the Tukey’s test applied for paired comparisons of mean values. The 
p value was set at 0.05. 
 
3.4 Results  
3.4.1 Anti-proliferation activity 
Both piperine and capsaicin inhibited the proliferation of Caco-2, LLC-PK1 and L-
MDR1 cells in a concentration-dependent manner (Figure 3.1). The anti-proliferation 
activity of piperine and capsaicin was also dependent on cell type. While the Caco-2 cell 
growth was significantly inhibited at 10 µM of piperine (Figure 3.1A), the proliferation 
of LLC-PK1 and L-MDR1 cells was significantly inhibited only when the concentration 
of piperine was 50 µM or higher. In the case of capsaicin (Figure 3.1B), only the 
proliferation of L-MDR1 cells was inhibited at the concentration of 10 µM, whereas 
capsaicin at 50 and 100 µM inhibited the proliferation of all three cell lines.  
 
Of the three cell types, the LLC-PK1 cells appeared to be most resistant to the anti-
proliferation effects of piperine and capsaicin. As the LLC-PK1 cells were the parental 
cells from which the L-MDR1 cells were derived, it led to a concern that piperine and 
capsaicin might be more potent in inhibiting the proliferation of cells with higher P-gp 
expression. If this selection process existed among the L-MDR1 cells, a lower than 
baseline P-gp level would be expected in the surviving L-MDR1 cells following piperine 
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or capsaicin exposure. Subsequent experiments performed on Caco-2 cells indicated that 
this was not the case (section 5.4.2), for a prolonged exposure to piperine and capsaicin 














































Figure 3.1 Effects of (A) piperine and (B) capsaicin on the proliferation of Caco-2, LLC-
PK1 and L-MDR1 cells after 72 h of co-incubation. Data are presented as mean ± S.D. 
(n=8). *, significantly different from control group (p<0.05). MED, culture medium 
(control); P 10, piperine 10 µM; P 50, piperine 50 µM; P 100 piperine 100 µM; C 10, 
capsaicin 10 µM; C 50, capsaicin 50 µM; C 100 capsaicin 100 µM. 
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3.4.2  Cell cycle analysis 
The effects of piperine and capsaicin on the cell cycles of Caco-2, LLC-PK1 and L-
MDR1 cells were analyzed by flow cytometry after 24 and 48 h of co-incubation. These 
co-incubation times were different from that for the anti-proliferation experiments. An 
incubation time of 72 h was chosen for the latter in order to correlate the anti-cell 
proliferation activity of the spices with their capacity to modulate the expression of the P-
gp transporter (Chapter 5). This longer time frame could not, however, be applied to the 
cell cycle analysis because it would lead to cell confluence, and artificially raise the 
percent of cells in the G1/G0 phase. Moreover, as the interval between mitosis in 
mammalian cells is typically of the order of 12 to 24 h, the incubation periods of 24 and 
48 h would cover at least two cell cycles, and allow for any spice-mediated interferences 
of cell cycle progression to be manifested in the 3 cell lines.   
 
As shown in Figures 3.2 to 3.4, exposure to piperine moderately delayed the cell cycle 
progress of all 3 cell lines at the G1/G0 phase. There were, however, subtle differences in 
response among the cell types. The percentage of LLC-PK1 cells in the G1/G0 phase was 
significantly increased by co-incubation for 24 h with either 50 or 100 µM of piperine, 
but when the incubation time was prolonged to 48 h, the effect was seen only with 
piperine at 100 µM (Figure 3.2). With the L-MDR1 cells, cell cycle delay at the G1/G0 
phase was observed after 24h incubation with 100 µM of piperine, and with both 50 and 
100 µM of piperine after 48h incubation. Co-incubation of Caco-2 cells with up to 100 
µM of piperine for 24h did not yield significantly different results (Figure 3.4), but when 
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the treatment was prolonged to 48h, piperine at both 50 and 100 µM caused a G1/G0 










































Figure 3.2 Cell cycle distribution of LLC-PK1 cells after (A) 24 h; (B) 48 h of 
incubation with piperine and capsaicin. CON, control; C 50, capsaicin 50 µM; C 100, 
capsaicin 100 µM; P 50, piperine 50 µM; P 100, piperine 100 µM. Data are expressed as 
mean ± S.E.M. (n=3). *, significantly different from control group (p<0.05). 
 
Exposure to capsaicin also led to moderate prolongation of the G1/G0 phase, again with 
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observed for LLC-PK1 cells after 24h of incubation with capsaicin (100 µM), but not at 
48h of incubation (Figure 3.2), while the converse was true of L-MDR1 cells (Figure 3.3). 
Capsaicin did not affect the cell cycle progression of the Caco-2 cells under the 






































Figure 3.3 Cell cycle distribution of L-MDR1 cells after (A) 24 h; (B) 48 h of incubation 
with piperine or capsaicin. CON, control; C 50, capsaicin 50 µM; C 100, capsaicin 100 
µM; P 50, piperine 50 µM; P 100, piperine 100 µM. Data are expressed as mean ± S.E.M. 
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Figure 3.4 Cell cycle distribution of Caco-2 cells after (A) 24 h; (B) 48 h of incubation 
with piperine or capsaicin. CON, control; C 50, capsaicin 50 µM; C 100, capsaicin 100 
µM; P 50, piperine 50 µM; P 100, piperine 100 µM. Data are expressed as mean ± S.E.M. 
(n=3). *, significantly different from control group (p<0.05). 
 
3.5     Discussion  
Xenobiotics could induce cytotoxicity by interfering with cellular regulation (Fischer et 
al., 2000), intracellular synthesis of macromolecules (Zhang et al., 1992) or cellular 
transduction signaling (Kanno et al., 2001). Using the MTT assay, we have shown that 
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capsaicin at concentrations that would otherwise not impart cytotoxicity against the cells 
on immediate contact. In addition, cell cycle analysis indicated that both spices 
modulated the cell cycle progression of the 3 cell lines. On this basis, it would be natural 
to correlate the two effects, for some studies have demonstrated the ability of cells to 
delay or arrest their replication cycle in the G1/G0 or G2/M phase in order for repair to 
take place (Lin et al., 1999). If the DNA repair system becomes overburdened due to too 
much damage, the cell will undergo apoptosis or other death processes, leading to a 
significant reduction of viable cells.  
 
However, compared with other known cell cycle modulators, such as curcumin, piperine 
and capsaicin could only be considered to have modest effects on the cell cycle of Caco-2, 
LLC-PK1 and L-MDR1 cells. Despite the statistically significant data, both spices did not 
mediate more than 30% increase in the percent of cells retained in the G1/G0 phase 
compared to controls. In contrast, curcumin has been shown to cause more than 50% 
increase in the accumulation of cells in the G2/M phase for the HCT-116 and other cell 
lines (Chen et al., 1999a; Moragoda et al., 2001). From this perspective, it may be 
concluded that piperine and capsaicin did not have a strong impact on the cell cycle 
progression of Caco-2, LLC-PK1 and L-MDR1 cells over a 48h co-incubation period.  
 
The implication is that, apart from the arrest of the G1/G0 phase, other mechanisms might 
be in operation. In a study of endothelial cells (Min et al., 2004), Min et al suggested that 
capsaicin might modulate cell cycle progression by down-regulating the cyclin D1 
expression. In addition, the spices might interfere with cell signaling pathways, for both 
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piperine and capsaicin have been demonstrated to influence transcription factors, such as 
the nuclear factor-kappaB (NF-kB) (Pradeep and Kuttan, 2004; Patel et al., 2002a). 
Further experimentation will be required to confirm the operative mechanisms of piperine 
and capsaicin on cell proliferation. 
 
3.6 Conclusions 
Prolonged incubation with piperine and capsaicin can affect cell proliferation and cell 
cycle progression at concentrations which are non-cytotoxic upon short-term contact. 
Proliferation of Caco-2, LLC-PK1 and L-MDR1 cells was inhibited by 72h of co-
incubation with piperine and capsaicin at 50 and 100 µM. The anti-cell proliferation 
activities of the two spices were influenced by the concentration and duration of exposure 
to the spice. Piperine and capsaicin at comparable concentrations also caused cell cycle 
delay at the G1/G0 phase for the LLC-PK1 and L-MDR1 cells. The cell cycle progression 
of the Caco-2 cells was similarly affected by piperine but not by capsaicin. Compared to 
established cell cycle modulators, the two spices could only be regarded to have modest 
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4.1 Introduction 
We have shown in Chapter 2 that piperine and capsaicin, at concentrations higher than 
100 µM, could affect the paracellular transport pathway of Caco-2 cells. Experiments 
performed in this chapter aimed to evaluate the effects of piperine and capsaicin on the 
paracellular pathway upon prolonged co-incubation. Again, the prolonged incubation was 
to reflect the regular consumption of these spices over long periods by certain 
populations. A reason more specific to this project was to delineate the effects of the 
spices on the paracellular transport pathway from those on P-gp mediated efflux upon 
prolonged incubation. To fulfill this objective, [14C]-mannitol transport experiments were 
performed on Caco-2 cell monolayers co-cultured for 18 days with either piperine or 
capsaicin. In addition, the effects of the spices on the expression and distribution of tight 
junction (TJ) proteins were also evaluated using western blot and immunofluorescence  
staining techniques, respectively. In the following paragraphs, current knowledge related 
to the TJ and associated proteins are briefly discussed. 
 
The TJ is the most apical component of the junctional complex and it functions as the 
“fence” separating the apical from the basolateral domains (van Meer and Simons, 1986). 
In response to various signals, the TJ selectively opens and closes to allow or limit the 
passage of hydrophilic molecules across the epithelial barrier (Reuss, 1991; Powell, 
1981). The TJ of epithelial cells therefore serves as a “gateway” between the vascular 
circulation and the external environment. Compounds that disrupt the TJ may facilitate 
the opportunistic migration of microbes or macromolecules, e.g. toxins, allergens and 
other peptides, across the absorptive epithelia (Taylor et al., 1999; Tsukazaki et al., 2005) 
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On the other hand, the same compounds, when used judiciously, may serve as permeation 
enhancers by allowing sufficient levels of therapeutic peptides to permeate across 
absorptive epithelia (Artursson, 1990; Sakai et al., 1998).  
 
The TJ does not work independently. In intestinal epithelial cells, it is extensively linked 
with the actin network (Drenckhahn and Dermietzel, 1988) and the adherens junctions 
(Madara, 1987). Ten proteins are known to be specifically localized to the TJ (Stevenson 
and Keon, 1998). Among these, the zonula occludens-1 (ZO-1) was the first to be 
characterized (Stevenson et al., 1986). The ZO-1 (Figure 4.1) is a phosphorylated protein 
of 210 to 225 kDa (Stevenson et al., 1986) that is found at the points where the TJ 
membrane contacts the polarized epithelial and endothelial cells (Anderson et al., 1988; 
Stevenson et al., 1986). It is also found in some cadherins junctions, such as the 
intercalated discs of cardiac myocytes (Hresko et al., 1994), and in the nucleus under 
certain experimental and physiological conditions (Gottardi et al., 1996). Phosphorylation 
of ZO-1 at the serine residues has been demonstrated at steady state conditions, whereas 
tyrosine phosphorylation occurred in response to certain extracellular stimuli (Anderson 
et al., 1988; Kurihara et al., 1995; Staddon et al., 1995). This suggests that the ZO-1 may 
serve multiple roles in cells. Two isoforms of ZO-1 (ZO-1a- and ZO-1a+) have been 
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Figure 4.1  Model depicting the protein components of the apical junction complex, the 
tight and adherens junctions, in a highly polarized epithelial cell. (a) Continuous cell-cell 
contact is made at the apical end of the lateral interspace where a ring of bidirectional 
actin filaments is concentrated. (b) The boxed region is depicted at higher magnification, 
showing identified proteins and their protein associations. Some proteins are specific to 
one junction; others may be shared (broken boxes). (c) Interpretation of freeze-fracture 
EM images showing barriers formed by the intercellular contact of branching linear 
polymers of occludin and its cytoplasmic scaffold (Mitic and Anderson, 1998). 
 
ZO-1 belongs to the membrane-associated guanylate kinase (MAGUK) family of proteins 
(Anderson, 1996). The common properties of MAGUK proteins are that they all have a 
core group of protein-protein interaction domains and they localized at the cytoplasmic 
surface of the plasma membrane (Traweger et al., 2003). Genetic and biochemical studies 
indicate that MAGUK proteins are involved in organizing transmembrane protein 
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complexes (Fanning et al., 1996), maintaining TJ function, and signal transduction 
(Dimitratos et al., 1999; Pfister et al., 2003). 
 
ZO-1 binds to the COOH-terminal tail of occludin (Figure 4.1) (Furuse et al., 1994), 
another transmembrane protein that plays a direct role in the paracellular permeability 
barrier (Furuse et al., 1993). Occludin is the only known integral membrane component 
of the TJ with molecular size of 60 to 80 kDa (Furuse et al., 1993). Under the electron 
microscope, it appears as rows of intramembrane particles with long branching fibrils 
circumscribing the cell (Claude, 1979). Occludin comprises four transmembrane domains, 
with both N and C termini oriented into the cytoplasm and two extracellular loops 
projecting into the paracellular space (Figure 4.1). It is possible that the paracellular loops 
of certain occludin molecules interact with those from neighboring cells so that the 
paracellular compartment of the cells is sealed. Occludin is a phosphorylated protein and 
its actual size varies between 62 and 82 kDa, depending upon the degree of 
phosphorylation (Sakakibara et al., 1997; Wong, 1997). Phosphorylation occurs on the 
serine or threonine residues, and the degree of phosphorylation may affect its localization 
in the cell. The smaller, less phosphorylated forms are found in the basolateral membrane, 
cytosol and TJ, whereas the larger, more heavily phosphorylated form is concentrated 
exclusively in the TJ (Sakakibara et al., 1997). 
 
Other major TJ proteins include Cingulin (Citi et al., 1988), 7H6 (Zhong et al., 1993), 
RAB3B (Goud et al., 1990), Symplekin (Keon et al., 1996), AF-6 (Prasad et al., 1993), 
19B1 (Merzdorf and Goodenough, 1997) and actin (Hirokawa and Tilney, 1982). Actin 
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was actually the first protein shown by morphological techniques to be associated with 
the junctional membrane, although it is not exclusively localized to the TJ (Hirokawa and 
Tilney, 1982). Treatment of epithelial cells with agents that disrupt the actin cytoskeleton 
resulted in alterations in junction architecture and flux through the paracellular space 
(Bentzel et al., 1976). Similarly, manipulations that alter junctional permeability have 
been found to cause perturbations in actin filament arrangement (Madara, 1983). 
 
The identification of TJ proteins in the Caco-2 cell monolayers was performed using 
western blot techniques. Among the methods for protein determination, the western blot 
is one of the most widely used (Burnette, 1981). It requires the extraction of cell 
membranes followed by the denaturation of proteins which are size-fractionated by 
polyacrylamide gel electrophoresis. The protein is further transferred onto nitrocellulose 
or PVDF (polyvinylidene fluoride) membrane and probed with appropriate antibodies. 
The denaturing and reducing conditions allow for the determination of the precise size of 
the target protein. Immunofluorescent staining of TJ proteins was also carried out to 
assess their morphology and distribution in the cell. 
 
4.2 Materials 
Anti-ZO-1 polyclonal antibody was from Zymed Laboratories (South San Francisco, CA, 
USA); anti-occludin polyclonal antibody was from Santa Cruz Biotechnology (Santa 
Cruz, CA, USA); anti-actin antibody, horseradish peroxidase antibodies (secondary 
antibody to ZO-1, occludin and β-actin, respectively), FITC-conjugated secondary 
antibody to ZO-1, paraformaldehyde, bovine serum albumin (BSA), Kodak film and 
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N,N,N’,N’-tetramethyl-ethylenediamine (TEMED) were purchased from Sigma-Aldrich 
Inc; Texas red-X phalloidin was from Molecular Probes, Inc. (Eugene, OR, USA); 
SuperSignal West Pico chemiluminescent substrate was from Pierce, Inc. (Rockford, IL, 
USA); β-mercaptoethanol was from Merck & Co., Inc. (Damstadt, Germany); PVDF 
membrane, protein assay dye reagent, dithiothreitol (DTT), bromophenol blue and 
acrylamide/bis solution were from Bio-Rad Laboratories, Inc; the protease inhibitor was 
from Roche Singapore Pte. Ltd., (Singapore). All other materials used were similar to 
those listed in sections 2.2 and 3.2. 
 
4.3 Methods 
4.3.1 Cell culture 
Caco-2 cells (passage 60 to 70) were cultured in MEM medium as described in section 
2.3.3. Cells were seeded onto TranswellTM inserts (1-2×105 cells/well) and 75 cm2 tissue 
culture flasks (3×105 cells/flask) for the [14C]-mannitol transport and immunoblotting 
experiments, respectively. For the confocal microscopy experiments, the cells were 
seeded onto Lab-Tek Chamber Slide (Nalge Nunc International, Rochester, NY, USA) at 
2×105 cells/cm2. On Day 2, the MEM culture medium was sterilely supplemented with 
piperine (10, 50 and 100 µM) or capsaicin (10, 50 and 100 µM), and the cells cultured for 
a total of 18 days. Control cells were cultured in MEM medium devoid of spices over the 
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4.3.2  Transepithelial electrical resistance and [14C]-mannitol transport 
On the day of the transport experiment, the culture medium was replaced with an equal 
volume of prewarmed HBSS-HEPES solution, with or without spice supplementation at 
the same concentration ranges as were used during culture, and the cell monolayers were 
allowed to equilibrate for 30 min at 37°C in the CO2 incubator. The integrity of the Caco-
2 cell monolayers was determined by measuring the TEER and confluent cell monolayers 
with TEER values greater than 200 Ω·cm2, after correction for the resistance obtained in 
blank wells, were used for transport experiments. 
 
[14C]-mannitol control and test solutions were prepared as described in section 2.3.5. 
Permeability experiments were initiated by applying the appropriate [14C]-mannitol 
solution to the apical chamber (0.5 ml; for AB transport studies) or basal chamber (1.5 ml; 
for BA transport studies). After 0, 30, 60, 120 and 180 min, 50 µl of the transport 
medium was sampled from the receiver chamber and replaced with 50 µl of fresh HBSS-
HEPES solution. Each sample was incubated overnight with 3 ml of scintillation cocktail 
before analysis in a liquid scintillation counter. Apparent permeability coefficients (Papp) 
and net efflux ratio were calculated using equations 1 and 2 (section 2.3.5). 
 
4.3.3 Preparation of detergent-soluble membrane and detergent–insoluble cytoskeleton 
fractions  
Caco-2 cell monolayers after 18 days of culture in flasks and TranswellTM inserts were 
washed thrice with ice-cold PBS, and the cells scraped off using a spatula. After 
centrifugation at 3000 g, 4oC for 3 min, the cell pellet was incubated with lysis buffer A 
(PBS containing 1% of Triton X-100 and 1% of protease inhibitor) on ice for 30 min. The 
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cell lysate was centrifuged at 15,000 g for 30 min at 4 oC, and the supernatant, taken as 
the detergent-soluble fraction, was transferred to a microcentrifuge tube. The pellet 
(detergent-insoluble fraction) was incubated in lysis buffer B (1% of SDS in lysis buffer 
A) on ice for 30 min. Supernatants (cytoskeleton-associated fractions) were then obtained 
after centrifugation (36,000 g for 30 min at 4 oC). Protein concentrations in both fractions 
were measured using a Bio-Rad Protein Assay Kit (Bio-Rad Laboratories) according to 
the manufacturer’s instructions. 
 
4.3.4  Western blot 
Western blots were obtained using 20 µg of extracted membrane proteins in loading 
buffer (0.15 g/ml Tris base pH 6.8, 15% glycerol, 0.015 g/ml SDS, 0.005 g/ml 
bromophenol blue and 20% β-mercaptoethanol). Samples were separated by SDS-PAGE 
(sodium dodecyl sulfate polyacrylamide gel electrophoresis) (6% polyacrylamide gel) 
(Sub-Cell GT system, Bio-Rad) and transferred to PVDF membranes (Trans-Blot SD 
Semi-Dry Cell, Bio-Rad). Blots were blocked with 5% nonfat milk in TBS (Tris Buffered 
Saline) overnight, incubated sequentially with primary antibody (at the dilution ratios of 
1:3000 for ZO-1, 1:1000 for occludin and 1:3000 for β-actin) for 1 h and secondary 
antibody (1:10000) for 1 h, and detected with chemiluminescence reagent. Protein bands 
were quantified by densitometry using the Quantity One software (Bio-Rad Laboratories). 
 
4.3.5  Immunofluorescence staining 
Caco-2 cells cultured on Lab-Tek™ chamber slide for 18 days with and without piperine 
or capsaicin were washed with PBS, fixed with 3.7% of paraformaldehyde and 
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permeabilized with 0.5% of Triton X-100 in PBS. Nonspecific binding was blocked by 
incubating the cells with 1% of goat serum mixed with 1% of BSA in PBS for 1 h. 
Primary antibody ZO-1 was diluted at the ratio of 1:100 with blocking solution and 
incubated with the cells for 1 h at 37oC. After washing thoroughly with PBS, the cells 
were incubated with 1% of FITC-conjugated secondary antibody in blocking solution for 
30 min. For actin staining, the cells after permeabilization were incubated for 1 h at 37oC 
with Texas red-conjugated phalloidin, diluted at the ratio of 1:100 in PBS. The cells were 
then mounted (DakoCytomation Fluorescent Mounting Medium), and the distributions of 
cellular ZO-1 and actin were visualized under a confocal microscope (Carl Zeiss Lsm510 
META, Germany). 
 
4.3.6  Statistical analyses 
Differences between mean values were evaluated using the one-way ANOVA with the 
Tukey’s test applied for paired comparisons of mean values (SPSS 10.0, SPSS Inc., 
Chicago, IL, USA). A difference between means was considered significant if the p value 
was less than or equal to 0.05. 
 
4.4  Results 
4.4.1 Transepithelial electrical resistance and [14C]-mannitol transport 
[14C]-mannitol transport experiments were carried out on the Caco-2 cell monolayers 
after 18 days of co-culture with the spices. The transport experiments were performed in 
HBSS-HEPES transport medium in the presence and absence of spices. Accordingly, the 
“control” refers to cell monolayers that had not been exposed to spices during culture or 
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during the transport experiments, “spice (+)” refers to cell monolayers exposed to a 
specified spice both during culture and during the transport experiments, while “spice (-)” 
refers to cell monolayers exposed to a spice in culture but not during the transport 
experiments. Baseline TEER for all cell monolayers was measured following 30 min of 
pre-incubation in HBSS-HEPES just prior to the transport experiments. There were no 
significant differences in baseline TEER (200 – 300 ohm.cm2) amongst the cell 
monolayers in the 3 groups.  
 
After the mannitol transport experiments, TEER was measured again for each cell 
monolayer. This TEER, expressed as a percent of the baseline TEER, is shown in Figure 
4.2 as a function of spice concentration. For control cell monolayers, there was no change 
in TEER after the transport experiments. Similarly, the TEER of spice (-) cell monolayers 
was maintained at baseline levels at the end of the transport experiments. In contrast, cell 
monolayers that had been exposed to either piperine or capsaicin during the transport 
experiments exhibited a moderate decrease in TEER (Figure 4.2). For comparison, the 
TEER values of Caco-2 cell monolayers which had not been cultured with spices but 
were exposed to either spice during the mannitol transport experiments (Table 2.2, 
section 2.4.2) are included in Figure 4.2. Under these circumstances, denoted as acute 
exposure, the cell monolayers showed significantly decreased TEER only when exposed 
to the spices at a high concentration of 100 µM. 
 
Papp values and net efflux ratios calculated from the [14C]-mannitol permeability data are 
summarized in Tables 4.1 and 4.2. For comparison purposes, the mannitol transport data 
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obtained for Caco-2 cell monolayers not previously exposed to the spices during culture 
(Table 2.1, section 2.4.2) are also presented in the same tables. In all cases, there was 
good correlation between the [14C]-mannitol Papp values and the monolayer TEER values, 
in that higher mannitol permeability was observed in cell monolayers with lower TEER.  
 
In summary, regardless of whether the Caco-2 cell monolayers were cultured with 
piperine, capsaicin or not, there were no significant differences in TEER nor mannitol 
permeability following the pre-incubation of the cell monolayers with HBSS-HEPES. 
Prolonged incubation (4-5 h) of the Caco-2 cell monolayers with spice-supplemented 
HBSS-HEPES medium, however, would eventually open up the paracellular pathway. 
This was reflected in the lower TEER and higher mannitol Papp values obtained. The 
permeabilization of the paracellular pathway was dependent on the type and 
concentration of spice used, with piperine exerting an apparently stronger effect than 
equivalent concentration of capsaicin. For Caco-2 cell monolayers not previously 
exposed to either spice during culture, increased paracellular permeability was also 
observed when the cell monolayers were incubated for 4-5 h with spice-supplemented 
HBSS-HEPES. This increase in permeability was, however, of a smaller magnitude 
compared to that observed in cell monolayers previously co-cultured in the respective 
spice. Thus, the addition of 100 µM of piperine was observed to increase the BA and AB 
mannitol Papp values by 1.4- and 2.2- fold, respectively, in cell monolayers not exposed to 
the spice during culture. The corresponding increases in Papp values for cell monolayers 
co-cultured for 18 days with 100 µM of piperine were 2.2- and 2.8 folds, respectively. 
Similarly, an acute exposure to 100 µM of capsaicin during the transport experiments 
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yielded a 1.5-fold increment in AB mannitol Papp, in contrast to the 1.8-fold obtained for 






































Figure 4.2 TEER of Caco-2 cell monolayers measured at the end of the mannitol 
transport experiments, and expressed as a percentage of TEER measured just prior to the 
transport experiments. (A) Effects of piperine; (B) Effects of capsaicin. Con, control (not 
exposed to spice during culture or transport experiments); P 10, piperine 10 µM; P 50, 
piperine 50 µM; P 100, piperine 100 µM; C 10 capsaicin 10 µM; C 50, capsaicin 50 µM; 
C 100, capsaicin 100 µM. Data are presented as mean ± SEM; *, significantly different 
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Table 4.1 AB and BA permeability coefficient (Papp) and net efflux ratio for [14C]-
mannitol transport across Caco-2 monolayers exposed to piperine.  
 
Papp (10-6 cm/s) Sample 
AB BA 
Net efflux 
Acute [Piperine (µM)]    
Control1 1.09±0.08 1.02±0.09 0.94 
10 1.10±0.08 1.09±0.06 0.99 
50 1.20±0.10 1.23±0.12 1.03 
100 2.21±0.13* 1.43±0.10* 0.65 
Long term [Piperine (+) (µM)]    
Control2 1.09±0.04 1.06±0.03 0.89 
10 1.21±0.08 1.01±0.11 0.83 
50 2.34±0.06* 2.38±0.07* 1.02 
100 2.80±0.05* 2.24±0.03* 0.8 
Long term [Piperine (-) (µM)]    
Control3 1.09±0.04 1.06±0.03 0.97 
10 1.02±0.02 0.94±0.08 0.92 
50 1.09±0.09 0.92±0.03* 0.84 
100 1.00±0.04* 0.96±0.06 0.96 
Acute: piperine was added during transport study only; Chronic [piperine (+)]: piperine 
was supplemented into the culture medium during cell culture and into the transport 
medium during transport study; Chronic [piperine (-)]: piperine was supplemented into 
the culture medium during cell culture but not into the transport medium during transport 
study. 1, control values obtained in the acute study; 2 and 3, control values obtained in 
the chronic study. Data are presented as mean ± SD, n=4. * p≤0.05 compared to control. 
Net efflux ratio was calculated as mean BA Papp to mean AB Papp. HBSS-HEPES (pH 7.4) 
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Table 4.2 AB and BA permeability coefficient (Papp) and net efflux ratio for [14C]-
mannitol transport across Caco-2 monolayers exposed to capsaicin.  
 




Acute [Capsaicin (µM)]    
Control1 1.09±0.08 1.02±0.09 0.94 
10 1.10±0.08 1.07±0.03 0.97 
50 1.15±0.20 1.15±0.10 1.00 
100 1.46±0.04* 1.47±0.08* 1.01 
Long term[Capsaicin (+) (µM)]    
Control2 1.13±0.04 1.12±0.05 0.99 
10 1.18±0.14 1.52±0.05 1.29 
50 1.89±0.19* 1.72±0.11* 0.91 
100 1.83±0.07* 1.88±0.12* 1.03 
Long term [Capsaicin (-) (µM)]    
Control3 1.13±0.04 1.12±0.05 0.99 
10 1.14±0.05 1.11±0.11 0.97 
50 1.13±0.02 1.02±0.05 0.90 
100 1.12±0.07 1.03±0.04 0.92 
Acute: capsaicin was added during transport study only; Chronic [capsaicin (+)]: 
capsaicin was supplemented into the culture medium during cell culture and into the 
transport medium during transport study; Chronic [capsaicin (-)]: capsaicin was 
supplemented into the culture medium during cell culture but not into the transport 
medium during transport study. 1, control values obtained in the acute study; 2 and 3, 
control values obtained in the chronic study. Data are presented as mean ± SD, n=4. * 
p≤0.05 compared to control. Net efflux ratio was calculated as mean BA Papp to mean AB 
Papp. HBSS-HEPES (pH 7.4) was the transport medium. Spices were added to both donor 
and receiver chambers.  
 
4.4.2 Western blot 
The effects of piperine and capsaicin on TJ protein expression were first investigated in 
Caco-2 cells cultured in flasks. Both the detergent-soluble and -insoluble fractions of the 
cells were subjected to western blot analyses. ZO-1, occludin and β-actin were detected 
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as clear bands in the detergent-soluble fractions (Figures 4.3 and 4.4), whereas only 
occludin and β-actin were detected in the detergent-insoluble fractions (Figure 4.5 and 
4.6). Occludin expressions in both fractions were not affected by co-culture with up to 
100 µM of piperine or capsaicin for 18 days. However, the ZO-1 level in the detergent-
soluble fraction was significantly up-regulated by co-culture with 100 µM of piperine. 
Although a higher mean ZO-1 level was also associated with cells co-cultured with 100 
µM of capsaicin, the increase was not statistically significant compared to control cells.  
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Figure 4.3 Effects of piperine on tight junction proteins (detergent soluble fractions) of 
Caco-2 cell monolayers. Cells were cultured for 18 days in tissue culture flasks in MEM 
medium supplemented with piperine. Western blots were probed with anti-ZO-1, anti-
occludin and anti-β-actin antibodies. Densitometry results are shown in the corresponding 
line graphs for relative expression level of ZO-1 and occludin as normalized to β-actin 
level. Con, control; P 10, 10 µM; P 50, 50 µM; P 100, 100 µM. All data are presented as 
mean ±SD from 3 independent experiments. *, significantly different from control cells 
(p<0.05). 
*
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Figure 4.4 Effects of capsaicin on tight junction proteins (detergent soluble fractions) of 
Caco-2 cell monolayers. Cells were cultured for 18 days in tissue culture flasks in MEM 
medium supplemented with capsaicin. Western blots were probed with anti-ZO-1, anti-
occludin and anti-β-actin antibodies. Densitometry results are shown in the corresponding 
line graphs for relative expression level of ZO-1 and occludin as normalized to β-actin 
level. Con, control; C 10, 10 µM; C 50, 50 µM; C 100, 100 µM. All data are presented as 
mean ±SD from 3 independent experiments. *, significantly different from control cells 
(p<0.05). 
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Figure 4.5 Effects of piperine on tight junction proteins (detergent insoluble fractions) of 
Caco-2 cell monolayers. Cells were cultured for 18 days in tissue culture flasks in MEM 
medium supplemented with piperine. Western blots were probed with anti-occludin and 
anti-β-actin antibodies. Densitometry results are shown in the corresponding line graph 
for relative expression level of occludin, normalized to β-actin level. Con, control; P 10, 
10 µM; P 50, 50 µM; P 100, 100 µM. All data are presented as mean ± SD from 3 
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Figure 4.6 Effects of capsaicin on tight junction proteins (detergent insoluble fractions) 
of Caco-2 cell monolayers. Cells were cultured for 18 days in tissue culture flasks in 
MEM medium supplemented with capsaicin. Western blots were probed with anti-
occludin and anti-β-actin antibodies. Densitometry results are shown in the corresponding 
line graph for relative expression level of occludin, normalized to β-actin level. Con, 
control; C 10, 10 µM; C 50, 50 µM; C 100, 100 µM. All data are presented as mean ± SD 
from 3 independent experiments. *, significantly different from control cells (p<0.05). 
 
To verify whether the expression of TJ proteins was dependent on culture conditions, the 
western blot experiments were repeated on Caco-2 cells cultured on porous TranswellTM 
membranes. Except for the culture vessels, all other experimental conditions were similar 
to those for cells cultured in tissue culture flasks. The TJ protein expression patterns were, 
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however, very different. In the case of Caco-2 cell monolayers cultured on porous 
membranes, the ZO-1 and occludin bands were detected in the detergent-insoluble 
fractions (Figure 4.7), but not in the detergent-soluble fractions (data not shown).  
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Figure 4.7 Effects of piperine and capsaicin on TJ proteins (detergent insoluble fractions) 
of Caco-2 cell monolayers. Cells were cultured for 18 days on TranswellTM inserts in 
MEM medium supplemented with piperine or capsaicin. Western blots were probed with 
anti-ZO-1, anti-occludin and anti-β-actin antibodies. Densitometry results are shown in 
the corresponding line graph for relative expression levels of ZO-1 and occludin. CON, 
control; P 50, piperine 50 µM; P 100, piperine 100 µM; C 50, capsaicin, 50 µM; C 100, 
capsaicin 100 µM. All data are presented as mean ±SD from 3 independent experiments. 
No significant differences were found between test and control cells (p>0.05). 
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Moreover, the ZO-1 and occludin proteins were of very high MW (220-250 kDa for ZO-
1, about 80 kDa for occludin), suggesting high levels of phosphorylation. Nevertheless, 
co-culture with piperine or capsaicin at up to 100 µM for 18 days did not significantly 
affect the ZO-1 and occludin protein levels in the Caco-2 cell monolayers. This suggests 
that the spice-modulated increase in paracellular permeability was not associated with 
changes in ZO-1 and occludin expression.  
 
4.4.3 Immunofluorescence staining 
The distribution of the cytoskeletal element ZO-1 in the Caco-2 cell monolayers was 
examined under a confocal microscope after immunofluorescence staining (Figure 4.8). 
Control cells showed a uniform definitive distribution of ZO-1 at intercellular junctions. 
This morphology became ambiguous in cells co-cultured with 50 µM or more of piperine, 
suggesting a translocation of cellular ZO-1, possibly from the intercellular region into the 
cytoplasm compartment. Capsaicin, on the other hand, did not alter the distribution of 
ZO-1 in the Caco-2 cells. 
 
The effects of piperine and capsaicin on F-actin filament organization in the Caco-2 cells 
was also investigated because these filaments are intimately associated with the tight 
junctional complex. Staining of F-actin with Texas red-phalloidin showed that co-culture 
with 10 µM or more of either piperine or capsaicin caused some disbandment of the 
perijunctional actin rings (arrowed in Figure 4.9). Nevertheless the disruption of F-actin 
filament organization was marginal compared to control cells, suggesting that F-actin 
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played a minor role in mediating the increase in paracellular permeability associated with 
the spices 
  
   
   
Figure 4.8 Confocal microscopy image showing the immunolocalization of ZO-1 in 
Caco-2 cell monolayers: background control (panel A), no spice treatment control (panel 
B), cells treated with 10 µM piperine (panel C), 50 µM piperine (panel D), 100 µM 
piperine (panel E), 10 µM capsaicin (panel F), 50 µM capsaicin (panel G), and 100 µM 
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Figure 4.9 Confocal microscopy image showing the actin architecture in Caco-2 cell 
monolayers: background control (panel A), no spice treatment control (panel B), cells 
treated with 10 µM piperine (panel C), 50 µM piperine (panel D), 100 µM piperine 
(panel E), 10 µM capsaicin (panel F), 50 µM capsaicin (panel G), and 100 µM capsaicin 




In this chapter, the influences of piperine and capsaicin on cellular permeability as well 
as TJ protein expression were evaluated in the Caco-2 cell monolayers. Acute exposure 
of confluent Caco-2 cell monolayers to piperine and capsaicin at concentrations of up to 
100 µM led to increased paracellular permeability as assessed by changes in cellular 
TEER and [14C]-mannitol transport profile. Such effects were significantly enhanced in 
cell monolayers previously cultured with the respective spices for 18 days. The 
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modulation effects were, however, reversible. This is because, for cell monolayers 
previously cultured with the spices, the removal of spices from the transport medium was 
observed to restore the mannitol Papp and TEER values to control levels.  
 
The effects of piperine and capsaicin on in vitro TJ permeability have previously been 
reported by Jensen-Jarolim et al. (Jensen-Jarolim et al., 1998). Their results were, 
however, different from those observed in the present study. Jensen-Jarolim et al. 
reported an increase in the TEER of 9-day old HCT-8 cells following exposure to 0.3 
mM of piperine for 12 min, while the exposure of the same cells to 5 mM of capsaicin for 
10 min resulted in decreased TEER. The divergence in results between the two studies 
might have been caused by differences in spice concentration, cell species and culture 
condition employed (Jensen-Jarolim et al., 1998). 
 
Data in the literature have indicated that changes in TJ permeability are almost invariably 
associated with the derangement of F-actin cytoskeleton, often but not always, 
accompanied by changes in the localization of junctional proteins (Stenson et al., 1993; 
Tsukazaki et al., 2005). For this reason, the effects of piperine and capsaicin on the 
expression and localization of cellular occludin, ZO-1 and F-actin were evaluated. 
Occludin, a major constituent of TJ strands, has highly phosphorylated serine/threonine 
residues under basal conditions, and it has been shown to undergo extensive 
dephosphorylation during TJ disruption (Clarke et al., 2000). ZO-1 is a member of the 
protein family MAGUK homologues that localize to the cytoplasmic side of the TJ. F-
actin belongs to the adherens junction, and it functions through a family of Ca2+- 
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dependent cell-cell adhesion molecules (Krendel and Bonder, 1999). Reorganization of 
the actin cytoskeleton may alter TJ function because the actin filaments are linked to TJ 
proteins (Kitamura et al., 1991).  
 
Of the 3 TJ proteins evaluated, occludin was shown to neither undergo degradation nor 
translocation in the presence of piperine or capsaicin, suggesting that it did not play a 
major role in mediating the increased paracellular permeability of cell monolayers 
exposed to the spices. Results on ZO-1 expression and distribution were dependent on the 
culture conditions employed for the cell monolayers. Western blot analysis showed 
changes in ZO-1 protein expression in the Caco-2 cells cultured in tissue culture flasks 
but not for those cultured in Transwell™ inserts. Immunofluorescence staining of Caco-2 
cells cultured in the Lab-Tek™ chamber slide revealed that piperine, but not capsaicin, 
caused a relocation of the ZO-1, possibly from the cell periphery towards the cell interior. 
Although this might suggest that ZO-1 relocalization played a role in the piperine-
mediated increase in paracellular permeability, the data for cells cultured in Transwell™ 
inserts, which corresponded to cells employed for the mannitol transport experiments, 
implicate a minor influence, if present. On the other hand, changes in the actin 
morphology, as revealed by the immunofluorescence staining experiments, indicate that 
piperine and capsaicin might influence paracellular permeability by modifying actin 
function and localization to some extent. 
 
The molecular basis for these effects is probably premature to explain at this stage. This 
is because, while TJ biogenesis appears to be regulated in part by classic signal 
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transduction pathways involving the heterotrimeric G proteins (Denker et al., 1996), 
release of intracellular Ca2+ (Nigam et al., 1992; Stuart et al., 1994) and activation of 
protein kinase C (Nilsson et al., 1996), much remains to be understood about the 
signaling pathways that alter TJ permeability. Still, a number of possibilities exist.  
 
Protein kinase C (PKC) is known to be important in the regulation of the barrier function 
of the cell sheet, its activation resulting in increased TJ permeability in both epithelia and 
endothelia tissues (Stenson et al., 1993; Lum and Malik, 1994). Moreover, the 
modification of TJ permeability by PKC stimulators and inhibitors was not associated 
with changes to the phosphorylation of the TJ phosphoproteins (ZO-1, ZO-2, ZO-3 and 
cingulin) (Balda et al., 1993; Citi and Denisenko, 1995), as was observed for cells 
exposed to piperine and capsaicin. Since PKC activation could up- or down-regulate TJ 
permeability depending on the isomers of the PKC modulator, differences between cell 
types, and experimental conditions (Balda et al., 1993; Stuart and Nigam, 1995), it would 
further explain the divergent data between this study and that by Jensen-Jarolim et al. 
(Jensen-Jarolim et al., 1998). Nevertheless, affirmative data are required, as the effects of 
PKC activation on TJ permeability are complex.  
 
ATP depletion is another possible cause of TJ hyperpermeability and redistribution of TJ 
proteins (Salzman et al., 1995; Madsen et al., 1995). ATP depletion was previously 
associated with changes in the actin cytoskeleton, notably a diminution and disruption of 
F-actin in areas of cell-to-cell contact (Tsukamoto and Nigam, 1997). However, ATP 
depletion was associated with a shifting of the ZO-1 and ZO-2 proteins into the Triton X 
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100-insoluble pool (Tsukamoto and Nigam, 1997), which was not observed in the present 
study. Instead, our data showed piperine to cause a relocation of ZO-1 out of the Triton 
X-100 insoluble pool for cells cultured in flasks. A shift of ZO-1 into the Triton X-100 
soluble region was more in line with the Ca2+ modulation theory, in which increased 
paracellular permeability was an indirect consequence of lower extracellular or increasing 
intracellular Ca2+ level (Nigam et al., 1992; Stuart et al., 1994).  
 
In summary, the mechanisms responsible for the increase in intestinal epithelial 
permeability induced by piperine and capsaicin remain incompletely understood at this 
juncture. Alterations in the morphologies of ZO-1 and F-actin might underpin the 
phenomenon, although piperine and capsaicin might also work through different 
mechanisms to bring about an increase in Caco-2 cell permeability. 
 
 
4.6  Conclusions 
Concurrent exposure to piperine or capsaicin enhanced the paracellular transport of [14C]-
mannitol across polarized Caco-2 cell monolayers. AB and BA mannitol Papp values were 
increased by 2.2 and 1.4 fold, respectively, by co-incubation with 100 µM of piperine. 
Capsaicin at the same concentration caused a 1.5-fold increase in both AB and BA 
mannitol Papp values. Such effects were intensified by pre-exposure of the Caco-2 cell 
monolayers to either spice for 18 days. However, the spices had to be present during the 
mannitol transport experiments. Spice removal just prior to the transport experiment 
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resulted in mannitol Papp values that were comparable with those obtained from cells 
which had not been previously exposed to either spice.  
 
Western blot and immunostaining revealed a minor morphological change in the TJ 
protein, ZO-1, by piperine, and marginal changes in F-actin distribution by piperine and 
capsaicin. No changes in the expression levels of ZO-1, occludin and actin, based on 
western blot analysis, were found in Caco-2 cell monolayers cultured on TranswellTM 
inserts. It is therefore unlikely that piperine and capsaicin work predominantly through 
the ZO-1, occludin or F-actin proteins to increase the paracellular permeability of the 
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Preliminary studies, reported in section 2.4.3 (Table 2.4), have demonstrated the 
inhibitory effects of piperine and capsaicin on P-gp activity. The results of these studies 
are in agreement with data generated from in vitro transport and toxicity experiments in 
other laboratories (Bhardwaj et al., 2002; Nabekura et al., 2005). On the other hand, there 
is no report to date on the effects of piperine and capsaicin on P-gp expression. Given 
that several inhibitors of P-gp efflux activity were subsequently found to also modulate 
the cellular expression of the transporter, e.g. St John’s wort (Durr et al., 2000), 
verapamil (Collett et al., 2004) and rifampin (Westphal et al., 2000), we hypothesized 
that piperine and capsaicin might also affect P-gp expression. The objective of the study 
in this section was to conduct a comparative evaluation of the long term effects of 
piperine and capsaicin on P-gp expression and activity in vitro, and to provide evidence 
on the modulation mechanism(s). 
 
The biological activities of piperine and capsaicin have rarely been compared in parallel 
experiments. Except for a report that studied the effects of piperine and capsaicin on 
dextran permeability across HCT-8 cell monolayers (Jensen-Jarolim et al., 1998), studies 
on piperine have tended to focus on its capacity to enhance drug bioavailability 
(Badmaev et al., 2000; Bajad et al., 2001; Bano et al., 1987; Berrill et al., 2004) whereas 
those on capsaicin were extensively associated with cancer research (Giri and Aggarwal, 
1998; Han et al., 2001; Park et al., 1998). Despite differences in physical properties e.g. 
in color, water solubility and melting point, piperine and capsaicin have a characteristic 
hot flavor and exhibit remarkably similar chemical structures (Figure 1.4).  
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They share in common an aromatic ring with two ortho oxygen atoms, which are either in 
an ether-phenol combination, as in the case of capsaicin, or as an acetal, as found in 
piperine. Both spices also have a HC chain bearing an amide group attached to the ring at 
position 4. These structural features allude to a similar spectrum of bioactivity for the two 
spices. Indeed, a survey of the literature have shown the two spices to (a) exhibit anti-cell 
proliferation activity; (b) inhibit P-gp transport; (c) inhibit CYP-mediated enzyme 
degradation; (e) activate the vanilloid receptor; (f) inhibit vascular endothelial cell growth 
and promote vascular endothelial cell growth factor expression; and (g) promote the oral 
bioavailability of co-administered drugs (Table 5.1). Therefore, we hypothesized that 
these two spices may exhibit comparable modulation on cellular P-gp expression and 
function. 
 
Several cell lines have been utilized to evaluate P-gp expression levels (Wu et al., 2003; 
Chan et al., 2006; Arora et al., 2005). Some of these cell lines, e.g. MCF-7, HepG2 and 
K562, express P-gp constitutively. However, the P-gp expression level in these cell lines 
is usually below the detection limit of western blot when the cells are cultured under 
standard culture conditions. To produce high levels of P-gp for an experiment, the cells 
often have to be co-cultured with an anti-cancer drug to induce functional P-gp (Wu et al., 
2003; Chan et al., 2006; Arora et al., 2005). The induction procedure prolongs the culture 
time and produces unpredictable cellular protein levels from one passage to another. For 
these reasons, cell lines transfected with the MDR1 gene have been developed as 
alternatives. An example is the L-MDR1 cell line used for the experiments in section 
2.3.3. However, while these transfected cells are useful for functional studies of the P-gp 
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Table 5.1 Summary of the common bioactivities of piperine and capsaicin reported in the 
literature. 
 Piperine Capsaicin 
Anti-cell proliferation 
(in vitro) 
Pradeep et al, 2004 (Pradeep and 
Kuttan, 2004) 
Roy et al, 2002 (Roy et al., 
2002); Chueh et al, 2004 
(Chueh et al., 2004); Jung et al, 
2001 (Jung et al., 2001); Patel et 
al, 2002 (Patel et al., 2002a); 
Zhang et al, 2003 (Zhang et al., 
2003); Mori et al, 2006 (Mori et 
al., 2006); Sanchez et al, 2006 
(Sanchez et al., 2006) 
Anti-cell proliferation 
(in vivo) 
Selvendiran et al, 2006 
(Selvendiran et al., 2006); 
Selvendiran et al, 2005 
(Selvendiran et al., 2005); Pradeep 
et al, 2003 (Pradeep and Kuttan, 
2003); Selvendiran et al, 2004 
(Selvendiran et al., 2004b) 
Tanaka et al, 2002 (Tanaka et 
al., 2002) 
Inhibition of P-gp 
function 
Bhardwaj et al, 2002 (Bhardwaj et 
al., 2002) 
Nabekura et al, 2005 (Nabekura 
et al., 2005); Han et al, 2006 
Effect on CYP activity 
Bhardwai et al, 2002 (Bhardwaj et 
al., 2002); Reen et al, 1996 (Reen 
et al., 1996); Kang et al, 1994 
(Kang et al., 1994) 
Zhang et al, 1993 (Zhang et al., 
1993) 
Activation of vanilloid 
receptor 
Mcnamara et al, 2005 (McNamara 
et al., 2005) 
Jacobsson et al, 2001 
(Jacobsson SO et al., 2001); 
Kim et al, 2006 (Kim et al., 
2006) 
Modulation of vascular 
endothelial cell growth  
Min et al, 2004 (Min et al., 




Bano et al, 1987 (Bano et al., 
1987); Bano et al, 1991 (Bano et 
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transporter, they could not be used for studies involving the evaluation of the MDR1 gene, 
unlike cell lines that constitutively express the P-gp (Wu et al., 2003). Consequently, the 
Caco-2 cell line was used for the experiments in this section. Anti-cancer agents were not 
used to induce a higher P-gp expression in the cells due to the difficulties in obtaining a 
predictable level of cellular P-gp after the induction procedure. In any case, the Caco-2 
cell monolayers were found to produce consistent levels of P-gp that were above the 
detectable limit of western blot after 21 days of culture on TranswellTM inserts. As the 
cell monolayers cultured on TranswellTM inserts could also be used for the study of P-gp-
mediated transport of digoxin, they allowed for a direct correlation of P-gp functional 
status to the expression level. 
 
Cellular P-gp protein level was determined using western blot. P-gp is an integral plasma 
membrane protein with extracellular glycosylation sites and intracellular ATP binding 
sites (Germann, 1996). Antigenic epitopes are found on either side of the membrane. 
Numerous monoclonal antibodies (MAbs) have been raised against both internal (C219, 
C494, JSB-1) and external (Hyb-612, MRK16, MRK17, 265/F4, 4E3. UIC2) epitopes of 
P-gp (van der Heyden et al., 1995). Among these antibodies, the C219 has been most 
widely applied for the qualitative and quantitative determinations of cellular P-gp 
expression (Lee et al., 2001), and it was therefore used in this study.  
 
The MDR1 mRNA level has been shown to correlate with the degree of drug resistance in 
MDR cell lines (Shen et al., 1986). Cellular MDR1 mRNA expression can be measured 
Chapter 5.    In vitro modulation of P-gp expression and function: a comparison of piperine 
and capsaicin 
 118
using polynucleotide probes in northern blot or slot blot analyses (Goldstein et al., 1989), 
reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ hybridization 
techniques. Amongst these, the RT-PCR is a highly sensitive method for the detection of 
small amounts of mRNA in cell samples. It is based on the principle of generating 
complementary DNA (cDNA) from mRNA by the reverse transcriptase (RT) enzyme 
(Noonan et al., 1990). A minute amount of cDNA generated can then be amplified 
several thousand folds by repeated cycles of heat-denaturation followed by annealing 
with the appropriate primers at a lower temperature. To obtain more accurate and reliable 
results, the MDR1 mRNA level can be quantified using real-time RT-PCR analysis. 
Unlike other forms of quantitative RT-PCR that detect the amount of final amplified 
product at the end-point, real-time RT-PCR quantifies the initial amount of template, and 
produces more specific, sensitive and reproducible mRNA data (Freeman et al., 1999). 
The real-time RT-PCR system is based on the detection and quantitation of a fluorescent 
reporter (Higuchi et al., 1993). It monitors the fluorescence emitted during the reaction as 
an indicator of amplicon production during each PCR cycle as opposed to the endpoint 
detection. By recording the amount of fluorescence emission at each cycle, it is possible 
to monitor the PCR reaction during the exponential phase where the first significant 
increase in the amount of PCR product correlates to the initial amount of target template. 
The higher the starting copy number of the nucleic acid target, the sooner a significant 
increase in fluorescence is observed. A significant increase in fluorescence above the 
baseline value indicates the detection of accumulated PCR product. In an experiment, a 
fluorescence threshold is set significantly above a defined baseline, and the parameter CT 
(threshold cycle) represents the cycle number at which the fluorescence emission exceeds 
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the fixed threshold. There are three main fluorescence-monitoring systems for DNA 
amplification (Wittwer et al., 1997). Among them, the hydrolysis probes, which utilize 
the fluorogenic 5’ exonuclease activity of Taq polymerase to measure the amount of 
target sequences in cDNA samples, are popular. Hydrolysis probes include the Taqman 
probes (Heid et al., 1996), molecular beacons (Mhlanga and Malmberg, 2001) and 
scorpions (Saha et al., 2001). In this study, the Taqman probe was utilized to detect the 
MDR1 and the endogenous control gene due to its sensitivity and specificity. 
 
5.2 Materials 
Caco-2 cells, and the materials for cell culture, western blot and [3H]-digoxin transport 
studies were the same as those listed in sections 2.2 and 4.2. Other materials utilized in 
this study were as follows: C219 (primary antibody) from Signet Laboratories, Inc. 
(Dedham, MA, USA); anti-mouse horseradish peroxidase antibody (secondary antibody) 
from Amersham Biosciences; RNeasy Mini Kit for RNA extraction from Qiagen (Hilden, 
Germany); Taqman reverse transcription reagents, Taqman universal master mix and 
Taqman probes for MDR1 and 18S detection and quantitation were commercial gene 
expression assays from Applied Biosystems (Foster City, CA, USA). 
 
5.3 Methods 
5.3.1 [3H]-Digoxin transport studies 
Caco-2 cells (passage 47-60) were cultured on TranswellTM inserts at a seeding density of 
2×105 cells per well in MEM medium, which was sterilely supplemented with piperine or 
capsaicin (50 and 100 µM) on Day 18 or Day 19. Control cells received medium devoid 
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of spice. Transport experiments were conducted on Day 21 on cells with TEER of 300-
400 ohms.cm2. Monolayer TEER was measured immediately before and after the 
transport experiments. 
 
To start the transport experiments, culture medium in the apical and basal chambers was 
replaced with 0.7 ml of Opti MEM, a serum-free transport medium. After 60 min of 
incubation in the CO2 incubator, the Opti MEM in either the apical (for apical-to-basal or 
AB transport) or basal (basal-to-apical or BA transport) chamber was replaced with 
digoxin solution (5 µM, 0.5 µCi/ml in Opti MEM). To delineate the effects of acute spice 
exposure, an additional series of experiments were conducted on the control cells, which 
received digoxin solution supplemented with 0 - 100 µM of piperine (or capsaicin) in the 
donor chamber, and the corresponding piperine (or capsaicin) concentration in Opti 
MEM in the receiver chamber. In addition, parallel experiments were conducted to 
validate the presence of functional P-gp in the control cells by adding 100 µM of 
verapamil (an established P-gp inhibitor) in place of spice into the donor and receiver 
chambers.  
 
At 0, 1, 2, 3 and 4 h, 50 µl-aliquots were removed from the receiver chambers, incubated 
overnight with 3 ml of scintillation cocktail and analyzed in a liquid scintillation counter 
(LS 3801, Beckman Instruments, Inc., CA, USA). Withdrawn samples were replaced 
with equal volumes of prewarmed transport medium to maintain the liquid volume in 
each chamber. Apparent permeability coefficient (Papp) and net efflux ratio were 
calculated using equations 1 and 2, respectively (section 2.3.5).  
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5.3.2 P-gp and MDR1 expression 
Caco-2 cells were cultured on TranswellTM inserts as described in the previous section, 
with supplementation of the MEM medium with piperine or capsaicin (50 and 100 µM) 
on Day 18 or Day 19. Control cells received medium devoid of spice. On Day 21, after 
exposure to the spices for 48 and 72 h, respectively, the cells were collected into 
eppendorf tubes by scraping with a small spatula. The cells were either lysed in 1% 
Triton X-100 in PBS for P-gp protein analysis or extracted for total cellular RNA using 
the RNA extraction kit. Protein extraction was conducted on ice to minimize protein 
degradation. 
 
5.3.3 Western blot analysis of P-gp protein 
Cellular protein concentrations were measured using a Bio-Rad Protein Assay Kit (Bio-
Rad Laboratories, Hercules, CA, USA) according to the manufacturer’s instructions. 
Western blots for the immunodetection of P-gp were obtained using 20 µg of extracted 
membrane proteins in loading buffer (0.15 g/ml Tris base pH 6.8, 15% glycerol, 0.015 
g/ml SDS, 0.005 g/ml bromophenol blue and 20% β-mercaptoethanol). Protein samples 
were separated on a 7.5% SDS-polyacrylamide gel and transferred onto a PVDF 
membrane as described in section 4.3.4. The membrane was blocked by incubating for 2h 
at room temperature with Tris-buffered saline containing 0.1% Tween 20 and 5% dried 
skim milk, then incubated for 2h with the primary monoclonal antibody, C219 (1:1000). 
The membrane was then incubated with anti-mouse IgG horseradish peroxidase 
conjugate (1:3000) for 1h followed by the chemiluminescence detection reagent for 5 min. 
Protein was visualized by exposing the membrane to a Kodak film for 2 min in a dark 
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room. β-actin served as internal standard, and it was detected using a mouse anti β-actin 
as primary antibody and anti-mouse IgG as secondary antibody. Band intensity was 
analyzed with the Quantity One software, and the P-gp expression was presented as a 
ratio of the P-gp band intensity relative to the β-actin band intensity obtained in the same 
blot (P-gp/actin [%]). 
 
5.3.4 Real time RT-PCR analysis of MDR1 mRNA 
Total cellular RNA was extracted using the RNeasy Mini Kit, and quantified at 260 nm 
(UV-visible-1601 spectrophotometer, Shimadzu, Japan). The purity of the RNA 
preparation was high, with OD (optical density) 260nm/280nm ratio in the range of 1.8 - 
2.0. Reverse transcription of the total RNA (0.2 µg) was carried out in a Flexigene 
thermal cycler (Techgene Ltd., Cambridge, UK) using Taqman reverse transcription 
reagents and random hexamers as primers according to the manufacturer’s protocol. 
 
For real time quantitative PCR, 1 µl (equivalent to 0.02 µg of total initial RNA) of the 
reverse transcription reaction mixture was used. Amplification and detection of samples 
were performed in a ABI 7500 sequence detection system using the ABI Assay-By-
Design Kit (Hs00184491_m1), which contained the forward primer, reverse primer and 
FAM labeled Taqman probe for MDR1 measurements (Foster City, CA, USA, 
http://www.appliedbiosystems.com). The endogenous control, 18S mRNA, was detected 
using the ABI 18S Kit (Hs99999901_s1). Reactions were multiplexed and performed in 
triplicates using the following protocol: 50oC for 2 min, 95oC for 5 min, followed by 35 
cycles of 95oC for 15 s, 60oC for 45 s, and 72oC for 45 s. Relative quantification was 
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obtained by the comparative threshold cycle (∆∆CT) method (Berrill et al., 2004) (RQ 
software, version 1.2.3, Applied Biosystems).  
 
5.3.5 Reversibility study 
Caco-2 cells cultured on TranswellTM inserts were exposed to piperine or capsaicin (50 
and 100 μM) on Day 18. On Day 21, after 72h of spice exposure, the medium was 
reverted to MEM devoid of spice, and the cells were cultured for another 3 days. Cellular 
P-gp level was then determined by western blot analysis, and compared to that in control 
cells not exposed to spice during the entire course of the experiment. 
 
5.3.6  In silico structure analysis of piperine and capsaicin     
Chemical structures of piperine and capsaicin were drawn using the Molecular Modeling 
Pro Plus software (ChemSW, Fairfield, CA, USA). The Log P value, representing the 
Log octanol/water partition coefficient, was calculated using the Moriguchi method 
(Moriguchi et al., 2006). The oral and CNS bioavailability of these two compounds were 
subsequently predicted according to the Rule of Five (Veber et al., 2002). 
 
5.3.7 Statistical analyses 
Differences between mean values were analyzed for significance by one-way ANOVA 








5.4.1  [3H]-Digoxin transport profiles 
[3H]-Digoxin showed polarized transport across the Caco-2 cell monolayers, the efflux 
ratio being 4.11 (Table 5.2). In the presence of 100 μM of verapamil, AB digoxin 
transport was enhanced while that in the BA direction was inhibited, and the efflux ratio 
was reduced to 1.1. This suggests an effective blockage of P-gp-mediated efflux activity 
in the BA direction, and in turn implicates the presence of functional P-gp in the Caco-2 
cell monolayers. 
 
Table 5.2   Apparent permeability coefficient (Papp) and net efflux ratio of bi-directional 
[3H]-digoxin (loading dose of 5 µM) transport across Caco-2 cell 
monolayers. 
  
Papp (×10-6 cm/s) Sample AB BA Net efflux 
Control 1.90±0.07 7.81±0.20 4.11 
100 µM 
Verapamil 3.32±0.06* 3.66±0.05* 1.10 
Piperine (µM)  
10 2.05±0.06 6.11±0.23* 2.98 
25 2.26±0.05* 5.63±0.06* 2.49 
50 3.32±0.10* 3.70±0.05* 1.11 
100 3.53±0.11* 3.69±0.08* 1.05 
Capsaicin (µM)    
10 2.49±0.08* 5.82±0.04* 2.34 
25 2.64±0.09* 5.05±0.11* 1.91 
50 3.63±0.08* 3.77±0.11* 1.04 
100 3.65±0.05* 3.64±0.11* 1.00 
Data are presented as mean ± SEM., n=4-6. 
Net efflux was calculated as the ratio of mean basal-to-apical Papp to mean apical-to-basal 
Papp. 
* p<0.05, significantly different from control group. 
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Piperine and capsaicin produced similar changes to the AB and BA digoxin transport 
profiles as verapamil, indicating that both spices also inhibited the P-gp function in the 
cells. The corresponding Papp values and efflux ratios are given in Table 5.2. The P-gp 
inhibitory effect of the spices was concentration-dependent, with capsaicin showing 
greater effectiveness at reducing the digoxin efflux ratio at lower concentrations. 
However, the discrepancy in activity level was negated when the spices were applied at 
higher concentrations of ≥ 50 µM. At a concentration of 50 µM, piperine and capsaicin 
produced comparable blockage of P-gp function as 100 µM of verapamil. The observed 
changes in [3H]-digoxin transport profile could not be mediated by paracellular transport 
as capsaicin and piperine at these concentration ranges did not produce significant 
changes to the transport of the paracellular marker, mannitol (Table 2.1, section 2.4.2).  
 
5.4.2  P-gp and MDR1 expression  
The effects of piperine and capsaicin on the expression of P-gp protein and MDR1 
mRNA in the Caco-2 cells were evaluated after 48 and 72h of co-culture in TranswellTM 
inserts. Induction of cellular P-gp (Figure 5.1 and 5.2) and MDR1 mRNA (Figure 5.3) 
were observed for both spices, the level of induction being influenced by the spice 
concentration and duration of exposure. Cellular P-gp expression was upregulated by 1.5 
and 2 folds, respectively, after 48 h of exposure to 50 and 100 µM of piperine. Extending 
the co-incubation time enhanced the modulating effect, with comparable P-gp levels 
observed in cells exposed to 50 μM of piperine for 72h and those exposed to 100 μM of 
piperine for 48h.  
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Compared with piperine, capsaicin was less effective at inducing the cellular P-gp at the 
shorter incubation time of 48h, a significant change in P-gp protein level being noted 
only at the higher capsaicin concentration of 100 µM (Figure 5.2). The efficiency of 
capsaicin as a P-gp inducer was, however, enhanced when the incubation time was 
prolonged to 72h. In this case, capsaicin produced a 2.4 fold increase in P-gp level at a 
concentration of 50 µM compared to a corresponding 2-fold increase for piperine. In 
addition, comparable P-gp levels were seen in cells exposed to 50 and 100 µM of 
capsaicin, suggesting that the cellular P-gp protein had reached an upper threshold level. 
This level was also observed of Caco-2 cells exposed for 72h to 100 µM of piperine.  
        
          72h                   48h  

































Figure 5.1 P-gp expression levels in Caco-2 cells cultured in TranswellTM inserts and 
exposed to 50 or 100 μM of piperine for 48 or 72h. P-gp protein level was determined by 
western blot using C219 as primary antibody. β-actin was used to confirm equal protein 
loading. Upper bands, P-gp; lower bands, β-actin. From left to right, control (culture 
medium), piperine 50 µM for 72h, piperine 100 µM for 72 h, piperine 50 µM for 48h and 
piperine 100 µM for 72 h. The result of one typical experiment out of three is shown. The 
bar graph shows the quantification of band intensity; data are expressed as mean ± S.E.M. 
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Figure 5.2 P-gp expression levels in Caco-2 cells cultured in TranswellTM inserts and 
exposed to 50 or 100 μM of capsaicin for 48 or 72h. P-gp protein level was determined 
by western blot using C219 as primary antibody. β-actin was used to confirm equal 
protein loading. Upper bands, P-gp; lower bands, β-actin. From left to right, control 
(culture medium), capsaicin 50 µM for 72h, capsaicin 100 µM for 72 h, capsaicin 50 µM 
for 48h and capsaicin 100 µM for 72 h. The result of one typical experiment out of three 
is shown. The bar graph shows the quantification of band intensity; data are expressed as 
mean ± S.E.M. (n=3). *, significantly different from control group (p<0.05). 
 
With regards to the capacity of the spices to induce the cellular MDR1 mRNA level, 
capsaicin was again more effective than piperine when applied at comparable 
concentration over the same period (Figure 5.3). While piperine at 100 µM caused a 4-
fold increase in the mRNA level after 72h of co-culture, capsaicin applied under similar 
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the common characteristics of mediating a greater increase in mRNA level at higher 














































Figure 5.3  RT-PCR analysis of MDR1 mRNA in Caco-2 cells exposed to (A) 
piperine and (B) capsaicin for 48 or 72 hours. MDR1 mRNA was quantified using real 
time PCR analysis standardized against the endogenous control 18S. C, control; P50, 
piperine 50 µM; P100, piperine 100 µM; C 50, capsaicin 50 µM; C 100, capsaicin 100 
µM. The data was normalized and expressed as percentage ratios to control levels (n=3). 
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The spice-mediated induction of P-gp protein was accompanied by increased P-gp 
function, as evidenced by an enhanced polarity in digoxin transport across the cell 
monolayers (Table 5.3). Net efflux ratios were significantly raised due to less efficient 
digoxin transport in the AB direction and increased digoxin transport in the BA direction 
in the cells. These data suggest the presence of functionally active induced P-gp protein 
in the spice-treated Caco-2 cells. Interestingly, despite the significant differences in 
induced P-gp protein and mRNA levels in the cells, only minor differences in [3H]-
digoxin Papp values were detected between cell monolayers exposed to piperine and 
capsaicin at equivalent concentration and duration.  
 
Table 5.3  Apparent permeability coefficient (Papp) and net efflux ratio of bi-
directional [3H]-digoxin (loading dose of 5 µM) transport across Caco-2 cell monolayers 
co-cultured with 50 or 100 μM of piperine or capsaicin for 48 or 72h prior to incubation 
with digoxin in the absence of spices. 
 
 48 h 72 h 




efflux AB BA 
Net 
efflux
Control 1.90±0.06 7.81±0.20 4.11 1.90±0.06 7.81±0.20 4.11 
Piperine 
(µM)   
50 1.54±0.05* 8.23±0.16* 5.34 1.40±0.03* 9.02±0.18* 6.44 
100 1.41±0.03* 10.4±0.19* 7.38 1.28±0.04* 12.90±0.20* 10.01 
Capsaicin 
(µM)   
50 1.65±0.06* 8.42±0.25* 5.09 1.42±0.07* 9.76±0.33* 5.45 
100 1.54±0.02* 10.05±0.33* 6.73 1.36±0.05* 12.07±0.11* 9.63 
Data are presented as mean ± SEM, n=4-6. 
Net efflux was calculated as the ratio of mean basal-to-apical Papp to mean apical-to-basal 
Papp.  
* p<0.05, significantly different from control group. 
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The P-gp induction effect of piperine and capsaicin was reversible. Upon the removal of 
the spice from the culture medium, P-gp expression in the cells was found to revert to 
baseline levels after 3 days of culture under standard conditions (Figure 5.4 and 5.5). The 
reversibility was observed whether the cell monolayers were previously exposed to 50 or 
100 µM of capsaicin. In the case of piperine, the results were less clear. Although the P-
gp protein level in the Caco-2 cells was not significantly different from control level 
following the removal of piperine from the culture medium (p =0.65), it was noted that 
the P-gp level in cell monolayers previously exposed to 50 or 100 µM of piperine was 























Figure 5.4 Reversibility of P-gp up-regulation by piperine. Caco-2 cells exposed to 50 or 
100 μM of piperine for 72h were cultured for another 3 days in the absence of piperine. 
P-gp protein level was determined by western blot using C219 as primary antibody. β-
actin was used to confirm equal protein loading. Upper bands, P-gp; lower bands, β-actin. 
From left to right, control (culture medium), piperine 50 µM treated cells, piperine 100 
µM treated cells. The result of one typical experiment out of three is shown. The bar 
graph shows the quantification of band intensity; Con, control; P 50, piperine 50 µM; P 
100, piperine 100 µM. Data are expressed as mean ± SEM. (n=3). *, significantly 
different from control group (p<0.05). 
 
























Figure 5.5 Reversibility of P-gp up-regulation by capsaicin. Caco-2 cells exposed to 50 
or 100 μM of capsaicin for 72h were cultured for another 3 days in the absence of 
piperine. P-gp protein level was determined by western blot using C219 as primary 
antibody. β-actin was used to confirm equal protein loading. Upper bands, P-gp; lower 
bands, β-actin. From left to right, control (culture medium), capsaicin 50 µM treated cells, 
capsaicin 100 µM treated cells. The result of one typical experiment out of three is shown. 
The bar graph shows the quantification of band intensity; Con, control; C 50, capsaicin 
50 µM; C 100, capsaicin 100 µM. Data are expressed as mean ± SEM. (n=3). *, 
significantly different from control group (p<0.05). 
 
5.4.3 Structural analysis of piperine and capsaicin  
Data obtained from the in silico analysis of piperine and capsaicin, as shown in Table 5.4, 
demonstrate remarkable similarities between the two spices with respect to their 
molecular weight, number of hydrogen bond acceptor, log P and polar surface area. As 
these structural characteristics are known to influence the degree of interaction with the 
P-gp (Bain et al., 1997; Seelig, 1998b; Seelig, 1998a; Osterberg and Norinder, 2000), 
Chapter 5.    In vitro modulation of P-gp expression and function: a comparison of piperine 
and capsaicin 
 132
such strong similarities between the two spices could implicate a common mechanism of 
P-gp modulating action. In addition, based on the Rule of Five (Lipinski et al., 2001), 
piperine and capsaicin would exhibit excellent oral bioavailability, and the absorbed 
spices could potentially affect the P-gp level of tissues other than the small intestine. If 
the P-gp expression in organs such as the liver and kidney are significantly changed, 
piperine and capsaicin could modify the disposition and distribution profiles of co-
consumed drugs that are P-gp substrates.  
 
Table 5.4 Parameters of piperine and capsaicin determined using the Molecular 
Modeling Pro Plus software. 
 
Parameters Piperine Capsaicin 
Molecular weight 285.34 305.41 
No of hydrogen bond donors 0 2 
No of hydrogen bond acceptors 4 4 
Log P* 2.73 3.49 
Polar surface area (Angstroms2) 41.93 61.72 
* Log P values were calculated by Moriguchi method. 
 
5.5 Discussion 
Intestinal P-gp plays a significant role in the absorption and pre-systemic elimination of 
many peroral xenobiotics, including drugs. Therefore, a study of the factors that regulate 
its function and expression is important both from the pharmacological and toxicological 
perspectives. In this study, we evaluated the effects of piperine and capsaicin on the P-gp 
function and expression in the Caco-2 cells. To our knowledge, this is the first report to 
examine the chronicity and reversibility of the modulating effect of piperine and 
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capsaicin on the P-gp expression and activity in the surrogate human intestinal epithelia. 
Considering that both compounds are the constituents of popular spices in the Asian 
cuisines, our data could have important implications. 
 
The digoxin transport data confirmed that the P-gp efflux activity in the polarized Caco-2 
cell monolayers was inhibited by sub-cytotoxic concentrations of piperine and capsaicin. 
This inhibitory action was dependent on spice concentration, and the P-gp function was 
abolished in the presence of 50 µM of either spice. The results were congruent with those 
obtained for the L-MDR1 cell monolayers (section 2.4.3, Table 2.3).  
 
The efflux ratio of 4.11 obtained for the polarized digoxin transport across the control 
Caco-2 cell monolayers was lower than the value of 8.51 reported by Bhardwaj et al.  
(Bhardwaj et al., 2002). This discrepancy could be attributed to differences in cell source, 
as well as laboratory culture conditions. Notwithstanding this differences, the data 
obtained by Bhardwaj et al. were in agreement with our data with regards to the effects of 
piperine on digoxin transport across the Caco-2 cell monolayers (Bhardwaj et al., 2002) 
Nabekura et al. has previously demonstrated that capsaicin could reverse doxorubicin 
resistance in human multidrug-resistant carcinoma KB-C2 cells by inhibiting the P-gp 
efflux pump (Nabekura et al., 2005). We affirmed the finding in the present study 
through the [3H]-digoxin transport data.  
 
At concentrations of 50 µM and higher, capsaicin and piperine were comparable 
inhibitors of the P-gp function in Caco-2 cells over a 4h-incubation period. Differential P-
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gp inhibitory activity was, however, evident at the lower spice concentration of 10 µM, 
with capsaicin being the stronger inhibitor on the basis of [3H]-digoxin Papp and efflux 
ratio values. To allow for a more quantitative comparison, the IC50 values were calculated 
for the two spices based on the net digoxin efflux ratio. This calculation was performed 
using the sigmoid model in the BioDataFit Online software 
(http://www.changbioscience.com/stat/ec50.html). The calculated IC50 for piperine and 
capsaicin were 28.9 and 12.8 µM, respectively, affirming capsaicin to be the stronger 
inhibitor of the P-gp function. 
  
Prolongation of the incubation time between the spice and the cells resulted in opposing 
effects. In this case, both capsaicin and piperine enhanced the P-gp mediated transport of 
digoxin across the Caco-2 cell monolayers, to the extent that an almost 2.5 fold higher net 
digoxin efflux was observed in cells exposed to 100 µM of either spice for 72h. This 
increase in digoxin efflux was well correlated with the higher P-gp protein and MDR1 
mRNA levels measured in the cells. The implication was that capsaicin and piperine were 
capable of inducing functional P-gp protein in the Caco-2 cells when the cells were co-
cultured with either spice at concentrations of 50 µM or higher for at least 48h. In 
addition, although the two spices induced different levels of P-gp in the cells when 
applied at equivalent concentrations over the same time frame, the [3H]-digoxin transport 
data suggest that piperine and capsaicin caused the cells to manifest comparable P-gp 
activity. The data therefore support our hypothesis that piperine and capsaicin exhibited 
comparable effects on cellular P-gp function upon acute and prolonged exposure.  
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Changes in intracellular protein levels could be attributed to modulation in gene 
transcription, protein synthesis or protein turnover rate (Chin et al., 1993; Gottesman and 
Pastan, 1993; Zhang et al., 2004). Piperine and capsaicin did not only up-regulated the P-
gp protein but also the associated mRNA level, indicating an influence at the 
transcriptional level. The underlying mechanism remains to be confirmed. However, it is 
unlikely to involve an activation of the pregnane X Receptor (PXR) because the Caco-2 
cells are regarded to be deficient in PXR (Geick et al., 2001; Mitin et al., 2004). In this 
respect, capsaicin and piperine might differ from other P-gp inducers, such as rifampin 
(Westphal et al., 2000), in regulating the expression of P-gp by a PXR-independent 
mechanism. Other mechanisms implicated in the induction of P-gp expression include the 
activation of NF-kB (Thevenod et al., 2000), protein kinase C (Flescher and Rotem, 2002) 
and PI3-kinase/Akt (Nwaozuzu et al., 2003) pathways. Identification of the specific 
mechanism will be important to further understand how the two spices interact with the 
cellular P-gp. The present study has, however, shown that both the P-gp protein and 
mRNA levels in the Caco-2 cells were induced by piperine and capsaicin, and that the 
induction process was readily reversed by the removal of the spices from the culture 
medium. In addition, the [3H]-digoxin transport data have shown the spice-induced P-gp 
protein to be functionally active.  
 
To examine whether the spice-mediated modulation of P-gp activity and expression was 
related to their cytotoxicity, we referred to the data generated in section 2.4.1 
(cytotoxicity) and 3.4.1 (anti-cell proliferation activity). Besides their effects on P-gp 
function, piperine and capsaicin also exhibited comparable cytotoxic profiles against the 
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Caco-2 cells (section 2.4.1). Both spices at concentrations of up to 100 µM were not 
cytotoxic towards the cells when the exposure time was limited to 4h. Therefore, the 
inhibition of P-gp function by acute exposure of the Caco-2 cells to piperine and 
capsaicin was not likely to be associated with cell damage or cell death. On the other 
hand, co-culture of the cells with piperine or capsaicin for 48h or longer resulted in 
inhibited cell proliferation, which could lead to the selection of cells with higher P-gp 
level. This is nonetheless debatable because the proliferation of L-MDR1 cells, which 
over-expressed the P-gp transporter, was previously shown to be more susceptible to 
piperine and capsaicin than the proliferation of the parental LLC-PK1 cells (section 3.4.1). 
The growth inhibition of Caco-2 cells is, however, in agreement with the anti-cell 
proliferation activity of piperine and capsaicin demonstrated in leukemia cells 
(Selvendiran et al., 2006), hepatocarcinoma cells (Jung et al., 2001) and lung cancer cells 
(Pradeep and Kuttan, 2004).  
 
5.6 Conclusions 
In conclusion, this study has shown piperine and capsaicin to have very similar effects on 
P-gp function. Exposure of Caco-2 cells to piperine or capsaicin for short duration of a 
few hours resulted in lower P-gp efflux activity in the cells. Prolonged exposure of the 
cells to piperine or capsaicin, on the other hand, led to an up-regulation of P-gp 
expression and enhanced P-gp efflux activity in the cells. Co-incubation with 50 or 100 
µM of piperine for 48 and 72h significantly increased the P-gp membrane protein levels 
in the Caco-2 cells as shown by the western blot results. Capsaicin exhibited a smaller 
induction effect in that a significantly higher P-gp level was obtained only after the 
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concentration was increased to 100 µM or the co-incubation time was prolonged to 72h. 
The P-gp induced by either spice was functionally active, as shown by the enhanced 
polarity in digoxin transport. Real-time PCR analysis demonstrated a concomitant up-
regulation of the mRNA levels of the MDR1 gene, suggesting a transcriptional 
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6.1 Introduction 
The potential of some chemicals to induce the P-gp in vivo has been investigated in 
animal and human models. Rifampin and St. John’s Wort administered orally for 5 days 
to mice were found to elevate the small intestinal P-gp expression by 3.7 and 1.6-fold, 
respectively (Matheny et al., 2004). However, P-gp levels in the mouse liver and brain 
were not affected, suggesting that the P-gp in these tissues were less readily inducible 
than that in the intestine. St John's Wort also induced the intestinal P-gp in the rat model, 
with accompanying up-regulation of the mdrl expression (Durr et al., 2000). A clinical 
study also showed the duodenal P-gp and MDR1 levels of 8 healthy male volunteers to 
increase by 1.4- and 1.5-fold, respectively, following the consumption of the herb for 14 
days (Durr et al., 2000). In addition, there was an 18% decrease in digoxin exposure 
following the administration of a single digoxin dose (0.5 mg) to these volunteers (Durr 
et al., 2000).  
 
The capacity of piperine and capsaicin to induce the expression of P-gp and MDR1 
mRNA in the Caco-2 cell monolayers following prolonged exposure has been 
demonstrated in Chapter 5. Given the important role of the P-gp in xenobiotic disposition 
and detoxification, it is pertinent to verify whether piperine and capsaicin were able also 
to modulate P-gp expression under the complex in vivo conditions.  
 
The purpose of the study in this chapter was to evaluate whether a prolonged 
consumption of piperine and capsaicin would modify the P-gp expression in the rat 
model. The rat was chosen as it is the most common laboratory animal for in vivo 
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experiments, and the toxicity profiles of piperine and capsaicin have been established in 
the rat (Piyachaturawat et al., 1983; Saito and Yamamoto, 1996; Monsereenusorn, 1983). 
In adult female rats, the i.p. and i.g. LD50 values for piperine were 33.5 and 514 mg/kg 
body wt, respectively (Piyachaturawat et al., 1983). Histopathological changes observed 
in subacute toxicity studies included severe hemorrhagic necrosis and edema in the GIT, 
urinary bladder and adrenal glands. Parallel piperine toxicity data for male rats were, 
however, not available. The oral LD50 values of capsaicin were 161.2 and 148.1 mg/kg 
for male and female rats, respectively (Saito and Yamamoto, 1996). Interestingly, while 
erosion and ulceration of the gastric fundus were seen in dead animals administered with 
capsaicin, no pathological changes were observed in the tissues of surviving animals. 
Subchronic toxicity studies indicated that the prolonged oral consumption of capsaicin at 
a dose of 50 mg/kg gave rise to only a mild effect on the experimental animals 
(Monsereenusorn, 1983). Based on these literature reports, it may be concluded that the 
acute oral LD50 of piperine and capsaicin are greater than 100 mg/kg whereas the 
subchronic LD50 values are above 50 mg/kg.  
 
For this study, piperine and capsaicin were administered to male Wistar rats at doses of 
112 and 128 µg/kg, respectively. These doses were chosen based on several 
considerations. The content of piperine in black pepper is between 5 to 9%, suggesting a 
daily consumption of approximately 280 to 520 µg/kg (60-110 µM) of piperine in 
populations that use black pepper regularly in their diet (Bhardwaj et al., 2002). A typical 
Indian or Thai diet, on the other hand, has been reported to yield about 128 μg of 
capsaicin per kg human body weight (Rumsfield and West, 1991). Therefore, the piperine 
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and capsaicin doses would reflect the levels consumed by populations who regularly used 
pepper and chilli in their diet (Rumsfield and West, 1991; Bhardwaj et al., 2002). The 
doses were also intended to be much lower than the reported LD50 doses in rats so as to 
reduce the potential for overt organ toxicity in the experimental animals. In addition, 
these spice concentrations had been shown to be ineffective in inhibiting the proliferation 
of L-MDR1, LLC-PK1 and Caco-2 cells (Chapter 3). 
 
6.2 Materials 
Pentobarbital was supplied by the Laboratory Animal Centre of the National University 
of Singapore; HistoClear™ solution was from Innovative Biotech Pte. Ltd, Singapore; 
hematoxylin, eosin and DPX mounting medium for staining were supplied by the 
Electron Microscopy Lab, National University of Singapore; mannitol was from Sigma-
Aldrich Inc.; Trizol reagent was from Gibco BRL Life Technology; sucrose and ethidium 
bromide were from Bio-Rad Laboratories, Inc.; One-step RT-PCR kit, DNA loading dye 
and 100bp DNA ladder were from Promega Corporation (Madison, WI, USA), primers 
were from Proligo Primers and Probes (Boulder, CO, USA); and agarose powder was 
from BioWhittaker Molecular Applications, Inc. (Rockland, ME, USA). All other 
materials were the same as those listed in section 5.2. 
 
6.3   Methods 
6.3.1 Animals 
Male Wistar rats provided by the Laboratory Animal Centre of the National University of 
Singapore were weighed (220-320g) and randomly assigned to the control or treatment 
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groups. All animal experiments were conducted in accordance with the National 
University of Singapore guidelines for the care and use of laboratory animals. 
 
6.3.2   Spice administration and rat tissue collection 
Piperine and capsaicin were separately dissolved in DMSO, then diluted with 0.9% NaCl 
to give final concentrations of 22.4 and 25.6 µg/ml, respectively. The final DMSO 
concentration in the spice solutions was 1%. Rats in the treatment group received 
intragastrically, via a gavage needle (16 gauge, Kent Scientific, Torrington, CT, USA), 
112 µg/kg (body weight) of piperine or 128 µg/kg (body weight) of capsaicin once daily 
for 14 consecutive days. Rats in the control group received the equivalent volume of 1 
ml/0.2 kg (body weight) of vehicle (1% of DMSO in 0.9% NaCl solution). All animals 
were fasted for 1h just prior to and immediately after spice administration, but were 
otherwise allowed free access to food and water during the experiments.  
 
Animals were fasted overnight on day 14 and euthanized on the morning of day 15 by i.p. 
injection of pentobarbital (50 mg/kg body weight). Liver and kidney samples were 
collected from the same lobe for each rat. Intestinal samples were harvested as follows: 
the first 20-cm segment proceeding from the pyloric sphincter was denoted as the 
duodenal sample, the middle 50-cm segment as jejunum sample and the posterior 20-cm 
segment just preceding the colon as ileal sample. The central portion of each of these 
samples was further sectioned into 2-cm segments for western blotting, RNA extraction 
and histological examination.  
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6.3.3   Histological evaluation 
Samples of the rat duodenum, jejunum and ileum were embedded in paraffin and 
sectioned at 7 µm thickness using a microtome (Leica RM2125, Chatsnorth, CA, USA). 
The sections were rinsed with 75% ethanol, fixed onto glass slides, and allowed to dry 
overnight at 37oC on a slide warmer (Electron Microscopy Sciences, PA, USA). After 
rinsing with Histoclear™ to remove the paraffin, followed by ethanol solutions of 
decreasing concentrations to hydrolyze the tissues, the tissues were stained with 
hematoxylin and eosin, followed by further washings with ethanol solutions of increasing 
concentrations and Histoclear™. The slides were then mounted with coverslips in DPX 
mounting medium and dried overnight under ambient conditions. Prepared slides were 
observed under a light microscope (Olympus, CX31 series, Tokyo, Japan) at 100 and 400 
x magnifications. 
 
6.3.4   Western blot  
For the western blot analyses, about 100 mg of rat tissue samples were cut into small 
pieces and homogenized (eppendorf tube-compatible homogenizer, Sigma-Aldrich Inc.) 
in 500 µl of homogenizing buffer (250 mM sucrose/5mM HEPES with 2% protease 
inhibitor, pH 7.4). The crude homogenates were centrifuged with 500 µl of homogenizing 
buffer at 3000g, 4oC for 10 min to pellet the debris, nuclei and mitochondria. The 
supernatant was removed and centrifuged again at 15,000g, 4oC for 30 min to pellet the 
crude membrane fractions. The pellet was reconstituted in suspending buffer (50mM 
mannitol/20mM HEPES with 2% protease inhibitor, pH 7.4) and 50 µg of extracted 
membrane proteins was used for the immunodetection of P-gp by western blot. The 
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procedures for the western blot analysis were similar to those described for the in vitro 
experiments in section 5.3.3. The cellular β-actin level was employed as the internal 
standard to normalize protein loadings for different tissue samples. The tissue P-gp 
expression was presented as the ratio of the P-gp band intensity to the β-actin band 
intensity obtained from the same blot.  
 
6.3.5 RT-PCR 
Total rat RNA was extracted using the Trizol method according to the manufacturer’s 
instructions. The following primer sequences were used. For the mdr1a gene, the forward 
primer sequence was 5’-GATGGAATTGATAATGTGGACA-3’ and the reverse primer 
sequence was 5’-AAGGATCAGGAACAATAAA-3’ (Takara et al., 2003). The forward 
primer sequence for β-actin was 5'-GACGAGGCCCAGAGCAAGAGA-3' and the 
reverse primer sequence was 5'-CCAGAGGCATACAGGGACAACACA-3' (sequences 
were kindly provided by Dr. Theresa Tan, National University of Singapore). The RT-
PCR reaction was conducted in 12.5 µl of one-step reaction mix, which contained 1 µl of 
the extracted RNA (0.2 µg/µl), 1×TaqMan buffer, 1 mM MgSO4, 100 µM dNTP, 500 nM 
primers, and 1.25 U each of AMV reverse transcriptase and Tfl DNA polymerase. The 
mixture was incubated for 45 min at 48°C for the reverse transcription reaction and 
subsequently at 94°C for 2 min for AMV RT inactivation and cDNA/primer denaturation. 
This was followed by amplification for 25 cycles and incubation for 7 min at 68oC for the 
final extension. The PCR products were subject to electrophoresis through 1.5% agarose 
gels in the presence of ethidium bromide, and the resultant bands visualized under UV 
illumination (The Gel Doc XR documentation system, Bio-Rad Laboratories, Inc.). Band 
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intensities for mdr1a and β-actin were quantified using the Quantity One software, and 
the mdr1a expression level was expressed as a percentage relative to the β-actin RNA 
level. 
 
6.3.6 Statistical analyses 
Rat P-gp and mdr1a levels were expressed as mean ± SEM (n=3). Differences between 
mean values were analyzed for significance by one-way ANOVA using the SPSS 10.0 
software. p values ≤0.05 were considered significantly different. 
 
6.4    Results 
6.4.1 Histological changes 
None of the rats in the treatment or control groups exhibited significant changes in body 
weight over the 14-day duration of the experiment (data not shown). Intestinal tissues, 
whether from the duodenal, jejunal or ileal segments, harvested from these rats following 
euthanasia also did not show any apparent inflammation or lesion (Figure 6.1 and 6.2). 
Neither were there overt changes in the intestinal epithelia morphology for all tissues. 
The implication is that piperine and capsaicin, at the respective doses of 112 and 128 
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                                 A                                  B                                 C 
   
   
Figure 6.1 Histological staining of intestinal tissues (A, duodenum; B, jejunum and C, 
ileum) harvested from rats administered intragastrically with vehicle (Upper row) and 
piperine at a dose of 112 µg/kg (Lower row) for 14 days. One representative tissue slide 
out of 5 is shown.  
                                   A                               B                                 C 
   
   
Figure 6.2 Histological staining of rat intestine (A, duodenum; B, jejunum and C, ileum) 
harvested from rats administered intragastrically with vehicle (Upper row) and capsaicin 
at a dose of 128 µg/kg (Lower row) for 14 days. One representative tissue slide out of 5 is 
shown. 
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6.4.2  Western blot analysis  
The effects of peroral piperine and capsaicin on P-gp expression in the rat intestine, liver 
and kidney were evaluated by western blot analysis. In all the tissues examined, the P-gp 
was detected as a band corresponding to a protein of 170 kDa. In agreement with the 
reportedly low and, sometimes, undetectable levels of P-gp in the duodenum and jejunum 
(Gustafson and Long, 2001), inconsistent levels of P-gp, with some below the detection 
threshold, were observed for the duodenal and jejunal tissues, regardless of whether the 
tissues were harvested from control or treated rats. For this reason, the P-gp levels of 
these tissues were not quantified in this study. The western blots of the rat ileal tissues are 
shown in Figures 6.3 and 6.4. Quantification of the band intensity suggested that the daily 
consumption of 112 µg/kg of piperine for 14 days caused a 1.4-fold induction of P-gp 
expression in the rat ileum (p<0.05). A 1.5-fold higher P-gp level was also observed in 
the ileal tissues of rats fed daily over 14 days with 128 µg/kg of capsaicin; however, this 

































Figure 6.3 Expression of P-gp protein in the ileum of rats administered intragastrically 
with vehicle (control, n=4) and piperine at a dose of 112 µg/kg (treated, n=4) once daily 
for 14 consecutive days. Rats were sacrificed on day 15. Proteins were determined by 
western blot using C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, quantification of band 































Figure 6.4 Expression of P-gp protein in the ileum of rats administered intragastrically 
with vehicle (control, n=4) and capsaicin at a dose of 128 µg/kg (treated, n=4) once daily 
for 14 consecutive days. Rats were sacrificed on day 15. Proteins were determined by 
western blot using C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, quantification of the 
band intensity; data are expressed as mean ± SEM (n=4). *, significantly different from 
control group (p<0.05). 
 
 
Western blots of rat liver homogenates are shown in Figures 6.5 and 6.6, while those for 
the rat kidney homogenates are shown in Figures 6.7 and 6.8. Contrary to their effects on 
the ileal P-gp, both the piperine and capsaicin treatments resulted in significantly down-
regulated hepatic P-gp level in the rats, the mean hepatic P-gp levels in the treated rats 
being, respectively, 60% and 70% of that in the control rats. On the other hand, the 
prolonged consumption of piperine did not significantly change the rodent kidney P-gp 
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level, while the administration of capsaicin significantly decreased the kidney P-gp 






















Figure 6.5.Expression of P-gp protein in the liver of rats administered intragastrically 
with vehicle (control, n=4) and piperine at a dose of 112 µg/kg (treated, n=4) once daily 
for 14 consecutive days. Rats were sacrificed on day 15. Proteins were determined by 
western blot using C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, quantification of the 
band intensity; data are expressed as mean ± SEM (n=4). *, significantly different from 




























Figure 6.6 Expression of P-gp protein in the liver of rats administered intragastrically 
with vehicle (control, n=5) and capsaicin at a dose of 128 µg/kg (treated, n=5) once daily 
for 14 consecutive days. Rats were sacrificed on day 15. Proteins were determined by 
western blot using C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 5 lanes, control; right 5 lanes, treated group. B, quantification of the 
band intensity; data are expressed as mean ± SEM (n=5). *, significantly different from 





























Figure 6.7 Expression of P-gp protein in the kidney of rats administered intragastrically 
with vehicle (control, n=4) and piperine at a dose of 112 µg/kg (treated, n=4) once daily 
for 14 consecutive days. Rats were sacrificed on day 15. Proteins were determined by 
western blot using C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, quantification of the 





























Figure 6.8 Expression of P-gp protein in the kidney of rats administered intragastrically 
with vehicle (control, n=4) and capsaicin at a dose of 128 µg/kg (treated, n=4) once daily 
for 14 concecutive days. Rats were sacrificed on day 15. Proteins were determined by 
western blot using C219 as primary antibody. A, immunoblots. Upper bands, P-gp; lower 
bands, β-actin. Left 4 lanes, control; right 4 lanes, treated group. B, quantification of the 
band intensity; data are expressed as mean ± SEM (n=4). *, significantly different from 
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6.4.3 RT-PCR analysis of mdr1a expression 
Rodent P-gp is encoded by the mdr1a and mdr1b genes, both of which produced the 
efflux protein associated with MDR, same as the human MDR1 gene. In this study, the 
expression of the mdr1a was analyzed by RT-PCR in order to determine the effects of 
peroral piperine and capsaicin on the P-gp encoding gene in the rat model.  
 
Despite several trials, the RT-PCR technique was unable to yield clear bands for the 
rodent liver and kidney mdr1a. Therefore, only the results for the rodent intestinal tissues 
are presented, in Figures 6.9 and 6.10, respectively, for animals administered with 
piperine and capsaicin. In contrast to the difficulty associated with obtaining consistent 
signals for P-gp in the rat duodenum and jejunum, clear bands for mdr1a were observed 
for the rodent duodenal, jejunal and ileal tissues. This suggests that the P-gp and mdr1a 
might not be co-expressed in tandem in the rat duodenum and jejunum. In addition, while 
the piperine consumption was shown to induce the intestinal P-gp expression, it had no 
effect on the intestinal mdr1a mRNA level (Figure 6.9). Like piperine, capsaicin also did 
not change the mdr1a mRNA level in the rodent duodenum, jejunum and ileum (Figure. 



































Figure 6.9 Expression of mdr1a in the intestine of rats administered intragastrically with 
vehicle (control, n=4) and piperine at a dose of 112 µg/kg (treated, n=4) once daily for 14 
concecutive days. Rats were sacrificed on day 15. mdr1a level were determined by RT-
PCR using β-actin as control. A, RT-PCR bands from duodenum; B, RT-PCR bands from 
jejunum; C, RT-PCR bands from ileum. Upper bands, P-gp; lower bands, β-actin. Left 4 
lanes, control; right 4 lanes, treated group. D, quantification of the band intensity; data 
are expressed as mean ± SEM (n=4). 
 



























Figure 6.10 Expression of mdr1a in the intestine of rats administered intragastrically 
with vehicle (control, n=4) and capsaicin at a dose of 128 µg/kg (treated, n=4) once daily 
for 14 concecutive days. Rats were sacrificed on day 15. mdr1a level were determined by 
RT-PCR using β-actin as control. A, RT-PCR bands from duodenum; B, RT-PCR bands 
from jejunum; C, RT-PCR bands from ileum. Upper bands, P-gp; lower bands, β-actin. 
Left 4 lanes, control; right 4 lanes, treated group. D, quantification of the band intensity; 
data are expressed as mean ± SEM (n=4). 
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6.5 Discussion 
The in vivo regulation of P-gp by clinically important drugs has been previously studied 
(Gustafson and Long, 2001). On the other hand, only a few food components and health 
supplements, notably St John’s Wort, have been evaluated in vivo for their effects on P-
gp expression. The present study is, to our best knowledge, the first report on the 
modulating effects of peroral piperine and capsaicin on P-gp expression in vivo. 
Administered continuously for 14 days to male Wistar rats at daily doses comparable to 
those normally encountered by populations that rely heavily on pepper and chilli to 
flavour their food, piperine and capsaicin were found to modulate tissue P-gp levels 
without causing overt damage to the intestinal epithelium or significant weight loss in the 
animals. P-gp expression in different tissues appeared to be independently modulated by 
the spices. While the rodent intestinal P-gp was induced by the peroral piperine, the 
hepatic P-gp was down-regulated while the kidney P-gp expression was unaffected by the 
spice. Capsaicin, on the other hand, down-regulated the hepatic and renal P-gp levels 
without affecting the intestinal P-gp expression.  
 
The piperine-induced P-gp level in the rat ileum was also not matched by a similar 
change in the mdr1a mRNA level, suggesting a post transcriptional regulation of P-gp by 
the spice. Tissue P-gp regulation remains incompletely understood, although the 
mechanisms involved in post-transcriptional regulation have been associated with P-gp 
glycosylation (Gribar et al., 2000) and trafficking (Maitra et al., 2001). Further 
experimentation will be required to explore the mechanisms by which peroral piperine 
and capsaicin modulate the rodent tissue P-gp levels.  
Chapter 6.    In vivo modulation of P-gp expression: a comparison of piperine and capsaicin 
 158
 
The in vivo data obtained with the rat model also did not mirror the in vitro data obtained 
with the Caco-2 cell monolayer (section 5.4.2). In the in vitro experiments, piperine and 
capsaicin were observed to induce comparable levels of P-gp in the Caco-2 cells 
following 48 h of exposure. The protein induction was accompanied by increased levels 
of MDR1 mRNA, indicating a transcriptional modulation of the transporter protein by the 
two spices in the Caco-2 cells. In contrast, piperine and capsaicin exhibited divergent 
effects on P-gp expression in the different rodent tissues, and the changes in tissue P-gp 
levels were not matched by corresponding changes in mdr1a mRNA levels. In addition, 
while the inductive effect of peroral piperine on the rodent intestinal P-gp level was in 
agreement with the in vitro data, capsaicin did not affect the intestinal P-gp expression in 
vivo.  
 
The discrepant results between the in vitro and in vivo systems could be attributed to 
species difference, as the Caco-2 cells were derived from human colonic cells, and are 
widely applied as surrogate human intestinal epithelial cells. Another underlying reason 
could be the more complex system presented by the in vivo rat model. Unlike the in vitro 
system where the Caco-2 cells were exposed to the entire dose of spice administered, the 
processes of absorption, metabolism, distribution and elimination in vivo could 
significantly reduce the amount of spices that came in contact with the rodent intestine, 
liver and kidney. In a pharmacokinetic study involving the rat model (Bhat and 
Chandrasekhara, 1986), piperine administered intraperitoneally at a dose of 170 mg/kg 
was shown to reach peak concentration in the stomach and small intestine at about 6h 
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post-administration. About 0.1 - 0.25% of the oral dose was detected in the liver 0.5-6 h 
after administration, with only trace amounts (<0.15%) of piperine detected in the serum, 
kidney and spleen from 30 min to 24h. Similarly, peroral capsaicin has been reported to 
have a low bioavailability (Kawada et al., 1984); (Donnerer et al., 1990). It is almost 
completely metabolized before reaching the general circulation (Donnerer et al., 1990). 
Given their low systemic levels following oral consumption, the capacity of piperine and 
capsaicin to attenuate the P-gp level in the rat liver and/or kidney is particularly 
intriguing. It also raised the possibility that piperine and capsaicin might have modulated 
the rodent P-gp levels via active metabolites. 
 
Notwithstanding the differences between the in vitro and in vivo data, it is evident that a 
prolonged exposure to dietary amounts of piperine and capsaicin could influence tissue P-
gp expression. These findings may have significant implications on drug absorption and 
disposition in populations that use these two spices liberally in their diet. As the rat model 
has limitation in generating clinically relevant data, the present findings that intestinal 
and hepatic P-gp expression could be modulated by prolonged spice consumption should 
stimulate further studies using human models. It is further noted that the up-regulation of 
intestinal P-gp level by piperine, which can adversely affect the absorption of P-gp 
substrates, may be counter-balanced by the piperine-mediated down-regulation of P-gp 
level in the liver and kidney, which reduce the rate of elimination of P-gp substrates. As 
such, it is critical that studies be conducted to determine whether the regular consumption 
of piperine and capsaicin will change the clinical outcome of drugs that are P-gp 
substrates. 
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6.6 Conclusion 
Western blot analysis indicated that the intragastric administration of 112 µg/kg of 
piperine for 14 consecutive days in the rat model increased the P-gp protein level in the 
ileum and reduced the P-gp level in the liver. The rat kidney P-gp level was, however, not 
affected by the prolonged consumption of piperine. In comparison, the intragastric 
administration of 128 µg/kg of capsaicin for 14 days down-regulated both the rat liver 
and kidney P-gp levels, but did not significantly change the rat intestinal P-gp level. The 
spice-induced changes in rodent tissue P-gp levels were not well correlated with the 
mdr1a mRNA levels as determined by RT-PCR analyses, suggesting a post-
transcriptional modulation of the P-gp protein expression. As the doses of piperine and 
capsaicin administered to the rats are equivalent to those consumed by human 
populations that depend heavily on pepper and chilli in their diets, these findings could 
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The hypothesis for this project was that spices consumed as food supplements could 
affect oral drug bioavailability by interfering with intestinal drug transport. A preliminary 
screening of spices commonly associated with South East Asian diets showed that 
piperine (active component of pepper), capsaicin (active component of chilli), the garlic 
derivative, diallyldisulfide (DADS), garlic aqueous extract and ginger ethanol extract, 
could indeed modulate the paracellular transport pathway of the Caco-2, L-MDR1 and 
LLC-PK1 cell monolayers. The modulating effects occurred at spice concentrations 
below the acute cytotoxic doses, and should therefore not be attributed to cell damage or 
cell death. The screening process also revealed that differential effects could be obtained 
for components isolated from the same spice. Both DAS (diallylsulfide) and DADS 
(diallyldisulfide) were derived from garlic, but while the former did not significantly 
modify mannitol transport across the Caco-2 cell monolayers at 100 and 300 µM, DADS 
caused a reduction in bi-directional mannitol permeability at equivalent concentrations. 
Another garlic sample, comprising the aqueous extract, was observed to enhance 
mannitol permeability at the concentrations of 1.5 and 3 mg/ml. Such data underscore the 
complexity of studying spice-drug interactions, in particular when whole spices are used, 
because of the inter-batch variability in composition commonly encountered in spices due 
to differences in species, culture conditions and post-harvest processing. For this reason, 
the project has chosen to focus on principal components of common spices. 
 
Further experimentation with piperine and capsaicin showed that a prolongation of spice 
exposure could further enhance the paracellular permeability of the Caco-2 cell 
monolayers. The addition of 100 µM of piperine was observed to increase the BA and 
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AB mannitol Papp values by 1.4- and 2.2- fold, respectively, in cell monolayers not 
exposed to the spice during culture. The corresponding increases in Papp values for cell 
monolayers co-cultured for 18 days with 100 µM of piperine were 2.2- and 2.8 folds, 
respectively. Similarly, an acute exposure to 100 µM of capsaicin during the transport 
experiments yielded a 1.5-fold increment in AB mannitol Papp, in contrast to the 1.8-fold 
obtained for cell monolayers exposed to 100 µM of capsaicin during culture and mannitol 
transport. The enhancement in paracellular permeability associated with prolonged spice 
exposure could have implications on populations that use these spices regularly in their 
diets. Although the spice-mediated increases in mannitol Papp appeared to be modest, they 
were nevertheless statistically significant, warranting further investigation into their 
clinical implications. Interestingly, the spices had to be present during the mannitol 
transport experiments. If piperine or capsaicin was removed from pre-exposed cell 
monolayers just prior to the transport experiments, the mannitol Papp values were reduced 
to control levels. The reversibility of the spice effects, if proven clinically, would be 
reassuring to physicians who need to prescribe peroral potent drugs with substantial 
paracellular access to patients who consumed these spices on a regular basis.  
 
The mechanisms by which piperine and capsaicin modulated the paracellular 
permeability of Caco-2 cell monolayers remained unclear. Immunostaining of the cells 
revealed marginal changes in F-actin distribution by piperine and capsaicin and in ZO-1 
distribution by piperine. However, western blot analysis showed no changes in the 
expression level of the tight junction proteins, ZO-1, occludin and actin, in the Caco-2 
cell monolayers cultured on TranswellTM inserts, the same culture conditions employed 
Chapter 7.    Final conclusions 
 164
for cells used for the mannitol transport experiments. On this basis, it was concluded that 
piperine and capsaicin were unlikely to work predominantly through the ZO-1, occludin 
or F-actin proteins to increase the paracellular permeability of the Caco-2 cell monolayers.  
 
The spices involved in the preliminary screen were observed to not only affect the 
paracellular transport pathway, but also the P-gp-mediated efflux pathway. Bi-directional 
[3H]-digoxin transport data across polarized L-MDR1 cell monolayers indicated that the 
P-gp function was inhibited by sub-cytotoxic concentrations of piperine and capsaicin, 
with both spices capable of producing comparable inhibitory activity as the established P-
gp inhibitor, verapamil. Although the ethanolic ginger extract also showed potential 
inhibitory action on P-gp efflux activity, it was a significantly weaker agent. Garlic 
aqueous extract and its constituents, DAS and DADS, also modified the digoxin transport 
profile, but not in a manner consistent with a P-gp inhibitor. For these reasons, only 
piperine and capsaicin were considered for further investigation into their P-gp 
modulating activity. 
 
To delineate the action of the spices on the P-gp transporter, the cytotoxicity of piperine 
and capsaicin was evaluated. A preliminary MTT assay conducted to determine the 
appropriate spice doses to be used for the drug transport experiments had shown 
capsaicin to be cytotoxic towards the Caco-2 cells, but not against the L-MDR1 and 
LLC-PK1 cells, when it was incubated with the cells for 4h at ≥ 500 µM. Exposure for 4h 
to piperine at up to 500 µM did not affect the viability of the 3 cell lines. Both spices, 
however, showed anti-cell proliferation activity when incubated for prolonged periods 
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with the cells at concentrations which did not produce cytotoxicity upon acute contact. 
Thus, while piperine and capsaicin at the concentrations of 50 and 100 µM did not reduce 
cell viability at 4h exposure, the same spice concentrations inhibited the proliferation of 
Caco-2, L-MDR1 and LLC-PK1 cells after 72h of co-incubation. This anti-cell 
proliferation activity could be used to advantage in cancer chemotherapy, as has been 
explored for capsaicin in several published studies. On the other hand, if the two spices 
also inhibit the renewal of normal cells, it could become an issue of concern for 
populations that regularly consume the spices in large quantities. Nonetheless, in vivo 
studies in this project have shown that piperine and capsaicin did not cause overt 
pathological and histological changes to the intestinal epithelium of male Wistar rats 
when administered intragastrically at dietary doses over 14 days. In the in vitro cell 
model, however, greater anti-cell proliferation activity was observed for both spices at 
higher spice concentrations and longer exposure times. Cell cycle analysis showed the 
accumulation of cells at the G1/G0 phase but, compared to established cell cycle 
modulators, piperine and capsaicin could only be regarded to have modest effects on the 
cell cycle progression of the 3 epithelial cell lines evaluated.  
 
Further experiments conducted on Caco-2 cell monolayers indicated that piperine and 
capsaicin had very similar effects on P-gp expression and activity in vitro. This study was 
novel, because the biological activities of piperine and capsaicin have rarely been 
compared in parallel experiments despite their remarkably similar chemical structures. 
Exposure of the Caco-2 cells to piperine or capsaicin at 50 or 100 µM for short duration 
of 4 h resulted in lower P-gp efflux activity, whereas a prolonged exposure (48 or 72h) of 
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the cells to either spice led to an up-regulation of P-gp expression accompanied by 
enhanced P-gp efflux activity. Western blot results indicated that capsaicin was a 
relatively weaker inducer of the P-gp protein, but it produced a comparative changes to 
the P-gp mediated transport of [3H]-digoxin as an equivalent dose of piperine. Real-time 
PCR analysis demonstrated a concomitant up-regulation of the MDR1 mRNA level in the 
exposed cells, suggesting a transcriptional mechanism by both spices.  
 
In contrast, the experiments conducted on male Wistar rats suggest that piperine and 
capsaicin had different modulating effects on tissue P-gp expression under the complex in 
vivo conditions. Western blot analysis indicated that the intragastric administration of 112 
µg/kg/day of piperine increased the P-gp protein level in the rodent ileum and reduced 
the P-gp level in the liver after 14 days. The rat kidney P-gp level was, however, 
unaffected by the prolonged consumption of piperine. In comparison, the intragastric 
administration of 128 µg/kg/day of capsaicin for 14 days down-regulated both the rat 
liver and kidney P-gp levels, but did not significantly change the rat intestinal P-gp level. 
Aside from the differential effects of the spices, the changes in rodent tissue P-gp levels 
were also not well correlated with the mdr1a mRNA levels, suggesting a post-
transcriptional modulation of the P-gp protein expression in vivo, unlike the proposed 
mechanism for spice-induced P-gp expression in the cell-based experiments. Factors that 
could account for the discrepancies between the in vitro and in vivo data include (1) the 
Caco-2 cells were derived from human, while the in vivo study was performed in the rat 
model; (2) P-gp expression in a cell might be governed by unique signal transduction 
pathways that meet with the specific functions of the cell; and (3) the spice concentration 
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presented to different tissues in vivo is governed by the processes of absorption, 
distribution, metabolism and elimination, unlike the closed compartment model presented 
by the cell-based system.  
 
The findings of this project therefore provide much scope for further studies. As the 
doses of piperine and capsaicin administered to the rats were equivalent to those 
consumed by human populations that depend heavily on pepper and chilli in their diets, it 
will be pertinent to determine whether the spice-mediated changes in tissue P-gp 
expression will translate into differences in drug bioavailability and disposition in these 
populations. Such studies are critical because of the lack of evidence in current literature 
to support the manifestation of significant clinical interactions associated with spice and 
drug co-administration in humans. Food-drug interactions can cause significant clinical 
impact, especially for drugs with poor oral bioavailability and a small therapeutic 
window. For drugs which are P-gp substrates, food-drug interactions mediated by P-gp 
efflux transport must be considered. Until studies involving human subjects are 
conducted to determine the clinical importance of piperine and capsaicin as modulators of 
drug bioavailability, the data in this study suggest caution when potent drugs known to be 
P-gp substrates are to be administered to patients whose daily diets are strongly flavored 
with piperine or capsaicin. This advice is particularly pertinent given the growing 
popularity of piperine as a nutrient enhancer and capsaicin as a supplement in herbal 
medicines. The results from this study may also have important implications for 
ethnicity-based variation in oral drug bioavailability. Given the pronounced differences in 
piperine and capsaicin consumption between ethnic groups, it is reasonable to 
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hypothesize that population pharmacokinetics may be influenced by spice-mediated P-gp 
expression status. In addition, such effects may well be intensified in populations which 
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Piperine and capsaicin have been shown in this project to modulate the paracellular and 
P-gp mediated transport pathways in in vitro cell-based models. By comparison, the 
human body represents a much more complicated in vivo system. In this regard, clinical 
pharmacokinetic and pharmacodynamic studies are desired to determine whether the 
acute and long term consumption of piperine and capsaicin at dietary doses would affect 
the absorption, distribution and elimination of clinical drugs. Drugs such as heparin and 
insulin could serve as paracellular markers while digoxin and celiprolol are established 
markers for P-gp mediated transport. Mechanistic data could be obtained from animal 
models. For example, PK and PD studies in P-gp knockout animals, such as the mdr1a/1b 
(-/-) mice, can be especially useful in determining the extent to which piperine and 
capsaicin affect clinical therapeutic outcomes through their interaction with the P-gp 
transporter. 
 
Studies should also be designed to provide further understanding of the mechanisms of 
action of piperine and capsaicin in modulating the paracellular transport pathways. The 
observed enhancement in paracellular permeability associated with prolonged spice co-
incubation, as well as the immediate reversibility of paracellular permeability upon spice 
removal, are particularly intriguing. Experiments could be designed to study the effects of 
piperine and capsaicin on cellular signaling processes associated with the regulation of 
intercellular tight junctions to further elucidate the mechanism of action of the spices.  
 
The mechanisms by which the two spices interact with the P-gp efflux pump also warrant 
further investigation. Although the enhanced P-gp function in Caco-2 cells has been 
Chapter 8.    Proposed future studies 
 171
linked to increased gene transcription upon prolonged spice exposure, the results were 
not supported by the in vivo data. In addition, the mechanisms underlying the reduction in 
P-gp efflux activity upon acute exposure to piperine and capsaicin is not known, as the 
widely regarded PXR-mediated pathway could not be applied to the cell system used in 
this project. Therefore, further studies to correlate the triggering of specific cellular 
signals to the modulation of the P-gp transporter activity will be valuable.  
 
The P-gp is the drug transporter of focus in the present study because of its association 
with multidrug resistant phenotypes and its role in determining the pharmacokinetic 
profiles of many drugs. However, in consideration of the complicity of the human body, 
the influence of other transporters, such as the MRPs, on drug bioavailability and 
disposition should not be ignored. Metabolic enzymes that are located in the intestinal 
epithelia and hepatic cells, such as CYPs, are also enrolled in the drug absorption and 
excretion processes. The wide variety of drug transporters and metabolic enzymes in the 
human body should provide abundant scope for future in vitro and in vivo studies into 
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